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Abstract
Signals generated following stimulation of CD28 and the TCR synergize resulting in T 
cell proliferation, cytokine secretion and cell survival. Investigations of the mechanism 
by which CD28 costimulates the activation of a resting T cell have not identified an 
obligate effector responsible for all of the effects occurring subsequent to the ligation of 
CD28. The role of proximal signalling molecules in CD28 signalling was examined. 
In T cell models it was observed that lck and fyn but not ZAP70, in response to 
ligation of CD28 by CD80, increased the phosphorylation of CD28 and PI 3-kinase. 
Although fyn and lck are tyrosine kinases, changes in tyrosine phosphorylation levels 
were small compared to increases in the phosphorylation of tyrosine/ serine / threonine 
residues on CD28 and PI 3-kinase. This would suggest that fyn and lck facilitate the 
recruitment of additional molecules to CD28 and ligation of CD28 by CD80 lead to 
activation of an acidic sphingomyelinase activity. However neither sphingomyelinase, 
nor the products of sphingomyelin hydrolysis by sphingomyelinase, C2 ceramide and 
phosphocholine replaced CD80 as a costimulus for resting T cell proliferation . Indeed 
sphingomyelinase/ C2 ceramide inhibited costimulated T cell proliferation. The 
inhibition of proliferation caused by sphingomyelinase/ C2 ceramide was accompanied 
by a delay in the upregulation of surface expression of the activation markers CD69 
and CD25. This delay was dependent on the primary proliferative stimulus being 
aCD3 mAb rather than the PKC agonist, PMA. In contrast PMA, CD80-costimulated 
T cell proliferation was inhibited by C2 ceramide and this would suggest that C2 
ceramide has more than one mechanism of altering T cell responses. Analysis of a 
distal substrate of CD28, JNK, revealed that CD3, CD28 costimulation of resting T 
cells did not phosphorylate c-Jun, a substrate of the JNK family members, as markedly 
as PMA. Despite the ability of sphingomyelinase/ C2 ceramide to inhibit T cell 
proliferation, JNK activation was unaltered. It may be suggested that the inhibition of 
proliferation due to sphingomyelinase/ C2 ceramide in costimulated T cell cultures was 
not effected by inhibition of c-Jun phosphorylation, an event necessary for the 





1 The Immune System
The immune system comprises an innate and an adaptive component. The innate immune 
system defends the body by the use of skin, epithelial linings e.g. mucous and cilia, 
sneezing and swallowing which serve to keep matter not generated by host DNA, i.e. 
foreign matter, external from the body. Should the innate immune system be overcome or 
bypassed and foreign matter enters the body after crossing cellular membranes, an 
adaptive immune response may be generated. In this case the foreign matter is known as 
an antigen. Antigenic matter may also be generated within the body and differentiation 
between self and non-self antigens is an important part of the immune system (Clarke, 
1980).
1.01 Antigen Presentation
The adaptive immune system comprises a number of elements, some give it "memory" 
i.e. the ability to mount a quick reaction against recurrent infections, while other parts are 
involved in recognition of new antigens and clearance of these from the body. Thus a 
sophisticated array of cell types is necessary to implement the various functions of the 
immune system. In the humoral arm of the adaptive immune system, antigen circulating 
in the blood or lymphatic system is bound by antibodies (immunoglobulins) secreted by 
B cells. This is an antigen dependent step and ultimately leads to clearance of the bound 
antigen-antibody complex from the body. In a tissue based or cellular response, antigens 
are processed by a number of specialised cells known as antigen presenting cells (APCs) 
including B cells, dendritic cells and Langerhan cells (June et al., 1994; Damle et al.,
1992). These cells are positive for the human leukocyte antigen (HLA-DR, DQ, DP) 
alleles and serve to immobilise the antigen on the cell surface in a complex with a major 
histocompatibility (MHC) molecule. Antigenic proteins, phagocytosed by macrophage­
like cells, are degraded into smaller peptides. These are incorporated into the peptide 
binding grooves of MHC molecules and presented on the cell surface of the APC. The 
MHC-antigenic signal in combination with accessory signals from APCs provide the 
stimuli which T cells require to mount a functional immune response.
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1.02 The Role of T cells
T cells may be classified according to the expression of CD4 or CD8  glycoproteins on 
their cell surface membranes. Usually CD8  cytotoxic T lymphocytes (CTLs) recognise 
cytosolic or nuclear-derived antigen associated with MHC class I and eliminate virally 
infected cells or tumour cells. CD4 T helper (Th) cells respond to antigen associated with 
MHC class II and generate cytokine signals which stimulate a range of other immune 
responses (Germain and Marguiles, 1993). CD8  and CD4 bind invariant regions of their 
respective MHC molecules.
The delivery of antigen-APC signals to T cells induces the activation of the T cell, 
resulting in cytokine gene upregulation and secretion from the T cell. Human CD4+ T 
cells can be divided into four functional subsets Thp, ThO, Thl and Th2 according to their 
pattern of cytokine secretion. T helper precursors (Thp) are mainly limited to the 
production of interleukin (IL) 2. Activated Thp cells most likely differentiate initially into 
ThO-like cells producing IL2, IL4 and granulocyte/ macrophage-colony stimulating factor 
(GM-CSF), but not tumour necrosis factor (TNF)p or IL5. Subsequent maturation can 
lead to either, Thl like cells secreting IL2, interferon (EFN)'y, TNFp and GM-CSF or Th2 
like cells which produce IL4, IL5, IL10 and low levels of GM-CSF. Functionally the 
Thl phenotype is associated with cell-mediated immunity and Th2 with humoral 
responses (Semnani et al., 1994). IL2 is responsible for autocrine proliferation of the T 
cell involved in the antigen dependent activation event as well as induction of paracrine 
lymphocyte proliferation. Within a T cell there are regulatory elements to prevent the 
activation of the cell due to inappropriate antigen presentation, such as a requirement for a 
second costimulatory signal in addition to stimulation of the TCR. However sometimes 
these processes are ineffectual in discriminating between self and non-self antigens and 
autoimmune disorders arise. An understanding of the processes driving T cell activation 
and the biochemical pathways involved is essential if intervention therapies are to be 
applied in treatment of virulent pathogens or suppression of allograft rejection, both of 
which involve T cells (Clarke, 1980).
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An alternative classification of circulating T cells may also be made based upon their 
requirements for signals in order to mount an effective immune response. Resting T 
cells, characterised by being non-proliferative unless stimulated by a combination of 
antigenic-derived and accessory, or costimulatory, signals may be subdivided into naive 
and memory resting T cells. The naive population bear the surface phenotype CD45RA+ 
CD45RO- and the memory population the converse. It seems likely that both of these 
subpopulations arise from naive T cells and after encounter with antigen become 
CD45RO+ (Semnani et al., 1994). Thus naive T cells are classed as those which have 
not encountered antigen previously, while memory T cells have previously bound antigen 
but are no longer in an activated state. Both require stimulation additional to antigen to 
proliferate or become activated. A third type of T cell also exists which has encountered 
antigen and is deemed an antigen-activated T cell which requires minimal stimulation to 
cause proliferation (Damle et al., 1992).
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1.1 T cell Activation
An in vivo T cell immune response occurs following an antigen-induced clonotypic 
expansion of T cells in conjunction with accessory signals from APCs. The expansion 
of the antigen-responsive T cell clone is facilitated by the upregulation of IL2 gene 
expression in the clone and secretion resulting in clonal expansion. When coupled with 
expression of a range of cytokines from the activated T cell, other immune cells migrate 
to the area involved, become activated as well and perform their respective functions. T 
cell proliferation and activation frequently occur together. Activation, which may be 
regarded as an upregulation of cytokine gene expression (Granelli-Pipemo and Nolan, 
1991; Thompson et al., 1989), is concurrent with increased expression of the IL2 
receptor, CD25, and the early T cell activation marker CD69 (Semnani et al., 1994). 
However proliferation and activation are not indistinguishable responses in T cells. 
Proliferation to CD3 signals alone in activated T cells was not augmented by accessory 
signals and yet accessory signals did cause a 2 fold increase in RNA metabolism. In fact 
cytokine expression and secretion was upregulated over 50 fold with no marked effect on 
proliferation caused by the accessory signal (Thompson et al., 1989). Conversely 
proliferation of CD3 stimulated memory T cells was induced by some accessory signals 
without concomitant IL2 upregulation i.e. without activation of the T cell (Damle et al.,
1992).
1.11 Structure and Function of the T cell Receptor Complex
T cell activation is partially controlled in an antigen-dependent manner and a clonotypic
complex of molecules expressed on the surface of a T cell facilitates recognition of
antigen and passage of signals to the T cell nucleus, whereupon a range of genes is
upregulated resulting in an immune response. The T cell molecules involved in receiving
and transducing the MHC-antigenic signal are collectively known as the T cell receptor
complex (TCR). The TCR, a glycoprotein, comprises an antigen recognition heterodimer
which on 95% of peripheral T cells is composed of ocp chains. The a p  chains possess
variable (V), joining (J) and constant (C) regions with the p chain containing a diversity
domain (D) (Davis and Bjorkman, 1988). The V Ja and VDJp domains contain three
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hypervariable regions, one of which is proposed to interact with the antigen and the other 
two with the MHC molecule (Davis and Bjorkman, 1988). Gene rearrangement and 
recombination events of the several VDJ alleles generates a large TCR repertoire.
Autoreactive T cells recognise self antigen in the context of self MHC molecule and may 
be pathogenic. However clonal deletion of developing autoreactive T cells occurs in the 
thymus by a process which is poorly understood, although believed to be the primary 
mode of deleting autoreactive T cells before release of thymocytes to the peripheral 
circulatory system (Davis and Bjorkman, 1988). Following TCR a p  ligation by antigen- 
MHC molecules an associated complex of CD3 and the C, family of dimers are 
responsible for transducing the APC derived stimulus into the T cell. CD3 comprises y, 
8  and e chains while the £ dimers are ££, £rj or £y (Irving and Weiss, 1991) (fig. 1.1).
1.12 TCR Proximal Signalling Events
An early event after TCR ligation either by antigen or antibodies against the TCR, is the
tyrosine phosphorylation of certain proteins in the T cell. This response is rapid (within
30 seconds) and short in duration, although alone does not activate the T cell per se
(August et al., 1994; Harlan et al., 1995; Lu et al., 1994; Mustelin, 1994; Robey and
Allison, 1995). Unlike many other receptors involved in cellular proliferation, the TCR
has no intrinsic kinase activity in any of its subunits. Thus it must recruit various kinases
to its cytoplasmic domains. Tyrosine motifs serve as substrates for cytosolic protein
tyrosine kinases (PTKs) such as those of the sre and syk families. Members of these
kinase families reported to associate with the TCR include p59fyn and p56lck for the sre
PTKs and syk and p70ZAP kinase (ZAP70) for the syk PTKs (Mustelin, 1994). The
involvement of these kinases revolves around a conserved amino acid sequence, the
intracellular T cell activation motif (ITAM), YXX(L/I)X7 _gYXX(L/I) where X is any
amino acid, found in three copies on £ chains and one copy on each of the CD3 subunits.
Two isoforms of fyn exist which are the products of mutually exclusive splicing of
alternate seventh exons (Appleby et al., 1992). Transcripts utilizing exon 7B accumulate
primarily with the T lymphocyte population and exon 7A transcripts are localized in other
tissues, particularly the brain. Respectively these isoforms are referred to as p59fynT and
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p5 9 fynB (Appleby et al., 1992). In this study reference is only made to p59fynT (fyn). 
The involvement of fyn in T cell signalling appears to be stage specific. Interestingly 
while thymocytes from fyn null mice show reduced proliferation, splenocytes reaquire a 
proliferative response to stimulation of CD3 and PMA (Appleby et al., 1992). This 
would imply that the significance of fyn in T cell signalling is decreased as T cells 
mature. In patients with an autosomal recessive form of severe combined 
immunodeficiency disease, a double mutation in the kinase domain of ZAP70 was 
discovered. These mutations were absent from normal siblings and disease free parents. 
The effect of mutated ZAP70 kinase on T cell function following TCR ligation was a 
decrease in cellular tyrosine phosphorylation and calcium mobilization (Chan et al., 
1994). Therefore it may be suggested that ZAP70 contributes to TCR signalling and T 
cell function.
The order of PTK recruitment to the TCR is not defined and may indeed vary depending 
upon the type of stimulation and intracellular environment. While syk associates 
constitutively with CD3 i.e. in an activation independent fashion, lck and fyn are brought 
into association following ligation of the TCR. Fyn associates with CD3 while lck 
associates with CD4 (a transmembrane protein which stabilises TCR-MHC class II- 
antigen interactions). Both lck and fyn are believed to phosphorylate ITAMs. Following 
the dual tyrosine phosphorylation of the IT AM, ZAP70 associates with the TCR (Rudd 
et al., 1994; Hatada et al., 1995; Straus and Weiss, 1993). Subsequently it activates 
phospholipase Cyl (PLCyl) which catalyzes the conversion of P l4 ?5 P 2  to inositol 
triphosphate (IP3 ) and diacylglycerol (DAG). These products are second messengers 
involved in raising intracellular calcium levels and protein kinase C (PKC) activation 
(Vance and Vance, 1991). Both of these events ultimately result in induction of 
transcription factors such as the nuclear factor of activated T cells (NFAT), c-Fos and c- 









Fig. 1.1: Proxim al Signals Associated with TCR Ligation
Encounter with an APC bearing antigen, which can be recognised by the TCR, elicits 
activation of a number of proximal signalling molecules facilitating T cell activation and 
proliferation.
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1.13 Structure, Function and Regulation of Cytosolic PTKs
A sre kinase has two sites which may be phosphorylated. The carboxyl terminal site is 
negatively regulated by another tyrosine kinase p50csk (csk) (Nada et al., 1993; 
McFarland et al., 1992) and when these kinases are associated with the TCR, positive 
regulation arises from the action of a transmembrane protein tyrosine phosphatase, CD45. 
While sre PTKs are inhibited by csk, CD45 becomes activated by a csk-induced 
phosphorylation of two tyrosine residues (Nada et al., 1993). Dephosphorylation of the 
regulatory C terminal tyrosine residue (Autero et al., 1994) of a sre family PTK by CD45 
is proposed to release an intramolecular binding of the upstream SH2 domain of the sre 
family PTK, leaving the kinase motif available for activation (Mustelin, 1994) (fig. 1.2). 
However what phosphorylates and activates this kinase motif is unknown, even in the 
much studied TCR signalling cascade.
The mechanism(s) by which PTKs are recruited to the TCR is unclear, although in sre 
family PTKs a unique amino acid (N)-terminal moiety, myristate (myr)-Gly-X-X-X- 
Ser/Thr/Cys is believed to play a role in association of the PTK with substrates and 
determining specificity of the PTK (Resh, 1994). During translation of a sre PTK, an 
amino terminal initiator methionine residue is removed by methionine aminopeptidase and 
glycine becomes the first amino acid in the sequence. A covalent bond between the N 
terminal glycine and a myristate fatty acid catalyzed by N-myristyl transferase is stable for 
the half-life of the polypeptide i.e. is essentially irreversible (Resh, 1994). The myristyl 
moiety present in sre kinases, is absent in ZAP70, and dependent on the absence of other 
suitable hydrophobic sites, may prevent ZAP70 from membrane localization. As ZAP70 
is involved in TCR signalling (Straus and Weiss, 1993), it is evident that a myristate 
residue is not an obligate requirement for all proximal signalling molecules.
The N terminal sequences of sre family PTKs may supply specificity in kinase 
interactions with substrates and how they dock with other proteins.
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3 6  9 12 15
Fyn has the sequence: myr G C V Q C K D K E A T  K  L T  F
and lck has the sequence: myr G C V C S S  N P  E D D W M E N
The plasma membrane inner leaflet comprises some 30% negatively charged lipids, head 
groups extending to the hydrophilic cytosol, which are mainly phosphatidylserine and 
phosphatidylinositols. Thus a possibility exists that polybasic residues on molecules 
associating with the plasma membrane may stabilize their localization. For example fyn 
has three lysine (K) residues (indicated in bold type) which may fulfil this role and likely 
would have an electrostatic interaction with negatively charged head groups of membrane 
lipids. Lck lacks these and so other mechanisms to stabilize anchorage of lck may 
operate. For example dual acylation of cysteine residues (indicated in bold type) with the 
16 carbon fatty acid palmitate has been demonstrated (Shenoy-Scaria et al., 1993; Paige et 
al., 1993) on lck and fyn while many a  subunits of G proteins which are also recruited to 
the membrane share the sequence myrGC with 7 of 9 sre family PTKs which have this 
sequence (Resh, 1994). Palmityl thioesterases can cleave the thioester bond between 
cysteine and palmitate (Camp and Hofmann, 1993) providing a mechanism by which the 
stability of anchorage of lck or fyn may be undermined allowing the PTKs to interact with 



























TCR£/ CD3 and 
associates with 
CD28
Fig. 1.2: S tructure  of the src fam ily Protein  Tyrosine K inases
Structure of src family PTKs, p56lck and p59fyn. The N-terminus (70-80) residues 
contains largely unique residues except for the myristate (M) moiety. Lck interacts with 
CD4 and CD8 within 10-30 residues of the N terminus. The interaction of fyn with CD3 
and £ is mediated by the first 10 residues. The N terminus is followed by an SH3 and 
SH2 domain with moderate homology between src family PTKs. The highly conserved 
kinase domain possesses an autophosphorylation site at tyrosine (Y) 394 for lck and 420 
for fyn, and an ATP binding lysine, K residue. The C terminus possesses a negative 
regulatory site (Y505 for lck and Y531 for fyn) (Rudd et al., 1994).
12
1.2 Costimulatory Effects of CD2, CD28 and LFA-1
A number of other molecules which play a role in T cell activation have been identified. 
The receptors CD2, CD28 and LFA-1 (CD 11a/ CD 18) which are expressed on T cells 
may bind, respectively, the ligands LFA-3 (CD58), B7s (CD80 or CD 8 6 ) and ICAM-1 
(CD54). LFA-3, B7s and ICAM-1 are expressed on APCs (Parra et al., 1993). With at 
least three pairs of ligand-receptor interactions sufficient to costimulate T cells, a 
possibility of functional redundancy exists. However each interaction has distinct effects 
on T cell activation and proliferation. Studies comparing the effects of ICAM-1, LFA-3 
or CD80 (and aC D 28 mAb 9.3) revealed differential responses from aC D 3 mAb 
stimulated T cells in the presence of these ligands (Semnani et al., 1994; Damle et al., 
1992; Sansom et al., 1993).
1.21 ICAM-1
ICAM-1, which may ligate the T cell receptor LFA-1, costimulated naive T cell 
proliferation and IL2 production (Semnani et al., 1994). Repeated costimulation of 
separate populations of either naive or memory T cells lead to the production of GM-CSF 
and IFNy and greater levels of these cytokines were recorded after the primary 
stimulation (Semnani et al., 1994).
1.22 LFA-3
LFA-3, the ligand for CD2, also costimulated memory T cell proliferation, secretion of 
EL2 and IFNy and upon further stimulation IL5 production was induced. However LFA- 
3 could not costimulate naive T cell proliferation, and its mode of action appeared to be 
dependent on a close association with the TCR (Semnani et al., 1994; Sansom et al.,
1993).
1.23 CD80 and CD86
CD80 and CD 8 6  are ligands of the B7 family, expressed on APCs, which bind CD28.
The B7s and CD28 are members of the larger immunoglobulin superfamily. CD80 (B7
or B7-1) is a 44-54 kDa glycoprotein while CD8 6  (B70 or B7-2) (Allison, 1994) is a 70
13
kDa glycoprotein, expressed on activated B cells, dendritic cells and monocytes (Harlan 
et al., 1995; Umlauf et al., 1993), although CD8 6  is also detectable on freshly isolated 
monocytes (Azuma et al., 1993). Furthermore CD 8 6  surface expression is rapidly 
elevated after activation of APCs and may perhaps be the primary ligand for CD28. In 
addition a 3 to 4 fold greater affinity between CD80 and CTLA4 over that of CD8 6  and 
CTLA4 has been demonstrated (Greene et al., 1996). Due to the correlation in the pattern 
of expression between CD 8 6  and CD28 compared to CD80 and CTLA4 surface 
expression, it might be expected that there is a mutually exclusive functional relationship 
between these pairs of ligands and receptors. However in the experiments of Kuchroo et 
al (Kuchroo et al., 1995) it was noted that costimulation of murine T cells by CD80 or 
CD8 6  lead to the induction of a Thl or a Th2 cytokine profile respectively, therefore both 
ligands are capable of activating T cell responses from activated T cells. In this study the 
ligands are referred to as either CD80 or CD8 6 , unless there was ambiguity in a report as 
to which member of the B7 family was involved whereby the generic term B7 was 
employed. In addition in some figures e.g. figs 4.4b and 4.5 the term B7 refers to 
CD80.
1.24 CD28 and CTLA4
CD28 is a member of the immunoglobulin superfamily expressed on 95 % of CD4 T cells 
and 50% of CD 8  T cells (Lu et al., 1992). As a monomer it has a predicted molecular 
weight of 23 kDa but after glycosylation migrates under reducing conditions at 44 kDa. 
It exists as a homodimer and is a transmembrane receptor for CD80 and CD8 6  (Aruffo 
and Seed, 1987). CD28 binds both ligands with comparable affinity (Greene et al., 1996) 
although CD 8 6  shows upregulated surface expression before CD80 and therefore CD8 6  
would initially interact with CD28 (June et al., 1994).
A homologue of CD28, the cytotoxic T lymphocyte antigen-4 (CTLA4) has upregulated
expression on activated T cells (Walunas et al., 1994) in parallel to the expression of
CD80 on activated APCs (June et al., 1994). In mice lacking CTLA4, fatal
lym phoproliferative disorders arise rapidly including m ultiorgan lymphocytic
proliferation and tissue destruction by 3-4 weeks of age (Tivol et al., 1995). Therefore
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CTLA4 appears to have a regulatory role in T cell biology. Accordingly a CTLA4Ig
fusion protein has been used to prevent B7-CD28 interaction, inducing the prolonged
acceptance of murine skin and cardiac allografts (Lakkis et al., 1997; Larsen et al.,
1996). CTLA4 is generally believed to limit the effect of CD28 in costimulation, either
through competition for B7 ligands or induction of anti-proliferative pathways (Harlan et
al., 1995; Robey and Allison, 1995; Stein et al., 1994; Schneider et al., 1995b; Walunas
et al., 1994). For example CTLA4 is capable of delivering negative regulatory signals to
costimulated T cells resulting in reduced or delayed cell cycling and lowered CD25 (IL2
receptor) and CD69 expression (Krummel and Allison, 1996) as well as decreased IL2
secretion from T cells (Krummel and Allison, 1996; Walunas et al., 1996). CTLA4 has
the ability to bind CD80 with twenty fold higher affinity than CD28 (Linsley et al., 1991)
but unlike CD28, which is expressed on resting and activated T cells, CTLA4 surface
expression is restricted to activated T cells (Walunas et al., 1994) and is mainly localized
intracellularly (Leung et al., 1995). On the cytoplasmic domain of CTLA4 an
intracellular localization motif was initially identified as T 16lTGVYVKMPPT (Leung et
al., 1995) and later Y 1 6 5  was found to be responsible for associating with the |x2 subunit
of the plasma membrane-associated adapter complex AP2 causing internalisation of
CTLA4 (Shiratori et al., 1997). Interestingly CTLA4 only associated with AP2 when
Y 1 6 5  was unphosphorylated. By contrast the PTPase Syp associates with CTLA4 when
Y 1 6 5  is phosphorylated (Marengere et al., 1996) and Syp also demonstrated PTPase
activity against the src homology and collagen adapter protein, p52SHC (Marengere et al.,
1996). These studies support the possibility that CTLA4 may negatively regulate T cell
activation by dissociating SHC from complexes of GRB2 and Sos, thereby preventing
Ras activation following TCR ligation (Marengere et al., 1996). Therefore CTLA4
function is controlled by the tyrosine phosphorylation of Y 1 6 5  whereby in its
unphopshorylated form, CTLA4 associates with AP2, is internalized and is therefore
incapable of interacting with its ligands CD80 and CD 8 6 . By contrast when
phosphorylated, Y 1 6 5  associates with Syp, a PTPase which may inhibit TCR-derived
Ras and MAPK pathway activation. A question remaining to be answered is what is the
identity of the kinase(s) which phosphorylate Y 1 6 5  , a residue which is critical to CTLA4
function. By contrast CD28 is mainly expressed on the T cell surface although it
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undergoes a transient downregulation following ligation at an mRNA level by 4 hours 
and surface expression from 12 to 24 hours (Linsley et al., 1993).
1.25 Functional Effects of CD28 Stimulation
CD28 although expressed on T cells appears to contribute to B cell activation as well.
For example CD28_/_ mice had depressed levels of serum immunoglobulin in addition to
the reduced proliferation of, and IL2 production from, splenocytes (Shahanian et al.,
1993). Therefore while CD28 costimulates T cell activation, it may also stimulate B cell
activation. This may be mediated by the interaction of CD28 with CD 8 6  which has a
relatively longer cytoplasmic domain compared to CD80, presenting a greater opportunity
for expression of localization motifs. Indeed three PKC phosphorylation sites are
expressed on the cytoplasmic domain of CD 8 6  (June et al., 1994) which possibly
contribute to activation of immunoglobulin gene promoters in B cells. The role of CD28
in regulating T cell activation revealed that antibody ligation of CD28 in combination with
TCR or TCR-like signals resulted in the production of a range of cytokines including
IL2, IFNy, TN Fa, lymphotoxin (LT) and GM-CSF from T cells (Thompson et al.,
1989) and therefore CD28 may modulate cell cycle progression through IL2, lysis of
tumour cells through T N F a and LT, anti-viral and anti-tumour responses of T cells
through IFNy and multilineage haematopoiesis through GM-CSF (Thompson et al.,
1989). The experiment also demonstrated a dichotomy between proliferation and
activation of T cells. While resting T cells require costimulation in order to proliferate
and become activated i.e. upregulate cytokine expression, the cells in the above study
were likely to be a mixture of resting and antigen-primed T cells, due to T cell
proliferation and cytokine secretion to aCD3 signals alone. A separation of proliferation
from cellular activation was apparent in that although CD28 did not increase levels of 3H
thymidine incorporation into DNA (which increases as cells proliferate), it doubled the
levels of labelled uridine incorporated into RNA in the T cell culture. Therefore CD28
stimulated gene expression, not DNA replication, in activated T cells. The study
mentions that the effect of CD28 on proliferation per se may only be seen with
suboptimal stimulation of CD3. However the effect of CD28 on gene activation was not
dependent on suboptimal CD3 signals. Therefore CD28 showed capability to augment T
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cell responses in resting and activated T cells as it costimulated proliferation and 
activation of resting T cells (Damle et al., 1992) and augmented RNA synthesis in 
activated T cells (Thompson et al., 1989).
An effective immune response in vivo requires more than a single type of costimulatory 
interaction. The binding of ICAM-1 to LFA-1 appears to have the capability of causing 
Thp cells to become activated and differentiate to firstly ThO cells and later T hl and to 
cause activation of naive T cells which neither CD28 nor CD2 derived costimulations 
were capable of in the studies discussed above (Semnani et al., 1994; Damle et al.,
1992). However CD28 and CD2 were able to transduce activation signals to resting 
memory cells and it has been proposed that the regulatory and effector functions of T 
cells are mainly carried out by memory T cells (Sanders et al., 1988) in which case CD28 
and/  or CD2 may be more significant players in T cell responses. Accordingly signals 
transduced through CD28, more than other costimulatory receptors, resulted in very high 
IL2 production, IL2 receptor expression and proliferation of memory T cells (Damle et 
al., 1992) illustrating the key role of CD28 in coordinating T cell responses in an immune 
response. An apparent similarity in responses of CD28 and CD2 after interaction with 
their respective ligands may be explained by the differences in subsequent cytokine 
profiles to which each contributes. In the study of Thompson which ligated CD28 
through the use of aCD28 mAb, a Thl range of cytokines (IL2, IFNy, TN Fa, LT and 
GM-CSF) were produced (Thompson et al., 1989), whereas for CD2 the converse was 
found. That is CD2 transduced signals leading to production of Th2-type cytokines e.g. 
IL5, and low levels of GM-CSF (Semnani et al., 1994; Damle et al., 1992). However a 
separate study indicated that secretion of the Thl cytokine IFNy was independent from 
CD28 ligation and that a Th2 cytokine response was depressed in the absence of CD28 -/- 
mice (Rulifson et al., 1997). It would appear from these data and that of Kuchroo 
(Kuchroo et al., 1995), i.e. that CD80 and CD8 6  induce respectively T h l/ Th2 
responses, that CD28 is capable of stimulating both responses.
CD28 also has other functions which control the fate of the cell upon which it is
expressed. Ligation of the TCR on a resting T cell by antigen or antibody in the absence
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of accessory signals normally supplied by an APC does not cause cellular activation or 
proliferation. In fact the cell becomes hyporesponsive i.e. anergized to subsequent 
combinations of antigenic and accessory signals (Schwartz, 1993). While CD28 may 
prevent anergy, stimulation of CD2 by LFA-3 cannot (Sansom et al., 1993). The effects 
of stimulating the TCR/ CD3 and/ or CD28 are summarized in figure 1.3 and the 
prevention of anergy may be facilitated by the differential association of fyn, lck and 
ZAP70 with the TCR (Boussiotis et al., 1996). Antigenic stimulation of CD4+ve T cell 
clones resulted in their anergy, tyrosine phosphorylation of TCR^ and association of 
TCR£ with fyn. By contrast costimulation of these cells resulted in the tyrosine 
phosphorylation of TCR£ and CD3e and their association with lck and later ZAP70, but 
not fyn (Boussiotis et al., 1996). Therefore it may be possible that B7 stimulation of 
CD28 leads to signals preventing anergy by inducing differential association of PTKs 
with the TCR, although ligation by CD80 or CD 8 6  induced comparable tyrosine 
phosphorylation profiles (Boussiotis et al., 1996).
T cell survival is also regulated by CD28. T cells are uniquely capable of undergoing a 
form of programmed cell death (apoptosis) known as activation induced cell death 
(AICD) which occurs as a result of repeated antigenic stimulation (Van Parijs et al., 
1996). This occurs following coexpression of Fas (CD95) and the Fas ligand (FasL). 
FasL expression on T cells (Lynch et al., 1995; Anel et al., 1994) leads to AICD 
following stimulation of Fas which can be prevented by CD28-mediated signals (Van 
Parijs et al., 1996). The anti-apoptotic function of CD28 is likely due to its upregulation 
of survival factors such as bcl-XL (Boise et al., 1995; Mueller et al., 1996) or possibly 
components of the transcription factor NFkB, c-Rel and Rel A, which were reported to 
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Fig. 1.3: Potential Outcomes of the In teraction between APCs and T cells
Individual APCs may supply antigen (ag) bound to MHC and / or CD80 (B7) or CD86 
(B70) ligand. Encounter with resting T cells expressing TCR and B7 receptor, CD28 
results in a) clonal expansion b) anergy or apoptosis c) no proliferative or anti­
proliferative effect; depending on signals from the APC.
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1.3 Biochemical Signalling through CD28
Unlike TCR derived pathways, very little is known about CD28 dependent events 
although it is accepted as a costimulatory molecule necessary and sufficient to induce IL2 
gene expression when combined with TCR derived signals. However, there is no 
consensus view on how CD28 acts to costimulate a T cell, although a number of 
observations have been reported which may lead to the description of definitive 
pathway(s) arising from the activation of CD28, which combine with TCR pathways to 
activate T cells. Whether or not CD28 acts to synergize with the TCR or merely to 
amplify its signals is debatable, as they share a number of down stream signalling 
elements. For example, ligation of CD28 by aCD28 mAbs activated PLCyl, with 
neither TCR ligation nor secondary crosslinking of CD28, leading to a rise in intracellular 
calcium levels (Nunes et al., 1993). On the other hand CD80 ligation of CD28 does not 
increase intracellular calcium or DAG levels (Ward et al., 1993). Consistent with 
characteristics of CD28 derived pathways, rather than TCR/ CD3 derived proximal 
effects, was the slower rate of PLCyl activation compared to its activation through CD3 
(Nunes et al., 1993). CD3 ligation activated PLCyl maximally by -3 0  seconds, while 
CD28 ligation took maximal effect after 60-120 seconds (Nunes et al., 1993). Thus, if 
under conditions of high aggregation CD28 does activate PLCyl, it may be for the 
purposes of prolonging calcium-dependent pathways. However, the observation that 
CD28 could signal through calcium independent pathways was noted upon the treatment 
of the cells with the calcineurin inhibitor, cyclosporin A (CsA) whereby CD28 could still 
activate JNK (Su et al., 1994), NFkB (Lai and Tan, 1994) and p70S6 kinase (S6 K) (Pai et 
al., 1994) independent from the TCR.
TCR derived signals are sensitive to CsA due to inhibition of the phosphatase calcineurin
which when activated dephosphorylates the cytoplasmic form of NFAT, an event
required for nuclear entry of NFAT (Liu, 1993). Due to the CsA-sensitivity of TCR-
derived NFAT nuclear translocation and T cell activation (Su et al., 1994; Lai and Tan,
1994; Pages et al., 1994; Kunz et al., 1993; Liu, 1993; Pai et al., 1994) and the
insensitivity of phorbol 12-myristate 13-acetate (PMA) and CD28-stimulated IL2
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secretion, it would appear that the target for CsA lies in the TCR pathway upstream of 
PKC (Kanoh et al., 1990; Linsley et al., 1991). This would indicate that while CD28 
may share some of the same signalling elements as the TCR, it also has distinct effectors 
which are insensitive to inhibitors which affect TCR activated pathways.
The TCR and CD28 share a number of substrates which would be compatible with the 
coordinate induction of IL2 expression. Distally JNK (Su et al., 1994) and S6 K (Pai et 
al., 1994) may be activated by both receptors. Proximally, the src family PTKs fyn and 
lck (Raab et al., 1995; Harlan et al., 1995; Mustelin, 1994; Boussiotis et al., 1996), Vav 
and Ras (Nunes et al., 1994), PLCyl (Nunes et al., 1993) and PI3K (Rudd et al., 1994) 
are associated with both receptors either functionally or physically. Two interpretations 
regarding the costimulatory role of CD28 are possible: either CD28 serves to amplify 
TCR derived signals to a threshold below which T cells would not display a response or 
different pathways activated through CD28 synergize with TCR derived signals to 
upregulate IL2 production (fig. 1.4). Both TCR and CD28 derived pathways contribute 
to PI3K activation and show additive activation of PI3K when both receptors are 
stimulated (Ward et al., 1993), although in another report it was suggested that the TCR 
did not activate PI3K and that the activation of PI3K was independent of PTKs e.g. fyn 
which were responsible for TCR proximal signalling events (Ward et al., 1992). The 
function of PI3K in CD28 signalling may be related to its homology with the yeast 
protein target of rapamycin (TOR) which is involved in sorting vacuolar and lysosomal 
proteins and G1 to S phase progression, the latter of which is induced in T cells by IL2 
(Kunz et al., 1993). As discussed below (see section 1.5) acidic sphingomyelinase 
(ASMase), an enzyme involved in generating the potent second messenger ceramide, is 
localised in lysosomes. Therefore if yeast TOR and human PI3K have related function, 
CD28 may be able to modulate sphingolipid availability at a proximal stage through 
activation of PI3K. There are CD28 pathways which are distinct from the TCR, such as 
activation of ASMase (Boucher et al., 1995), a rapamycin-sensitive activation of S6 K, 
CsA insensitive IL2 production (Price et al., 1992; Kunz et al., 1993) and the tyrosine 
phosphorylation of distinct substrates (Hutchcroft and Bierer, 1994). Ligated CD28
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Fig. 1.4: CD28 Signalling Pathw ays
CD28 is involved in many pathways and is necessary for full T cell activation. It 
induces a number of transcription factors which cause the upregulation of IL2, a cytokine 
with pleiotropic paracrine and autocrine effects. ?, proposed activation pathways; dashed 
arrows, multiple step pathways; solid arrows, cited direct association and/ or activation 
within pathways; pro-IL-2, IL-2 promoter.
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It has not been determined whether the regulation of TCR/ CD28-shared substrates or the 
modulation of CD28-specific effectors has the greater contribution to CD28 costimulatory 
effects.
1.31 The Cytoplasmic Domain of CD28
The intracellular domain of CD28 is 40 amino acids long and in single letter coding reads: 
180 190 200 210 220
I I I I I
RSKRSRLLHSDYMNMTPRRPGPTRKHYOPYAPPRDFAAYRS
Putative SH2 docking sites are indicated in heavy type and putative PKC phosphorylation 
sites are underlined. The cytoplasmic domain of CD28 bears the amino acid sequence 
YMNM (residues 191-194) which when tyrosine phosphorylated matches the reported 
consensus sequence requirement for binding p85, the regulatory subunit of PI3K. Like 
the binding of ZAP70 to IT AMs (Hatada et al., 1995), this occurs through SH2 domains, 
although the SH2 domains of p85 have the preferred sequence pY(M/V/I/E)XM where X 
is any amino acid (Songyang et al., 1993). Between ligation of CD28 and recruitment of 
PI3K, the SH2 binding site of CD28 must be tyrosine phosphorylated (Lu et al., 1994; 
Ueda et al., 1995; Stein et al., 1994; Raab et al., 1995; Ward et al., 1995; Prasad et al., 
1994; Pages et al., 1994; August and Dupont, 1994b). As CD28 has no intrinsic kinase 
activity, a cytosolic or membrane associated kinase must perform this function. The 
identity of such kinase(s) phosphorylating CD28 following ligation remains unknown 
although the necessity of src family kinases in CD28 derived costimulatory pathways has 
been suggested through the reputedly selective src kinase inhibitor, herbimycin A 
(Vandenberghe et al., 1992). The proximal role of PTKs in TCR signalling and the 
involvement of PTKs in CD28 signalling was suggested by the ability of PMA (a DAG 
mimic and thus PKC activator) and ionomycin (a calcium ionophore) to increase IL2 
expression and secretion in a herbimycin A-insensitive manner. However cells treated 
with PMA after CD28 crosslinking showed a decrease in IL2 production and a 100 kDa 
substrate was no longer tyrosine phosphorylated after the addition of herbimycin A
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(Vandenberghe et al., 1992). Herbimycin A markedly inhibits CD28-PI3K association 
(Lu et al., 1994) indicating a significant role for src family kinases in the CD28 
transduction pathway. However, PI3K recruitment to CD28 was not completely 
inhibited and one group reported that herbimycin A had no effect on CD28 signalling 
(Stein et al., 1994), although neither their data nor analysis parameters were discussed. 
Thus the necessity of PTKs in CD28 signalling remains contentious.
Another tyrosine kinase p72itk/EMT, a member of the Tec family of PTKs, associates
with CD28 (King et al., 1997) becoming activated after CD28 ligation (King et al., 1997;
Gibson et al., 1998). Tec PTKs possess an extensive amino terminus, an SH2, SH3 and
kinase domain although they lack the negative regulatory tyrosine residue common to src
PTKs (August et al., 1994). The SH2 and SH3 domains likely provide a mechanism by
which itk associates itself with CD28 and so becomes activated. Peptides representing
the diproline motifs on the cytoplasmic tail of CD28 when mutated P196A or P208A
revealed a greater reliance on the amino terminus proline P I96 in order to activate itk
(Marengere et al., 1997). Studies on itk activation through SH2 interactions are less clear
whereby one study which demonstrated a partial reliance on Y191 to activate itk also
demonstrated in the same study that mutation of all four tyrosine residues on the
cytoplasmic tail of CD28 augmented itk activation above control wild type levels of
activation (King et al., 1997). A separate study also indicated Y191 contributed to itk
activation, although in contrast to the previous report (King et al., 1997), mutation of
four tyrosine residues ablated itk activation (Gibson et al., 1998) possibly due to the use
of Jurkats transfected with murine CD28 rather than a chimaeric protein composed of
CD 8  extracellular and transmembrane domains coupled to CD28 intracellular domain in
the study of King (King et al., 1997). Similarly contradictory data exists on the direct or
indirect nature of itk activation following CD28 ligation. In one report a direct activation
of itk by CD28 was suggested by the rapidity of itk activation following CD28 ligation
and because itk was activated without CD28 crosslinking and preceded lck activation
(August et al., 1994). Other reports indicated that itk could not phosphorylate CD28 in
the absence of lck (Raab et al., 1995; Gibson et al., 1996) nor was it activated in an lck
-ve cell line, JCaM l (Gibson et al., 1998). An SH3 mediated interaction between itk and
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src PTKs may be suggested as it has been found that a proline rich m otif on itk, 
KKPLPPTPED, associates with the SH3 domain of fyn (Cheng et al., 1994). While the 
mechanism by which itk is activated remains to be firmly established, itk has been 
demonstrated to phosphorylate all four tyrosine residues on the intracellular domain of 
CD28 while lck appeared to phosphorylate only Y191 (King et al., 1997). Furthermore 
the role of itk in T cell biology may be one of negative regulation because a three fold 
increase in proliferation of CD3, CD28 stimulated murine itk-/_ T cells was observed over 
murine itk+/_ T cells (Liao et al., 1997).
Interestingly, CTLA4 , the CD28 homologue, also has the consensus motif for binding 
p85, although the particular sequence is YVKM (June et al., 1994). There are conflicting 
data on whether this sequence on CTLA4 , when phosphorylated can recruit PI3K in a T 
cell. In one report which details an association between CTLA4 and PI3K there was 
unfortunately no comparison against CD28 (Schneider et al., 1995b), although the 
production of D-3 lipids associated with CTLA4 immunoprecipitates compared to p85 
immunoprecipitates was small in comparison to the level of D-3 phospholipids associated 
with CD28 observed in other studies (Pages et al., 1996; Stein et al., 1994; Ward et al., 
1995). In another study, contrary to the results of Schneider, chimaeric constructs 
comparing the contribution of CD28 and CTLA4 cytoplasmic domains in the stimulation 
of IL2 secretion, revealed that CD28 but not CTLA4, bound and activated PI3K and 
stimulated IL2 gene expression (Stein et al., 1994). Therefore it appears likely that PI3K 
has a more significant role in CD28 signalling rather than that of CTLA4.
The intracellular domain of CD28 has three possible phosphorylation sites for PKC, 
namely the sequences SKR, TPR and TRK. Studies on the effect of PMA on the 
phosphorylation states of CD28 revealed that PMA stimulation of Jurkat T cells lead to 
threonine phosphorylation of CD28 and aCD28 mAb ligation of CD28 lead to tyrosine 
phosphorylation (Hutchcroft et al., 1996) and that PMA and CD28 signals together 
decreased the level of tyrosine phosphorylation observed (Hutchcroft et al., 1996). 
However the large increase in tyrosine phosphorylation observed may have been an
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artefact of antibody ligation because CD80 stim ulation of CD28 increased 
phosphorylation of tyrosine residues marginally and serine or threonine residues much 
more (Parry et al., 1997). Significantly PMA stimulation of Jurkats in conjunction with 
CD80 stimulation of CD28 decreased both the recruitment and activation of PI3K, a 
signalling molecule believed to be important in cell growth (Parry et al., 1997). 
Inhibition of PKC or PI3K using the inhibitors Ro-31 and wortmannin respectively did 
not affect the CD80-induced phosphorylation of CD28 (Parry et al., 1997) suggesting 
other kinases are involved in phosphorylation of CD28.
1.32 Phosphatidylinositol 3-Kinase; a Key Effector in CD28 Signalling
Phosphatidylinositol 3-kinase (PI3K) is a lipid kinase which phosphorylates 
phospholipids on the D3 position of the inositol ring resulting in the generation of 
phosphatidylinositol 3 phosphate (PI3 P), phosphatidylinositol 3 ,4  bisphosphate (Pl3 ,4 P2 ) 
and phosphatidylinositol 3 ,4 ,5  trisphosphate (Pl3 ,4 ,5 P 3 ). The function of these are not 
known although the physical association of PI3K and CD28 has been the subject of 
intense scrutiny. Various groups have shown an association between the cytoplasmic 
domain of CD28 and PI3K (Lu et al., 1994; Ueda et al., 1995; Stein et al., 1994; Raab et 
al., 1995; Ward et al., 1995; Prasad et al., 1994; Pages et al., 1994; August and Dupont, 
1994b) leading to PI3K activation and D3-phospholipids are believed to be important 
second messengers (Ueda et al., 1995).
PI3K may be activated in vitro by a tyrosine phosphorylated peptide derived from the
platelet derived growth factor receptor (PDGFR)(3 SH2 docking domain and other
molecules involved in proliferation of cells (see table 1.1) (Rudd et al., 1994; June et al.,
1994). The interaction between PI3K and receptors is based upon p85, the regulatory
subunit of PI3K. p85 has two SH2 domains which when bound to the tyrosine
phosphorylated sequences on a receptor are predicted to form a coiled coil between the
SH2 motifs, necessary and sufficient for the interaction of p85 with p i 10, the catalytic
subunit of PI3K (Hatada et al., 1995). The domain between the two SH2 sites, as
suggested for ZAP70 (Hatada et al., 1995), might also interact with tyrosine kinases e.g.
lck and fyn. Therefore PTKs may facilitate the activation of PI3K by tyrosine
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phosphorylation of the SH2 binding sites of p85 and/ or interacting with the domain 
between the SH2 regions. In fact PDGFR, EGFR (epidermal growth factor receptor), 
TCR, IL-2R, IL-4R and IL-7R (interleukin-2, -4 and -7 receptors) when ligated can 
activate PI3K to varying degrees (Rudd et al., 1994; June et al., 1994). As so many 
growth factor receptors recruit and activate PI3K, a role for PI3K in proliferation would 
seem likely after recruitment to CD28. However the effects of PI3K activation depend 
upon the cell type analyzed as demonstrated by the fungal metabolite, wortmannin, a 










Table 1.1: The Consensus SH2 Binding Sequence of PI3K Is Shared by
Many Receptors
PDGFRp, platelet derived growth factor receptor P chain; CSF-1, colony stimulating 
factor -1; MT middle T antigen; IRS-1, insulin receptor substrate -1; IL-7R, interleukin-7 
receptor; CTLA4, cytotoxic T cell associated antigen-4.
The irreversible binding of wortmannin to the ATP binding site on the catalytic subunit 
p i 10 of PI3K does not prevent CD28-PI3K association (Ward et al., 1995), but reduces 
IL2 production in resting T cells while in the leukaemic T cell line, Jurkat, it increases 
IL2 production (Ueda et al., 1995). In neurons wortmannin demonstrated an anti-
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apoptotic effect of PI3K (Yao and Cooper, 1995) following ligation of the nerve growth 
factor receptor. Thus PI3K appears to be involved in positive regulation of proliferation 
in resting T cells, negative modulation of proliferation in Jurkats and have an anti- 
apoptotic effect in neurons.
In T cell activation therefore there appears to be a stage specific change in the role of
PI3K. This may be caused by an alteration in the binding preference or availability of
PI3K from CD28 to CTLA4 as a T cell becomes activated. Some data suggest that the
binding site Y191 of PI3K on CD28 when mutated to Y191F in order to ablate PI3K
binding to CD28, also causes a sustained expression of CD28 on the cell surface (Cefai et
al., 1998). As such a mutant has previously been shown to prevent costimulation (Cai et
al., 1995), it is possible that internalization of CD28 is necessary for signal transduction
i.e. by preventing internalization of CD28 through disruption of the PI3K binding site,
CD28 may be prevented from reaching its signal transduction site. Paradoxically
sustained surface expression of CD28 may facilitate CD28 signalling by creating greater
opportunity for CD28-CD80/ CD8 6  interaction. Currently it is not known whether CD28
internalization is necessary for CD28 signal transduction. It was demonstrated that
complexes of CD28 and PI3K associated with clathrin associated AP2 complexes and
that 50% of internalized CD28 was directed toward lysosomes, while 50% was recycled
to the cell surface (Cefai et al., 1998). Interestingly the mutant Y209F showed twice as
much CD28 internalization as wild type CD28 indicating that Y209 may play a role in
sustaining CD28 surface expression. Additionally the mutant Y165F of the PI3K
binding site YVKM on CTLA4 showed enhanced surface expression (Leung et al.,
1995) similar to mutation of the CD28 PI3K binding site (Cefai et al., 1998). It would
therefore imply that both receptors may be internalized by a similar mechanism.
However while CTLA4 associates with the jx2 subunit of AP2, CD28 does not (Shiratori
et al., 1997). Furthermore the intracellular domain of CTLA4 does not possess a
consensus PKC phosphorylation site adjacent to the PI3K binding site unlike CD28 and
these differences may account for the delay in CTLA4 surface expression. Indeed PMA
can inhibit the association of CD28 and PI3K (Hutchcroft et al., 1995), the significance
of this may possibly be that in a costimulated T cell transduction cascade, PI3K initially
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associates with CD28 whereby CD28 is internalized. The ligation of the TCR may 
ultimately lead to CD28 phosphorylation through PKC activation in a manner analogous 
to incubation of T cells with PMA, a known PKC activator (Vance and Vance, 1991). 
The putative phosphorylation of CD28 by PKC may prevent further association of PI3K 
with CD28 and so PI3K may be recruited to an alternative receptor, namely CTLA4, 
initiating negative regulation of T cells.
1.33 CD28 and Cell Cycling
One response observed upon T cell costimulation is a large population expansion of the 
antigen-APC-responsive T cells. Cells in a resting state may be attributed to being in G l/ 
Go of the cell cycle. In overcoming the cell cycle entry checkpoint, whereby a cell may 
either stop cycling and enter Go or pass from G l to S phase, a variety of inhibitory and 
stimulatory factors are thought to be modulated (Alberts et al., 1989). The nature of 
these signals remains obscure in T cells (Smith, 1984). CD28 may be involved in 
facilitating the passage of resting T cells to cycling stages through signalling intermediates 
which finally stimulate S6 K, an enzyme which promotes cell cycle progression through 
phosphorylation of S6 , a ribosomal processing protein (Pai et al., 1994). PI3K 
activation (Burgering and Coffer, 1995; Franke et al., 1995) and so production of PI3 P 
(Franke et al., 1995) was demonstrated to be sufficient to activate protein kinase B 
(PKB=Akt=RAC), a serine/ threonine kinase, itself activated by phosphorylation on 
serine. The extent of PKB activation was four fold greater following stimulation by PI3 P 
than by the unphosphorylated precursor (Franke et al., 1995). Subsequently, activated 
PKB phosphorylated and activated S6 K (Burgering and Coffer, 1995). S6 K, like PKB 
is a serine/ threonine kinase and to become activated is phosphorylated on multiple serine/ 
threonine residues (Price et al., 1992). In turn it phosphorylates the 40S ribosomal 
subunit protein S6 , which was proposed not to activate T cells, but to initiate cell cycle 
progression from G l to S phase (Pai et al., 1994). This may then be the trigger by 
which resting T cells overcome the restriction point in G l to enter the proliferative phase 
of cell cycling (Alberts et al., 1989) and a mechanism for CD28 to effect cell cycling.
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The molecule rapamycin inhibits CD28 but not TCR derived pathways (Su et al., 1994; 
Lai and Tan, 1994; Sabatini et al., 1994; Price et al., 1992; Pai et al., 1994). While it is 
accepted that CD28 ligation leads to recruitment and activation of PI3K, evidence of its 
involvement in S6 K activation was circumstantial until it was shown that crosslinking 
CD28 alone was sufficient to cause S6 K activation (Pai et al., 1994). While CD28 (or 
IL2 (Kunz et al., 1993))-derived activation of S6 K could be inhibited by rapamycin, 
TCR-derived activation of S6 K was rapamycin insensitive. The independence of CD28 
from the calcium pathway was confirmed by an insensitivity to CsA, while the TCR 
could not activate S6 K after CsA treatment (Franke et al., 1995; Price et al., 1992). 
Although S6 K could not be activated through a CD28 derived pathway in the presence of 
rapamycin, the upstream activator PKB was insensitive to rapamycin, showing 
rapamycin to have a distal target in the CD28 signalling pathway. These data support the 
existence of separate signalling pathways in CD28 and TCR signal transduction which 
ultimately may impinge on shared substrates.
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1.4 CD28 Proximal and Distal Signals
The secretion of IL2 from T cells requires the translocation (from the cytosol to the 
nucleus) or induction of transcription factors which regulate IL2 promoter activity by 
association with their respective binding sites. The transcription factors involved in the 
stimulation of the IL2 gene promoter include the nuclear factor of activated T cells 
(NFAT), activation protein-1 (API ), activation protein-3 (AP-3), OCT-1 and nuclear 
factor kB (NFkB) (Granelli-Pipemo and Nolan, 1991). The contribution each of these 
makes to upregulation of the IL2 expression is unclear due to different methods and 
origins of T cells used to assess the impact of various mitogenic, primary and 
costimulatory signals (Umlauf et al., 1993) used to stimulate T cells to produce IL2. Of 
the data available the contribution CD28 and the TCR make to induce NFAT, NFkB and 
API is summarised in figure 1.5.
1.41 NFAT
The primary stimulus for T cell activation derived from ligation of the TCR/ CD3 results
in the dephosphorylation of a cytoplasmically located transcription factor, NFAT, which
is involved in IL2 promoter activation (Granelli-Pipemo and Nolan, 1991). When NFAT
is dephosphorylated by the calcium-dependent phosphatase calcineurin it may translocate
to the nucleus. Ligation of the TCR results in an increase in Ca2+i (Smazel and Resch,
1995) and ultimately translocation of NFAT to the nucleus which may be inhibited by
cyclosporin A (CsA) (Liu, 1993). CsA binds and inhibits the cis-trans isomerase activity
of cyclophilin and this complexes with calcineurin preventing activation of calcineurin.
Interestingly CD28 which is insensitive to CsA inhibition (Su et al., 1994; Lai and Tan,
1994; Pages et al., 1994; Kunz et al., 1993; Liu, 1993; Pai et al., 1994), surprisingly
may also activate PLCy (Nunes et al., 1993). Activation of PLCy following TCR ligation
generates the second messengers IP3 and DAG from PI4 5 P2 . IP3 causes a rise in
intracellular calcium levels and this leads to activation of the phosphatase calcineurin
(Smazel and Resch, 1995). However as only saturating concentrations of aCD28 mAb
activate PLCy (Nunes et al., 1993) it is doubtful whether or not CD28 in vivo i.e. under
stimulation from the B7 family of ligands, is capable of activating calcineurin or
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dephosphorylating NFATc allowing its subsequent translocation to the nucleus. The 
consensus view is that NFAT translocation is controlled by a TCR-stimulated signalling 
pathway.
1.42 NFkB
NFkB is a member of the Rel family of transcription factors. This family comprises the 
elements c-Rel, Rel A, Rel B, NFKB1 (p50 and precursor pl05) and NFKB2 (p52 and 
precursor p i00). NFKB1 p i05 and NFKB2 p i00 which sequester Rel family proteins, 
as Ik B oc does, were not down regulated by CD28 ligation, unlike I k B oc (A ai av5  Tav, 
1994). Increased levels of c-Rel were noted in the nucleus in the presence of CD28, 
PMA signals (Lai and Tan, 1994), although not with CD28 signals alone in resting T 
cells (Bryan et al., 1996). However another study showed CD80 could stimulate NFkB 
generation without additional signals in T cell blasts (Edmead et al., 1996). The 
mechanism of I k B oc down-regulation by CD28 may be through PKC£ which can 
phosphorylate I k B oc facilitating NFkB activation (Lozano et al., 1994). PKC£ , an 
atypical PKC isoform which is insensitive to activation by phorbol ester and calcium, 
may be activated by P ^ ^ P S ,  a PI3K product (Nakanishi et al., 1993). This may be the 
mechanism by which CD28 contributes to the activation of NFkB, a transcription factor 
involved in IL2 gene upregulation.
An inhibitor of CD28 signals, rapamycin, demonstrated the involvement of CD28 in 
inducing the translocation of the Rel family member, c-Rel to the nucleus (Lai and Tan, 
1994). There may be more than one target for rapamycin (it impinges on both S6 K 
activation and NFkB induction) including RAFT1 or a mammalian homologue of the 
yeast TOR (target of rapamycin) proteins (Pai et al., 1994; Kunz et al., 1993). 
Alternatively a single target of rapamycin may impinge on more than one signalling 
pathway. This would lie downstream of PKB and upstream of I k B oc, in which case the 



















Fig. 1.5: C ontributions of CD28 and the TCR to IL2 Expression
CD28 and the TCR differentially regulate signals inducing binding of the transcription 
factors NFAT, API and NFkB to the IL2 promoter, required for IL2 secretion.
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1.43 API
Another transcription factor required for IL2 transcription is A PI, which is formed from 
a complex of c-Fos and c-Jun proteins (Su et al., 1994). Induction of c-Fos is associated 
with TCR derived signals initiated after activation of the small GTPase Ras. Ras, a 
cytoplasmic GTP-binding protein with intrinsic GTPase activity is active in its GTP- 
bound form. The level of active Ras is regulated by a dynamic equilibrium in the 
exchange of GDP for GTP bound to Ras, whereby GTPase activating proteins negatively 
regulate Ras and guanine nucleotide exchange factors such as Sos (son of sevenless) and 
Vav promote Ras activation (Smazel and Resch, 1995). Association of Ras with the 
TCR, through a complex of the adaptor proteins SHC (src homology and collagen 
adapter protein), GRB2 (growth-factor receptor bound-protein 2) and SOS facilitates the 
exchange of GDP to GTP on Ras (Rudd et al., 1994). Interestingly antibody ligation of 
CD28 has been demonstrated to activate Ras but this effect was not observed by CD80 
ligation of CD28 (Nunes et al., 1994). Therefore, like the translocation of NFAT, c-Fos 
would appear to be sensitive to TCR, but not CD28, signals. One of the functions of Ras 
is to stimulate the MAPK cascade (fig. 1.6). After ERK1 and ERK2 activation, the 
transcription factor E lkl is induced to bind to a Fos promoter, upregulating Fos 
expression. The activation of ERK1 and ERK2 occurs in a CD28- and calcium- 
independent fashion i.e. are PKC-dependent although their activation alone showed no 
correlation with IL-2 production (Su et al., 1994).
API formation also requires another component, c-Jun (Su et al., 1994; Granelli-
Piperno and Nolan, 1991). JNK, a novel member of the MAP kinase group,
phosphorylates and augments the transcriptional activity of c-Jun and possibly JunD (Su
et al., 1994). PMA and calcium ionophore (Ionomycin) stimuli or alternatively
costimulation of the TCR and CD28 lead to full activation of JNK (Su et al., 1994).
Alone each stimulus resulted in little or no activation. The calcineurin inhibitor, CsA,
inhibited the synergistic activation of JNK. Thus at least at one level, an integration of
TCR and CD28 signals occurs, leading to induction of nuclear transcription factors which
can bind to the IL-2 promoter (Su et al., 1994). MAP kinase subfamily members ERK
and JNK, when phosphorylated and activated, translocate to the nucleus and so it is
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possible that CD28 and TCR derived signals synergize not only in the cytosol at JNK, 
but also in the induction of composite transcription factors, leading to T cell activation 
(Su et al., 1994). As the activation of JNK and IL2 production in the presence of PMA 
and ionomycin is further increased by CD28 ligation (Su et al., 1994), full T cell 
activation could be attributed to at least three distinct pathways involving calcium, PKC 
and CD28 which may be interdependent. While JNK is a distal cytosolic signalling 
element and the intermediate steps between CD28 ligation and JNK activation have yet to 
be found, PI3K has been proposed to regulate the MAP kinase cascade through Pl3 t4 t5 P3  
(Ward et al., 1995) (fig. 1.6). A complex cascade of events between ligation of the 
tyrosine kinase receptor, EGFR, and JNK activation has been shown to involve a 
number of small GTPases which are members of the Ras superfamily. The Rho 
subfamily GTPases R acl, 2 and Cdc42Hs, but not RhoA, were shown to activate 
proximal signalling elements leading to the activation of JNK (Minden et al., 1995). As 
CD28 has been previously shown to interact with Ras when crosslinked (Nunes et al., 
1994), it is possible that a CD28-Ras association may stimulate the induction of API , a 
transcription factor necessary for EL2 expression (Granelli-Pipemo and Nolan, 1991). 
However while antibody ligation of CD28 may lead to Ras activation, ligation by the 
ligand CD80 was found to be insufficient to activate Ras (Nunes et al., 1994). Therefore 
it would appear more likely that CD28 contributes to the activation of JNK through a 
Ras-independent mechanism. As P l3 ,4 ,sP3  has been demonstrated to be necessary for 
Rac activation (Rodriguez-Viciana et al., 1994) and Rac stimulates the activation of JNK 
(Minden et al., 1995), it is possible that CD80 ligation of CD28, shown to stimulate 
PI3K activation and recruitment to CD28 (Ward et al., 1995), provides a means by which 


















Fig. 1.6: Small GTPases Rac 1 and 2 and Possibly Cdc42Hs are
Involved in A ctivation of JNK.
Epidermal growth factor receptor (EGFR) associates with a GRB2, SOS complex and 
activates Ras. Subsequently MAP kinases and JNK are activated leading to transcription 
factors becoming phosphorylated and translocating to the nucleus. CD28 also associates 
with GRB2.SOS and can activate Ras upon crosslinking.
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1.5 Sphingomyelin and Ceramide
Sphingomyelin is a ubiquitous animal membrane component comprising a hydrophobic 
ceramide moiety which contains a mixture of fatty acids amide linked to sphingosine or 
other related long chain aliphatic amines (sphingoid bases) and a hydrophilic polar head 
(phosphocholine) (see fig. 1.7 below). Sphingomyelin may be synthesised in 
microsomes by cytidyl diphosphate (CDP) choline: ceramide phosphocholine transferase 
which catalyzes the transfer of phosphocholine from CDP-choline to ceramide to form 
sphingomyelin (Vance and Vance, 1991).
Sphingomyelin is catabolized by two sphingomyelinases (SMases). One of these has a 
neutral pH optimum (referred to as NSMase) and is membrane bound, the other is 
lysosomal and has an acidic pH optimum (referred to as ASMase) (Wiegmann et al., 
1994). The breakdown of sphingomyelin produces ceramide and phosphocholine. The 
latter of these two products is recycled in the CDP-pathway upon combination with 
choline to become CDP-choline. Choline phosphotransferase may combine CDP- 
choline with DAG to generate phosphatidylcholine (Vance and Vance, 1991). 
Sphingolipid metabolites such as sphingosine, sphingosine-1-phosphate and ceramide 
have other functions aside from being intermediaries in sphingolipid metabolism and 
these are discussed below.
The ceramide moiety embeds itself in hydrophobic diacylglyceryl chains of phospholipids 
and other membrane lipids (Vance and Vance, 1991). Sphingomyelin is distributed in 
intracellular and plasma membranes. In the latter it is symmetrically distributed. 
However carbohydrate-containing sphingolipids (glycosphingolipids) are predominantly 
found in the plasma membrane, asymmetrically distributed such that the polar head group 
extends toward the extracellular environment (Vance and Vance, 1991).
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Fig. 1.8: Function and Targets of Ceram ide in Cell Signalling
Ceramide has many targets and effects. Dashed arrow indicates multistep pathway; ? 
indicates that source of ceramide in vivo unclear i.e. could be N- or A-SMase derived; 
solid arrows indicate published effects.
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1.51 Ceramide
Ceramide is reported to have many targets as discussed below, as well as being a 
precursor for glycosphingolipids, which have modulatory function on transmembrane 
signal transduction (Felding-Habermann et al., 1990; Hakomori, 1990). Different forms 
of ceramide exist which are made from the combination of a sphingoid base being 
acylated by various fatty acids. The nomenclature of ceramides often refers to the 
number of carbon atoms in the acyl chain. For example when 2 carbons are present in 
the acyl moiety, the molecule would be referred to as C2 ceramide. Different versions of 
ceramide present the possibility of different function amongst ceramide molecules (Vance 
and Vance, 1991), although in murine splenocytes both C2 and C6  ceramide costimulated 
proliferation (Boucher et al., 1995; Chan and Ochi, 1995). A comparison of C6  and C l6  
ceramide on c-Raf activation revealed a quantitative difference in effect between the two 
types of ceramide in that c-Raf was less sensitive to activation by C6  ceramide in vivo 
whereas in vitro c-Raf could be activated comparably by either molecule (Huwiler et al.,
1996). The lower in vivo activity associated with the shorter chain length C6  ceramide 
may be due to reduced uptake of shorter ceramides as opposed to sphingoid molecules 
with a longer chain (Merrill et al., 1989). In this thesis where a particular species of 
ceramide has been reported reference is duly made, otherwise a generic term, ceramide is 
employed to describe acylated sphingoid bases ie ceramides. Targets of ceramide include 
a 97 kDa proline directed serine/ threonine ceramide activated protein kinase (CAPK) 
(Mathias et al., 1993; Liu et al., 1994). This is membrane bound, activated by ceramide 
after TNFR and IL-1R stimulation (Mathias et al., 1991; Mathias et al., 1993) and has 
been shown to activate Raf (Liu et al., 1994), implicating ceramide as a proximal effector 
of the mitogen activated protein kinase (MAPK) cascade. As repeated stimulation of the 
TCR can induce AICD (Van Parijs et al., 1996), it is possible that CAPK activation may 
lead to negative regulation of T cell viability. Activation of a cytosolic ser/ thr protein 
phosphatase, CAPP (Dobrowsky and Hannun, 1992), PKC£ (Lozano et al., 1994), p42 
MAPK (Raines et al., 1993), and JNK (Kyriakis et al., 1994) as well as downregulation 
of c-Myc (Kim et al., 1991; W olff et al., 1994), phosphorylation and inactivation of IkB 
(Machleidt et al., 1994) and nuclear translocation of NFkB (Schutze et al., 1992; Yang et
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al., 1993; Johns et al., 1994) and API (Johns et al., 1994) have been described in 
different systems as being attributable to ceramide.
In one study involving ceramide generation following TNFR1 (55kDa) stimulation, it 
was found that both neutral and acidic SMases were activated independently by different 
cytoplasmic domains of TNFR1 and each type of SMase was coupled to distinct 
pathways. Neutral (N)SMase-derived ceramide activated a proline-directed kinase, 
CAPK and a phosphatase, CAPP (a phosphatase (PP) 2A) while ASMase-generated 
ceramide caused the translocation and activation of NFkB (Wiegmann et al., 1994). 
Significantly there was no crosstalk between the two pathways. Further ASMase but not 
NSMase activation was stimulated by PC-PLC-generated DAG (as shown by the PC- 
PLC specific inhibitor, D609). The region of TNFR1 responsible for activation of both 
PC-PLC and ASMase also contains an amino acid motif referred to as a death domain, 
believed to be necessary for TNFR to transduce apoptotic signals (Schutze et al., 1992; 
Cifone et al., 1993). As ceramide is widely implicated in facilitating apoptotic pathways, 
this finding may be more than coincidental.
A contrary finding on the separation of function between NSMase and ASMase, whereby 
both could stimulate NFkB translocation (Schutze et al., 1992), may be explained by the 
experimental procedure. When either permeabilized or homogenised cells are used, 
mixing of lysosomal and plasma membrane SMases may occur. Therefore where N- and 
ASMase activities are mixed together it would be difficult to determine whether 
A/NSMase or both activities were responsible for NFkB activation. However as pH 
optima were adjusted for neutral and acidic conditions, it does appear that neutral as well 
as acidic SMase can induce transcription factor translocation (Schutze et al., 1992). The 
fate of exogenous SMase in cell culture has not been reported but as there is much 
sphingomyelin in the plasma membrane and cellular NSMase is reputed to be located on 
the outer leaflet of the plasma membrane (Das et al., 1984), hydrolysis of sphingomyelin 
by exogenously applied SMase may provide a route for it to associate/ embed itself within 
the cell.
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Ceramide can inhibit mitogenically stimulated splenic T cell growth (Felding-Habermann 
et al., 1990) and that of Molt4 leukaemic cells (Jayadev et al., 1995) and one possible 
effector of this function of ceramide may be CAPP (Dobrowsky and Hannun, 1992; 
Dobrowsky et al., 1993). While low concentrations of ceramide activate CAPP 
(maximum activation at 20|iM) (Dobrowsky et al., 1993), low concentrations of okadaic 
acid (IC5 0  of less than InM) inhibit a ceramide-induced activation of CAPP (Dobrowsky 
and Hannun, 1992). Similar concentrations of okadaic acid (Wolff et al., 1994) also 
attenuated a ceramide-induced down-regulation of c-Myc mRNA levels (Kim et al., 
1991). The retinoblastoma gene product Rb, in its dephosphorylated form, has been 
implicated in c-Myc down-regulation and in inhibiting cell cycle progression (Cooper and 
Whyte, 1989). Thus the inactive phosphorylated form of Rb, may present a substrate for 
CAPP, facilitating the role of ceramide in inhibiting cell growth and cell differentiation. 
Indeed C6 ceramide can dephosphorylate RbP and cause MOLT-4 cell cycle arrest. In 
cells lacking Rb, C6 ceramide could not induce cell cycle arrest indicating that ceramide 
may effect cell cycle arrest through dephosphorylation of RbP (Dbaibo et al., 1995).
With ceramide appearing to have so many targets, is it possible to draw a hypothesis on 
its mode of action in any one cell? In a simple model one could examine the paradox of 
ceramide having negative outcome on cell viability i.e. driving apoptosis (Cifone et al., 
1993) and positive function i.e. mitogenesis and activation of cells (Mathias et al., 1993). 
As two or more SMases exist with distinct cellular locations and apparently discrete 
signalling pathways, it is debatable whether or not additions of ceramide to cultures or 
preparations, acts on each pathway equally or shows a preference for one more than 
another. Low concentrations of C2 ceramide (e.g. 0.03|iM  N-acetyl-sphingosine) 
showed a dependence on additional signals from TNFR1 ligation to induce HL-60 cell 
differentiation to a monocytic phenotype. At 6|iM C2 ceramide could independently 
cause differentiation and inhibited cell growth by 57% with little or no effect on cell 
viability (85% viability by day 3 of culture) (Kim et al., 1991). Thus altering the 
concentration of exogenously added C2 ceramide changes the effect of C2 ceramide from 
that of differentiation to inhibition.
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Figure 1.8 summarises the involvement of ceramide in cell signalling. Much of these 
data were obtained from studies using different cell types and through stimulation of 
different receptors and so a generic receptor has been shown. It appears that NSMase 
was involved in cell differentiation (Raines et al., 1993; Kim et al., 1991), activation 
(Mathias et al., 1993) and possibly proliferation (an implied, but not demonstrated neutral 
SMase effect)(01ivera et al., 1992), while ASMase caused apoptosis (Cifone et al.,
1993). For example, Yang et al showed NFkB translocation occurred independently 
from PLC activation (Yang et al., 1993), which would exclude ASMase as an inducer of 
NFkB if PC-PLC (Machleidt et al., 1994) was the only means by which ASMase could 
be activated. Activation of SMases through different receptors e.g. TNFR (Wiegmann et 
al., 1994; Mathias et al., 1991), IL1R (Mathias et al., 1993) and Fas (CD95) (Cifone et 
al., 1993) may have their disparate functions controlled by the context of other signals 
generated by the receptor and also from subsequent metabolites of ceramide. For 
example, receptor ligation is often coupled to activation of PLC where its product DAG 
may activate PKC (Vance and Vance, 1991). PKC has been shown to protect endothelial 
cells against radiation induced apoptosis, most likely by inhibiting the apoptotic pathway 
rather than by enhancing DNA repair (Haimovitz-Friedman et al., 1994). In human 
myeloid leukaemia cells, it was found that activation of PKC (by DAG analogues or 
phorbol ester) arrested ceramide induced apoptosis at an early stage in the apoptotic 
pathway (Jarvis et al., 1994). The effects of ceramide and sphingoid bases (ceramide 
being an acylated version of sphingosine) on cell signalling may be more pervasive than 
currently accepted. Very high concentrations of sphingolipids, eg 330|iM , in vitro 
inhibited or stimulated c-src, respectively, depending on the absence or presence of an 
acyl group (Igarashi et al., 1989) i.e. while sphingosine would inhibit src, ceramide 
would stimulate it. Until more precise experiments dissecting concentrations in different 
cellular compartments are performed, it may be equally justifiable to suggest high 
concentrations are unphysiological or that local concentrations of second messengers may 
reach a critical concentration to activate a src PTK or an alternative effect.
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1.52 Ceramide and CD28
The wide acceptance that CD28 may be the key costimulus for T cell proliferation and
activation has been thrown into some confusion by its role in a TCR-independent
activation of ASMase (Boucher et al., 1995) because of the conflicting cellular responses
arising from ceramide. ASMase activity has been linked to apoptosis (Cifone et al.,
1993) but CD28 functions to costimulate activation and proliferation. Interestingly
support for ASMase as a mediator of apoptosis may be provided by observations of
lymphoblasts from Niemann-Pick patients. This disease arises from a deficiency of
ASMase and results in the resistance of lymphoblasts to apoptosis following ionizing
radiation (Santana et al., 1996), thereby implying ASMase is required to facilitate stress
related apoptosis. Paradoxically many of the targets of ceramide, the product of
sphingomyelin hydrolysis by ASMase, are shared by CD28. Ceramide is a potent
sphingolipid second messenger with many proposed functions such as activation of
PKC£ (Pushkareva et al., 1995) which leads to catabolism of I k B oc. CD28 may be
involved in PKC£ activation as it can activate PI3K (Stein et al., 1994). Activated PI3K
can generate PI3 4 5 P3  which has been shown to activate PKC£ (Nakanishi et al., 1993).
PK C£ may phosphorylate I k B oc (Lozano et al., 1994) facilitating the subsequent
translocation of NFkB to the nucleus (Boucher et al., 1995). NFkB nuclear translocation
has been demonstrated to be both a CD28 derived event (Boucher et al., 1995) and may
also be induced by ASMase (Boucher et al., 1995). A further role for ASMase in
contributing to T cell activation is provided by the serine/ threonine kinase CAPK
(ceramide activated protein kinase) which is activated by ceramide (Liu et al., 1994).
CAPK has a preference for the minimal amino acid sequence -TLP such as found on
EGFR and Raf. Raf was phosphorylated and activated by CAPK, suggesting ceramide
may influence signals of the MAPK cascade (Liu et al., 1994)which are believed to
contribute to positive regulation of T cell function. Another ceramide substrate is the
ceramide activated protein phosphatase, CAPP; a class 2A PTPase which may be
involved in anergy induction (Kolesnick and Fuks, 1995). CAPP and CAPK have been
linked to anergy and apoptosis respectively (Kolesnick and Fuks, 1995; Pushkareva et
al., 1995) while past data would indicate signals generated from CD28, leading to nuclear
translocation of cytoplasmic elements of NFkB (Lai and Tan, 1994; Boucher et al.,
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1995) are involved in cellular activation and proliferation rather than anergy or death. 
Data are not available on the effect of CD28 ligation on CAPP and CAPK. However it 
would be concordant if CD28 did not activate them due to their proposed involvement in 
apoptotic/ anergic pathways. Alternatively other signals may impinge on CD28-SMase 
derived effects. One possibility concerns the involvement of DAG-induced PKC 
activation (see section 1.51) which is proposed to rescue cells from apoptosis 
(Pushkareva et al., 1995; Kolesnick and Fuks, 1995), although no explanation as to the 
mode of action is offered. Clearly it cannot involve activation of the CD28-sensitive 
PKC£ as this is DAG insensitive (Pushkareva et al., 1995). Another possibility may be 
due to the existence of a number of forms of ceramide, which may be stimuli sensitive in 
their induction.
In T cell blasts ceramide appeared to share some of the costimulatory effects of CD28 
(Boucher et al., 1995) while the proliferation of murine splenocytes after mitogenic 
stimulation in the presence of ceramide was suppressed (Felding-Habermann et al., 
1990). However as IL2 secretion, IL2R expression and the affinity of IL2R for IL2 was 
unchanged it appeared that ceramide was specifically inhibiting cellular proliferation 
rather than activation. The differences in effect between ASMase on blasts and ceramide 
on splenocytes may be accounted for by different signals impinging on the intracellular 
environment. In the case of the splenocytes some of these may come for exogenous 
soluble factors or ligand-receptor interactions from neighbouring cells. The result of 
these influences may determine a pro- or anti-proliferative effect (fig. 1.9). Possible 
routes by which ceramide may exert an anti-proliferative effect are manifold. It may be 
converted to dimethylsphingosine (DMS) which strongly inhibits cell growth (Felding- 
Habermann et al., 1990). This would require deacylation of ceramide by ceramidase to 
generate sphingosine. A subsequent methylation of sphingosine would generate DMS 
(Vance and Vance, 1991). Alternatively by conversion to sphingosine, ceramide may 
inhibit PKC activity in resting and confluent cells, although not in rapidly dividing cells 
(Zhang et al., 1990).
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In extraneural cells ceramide may be converted to glucosylceramide, followed by the 
addition of a large variety of sugar residues to form complex glycosphingolipids e.g. 
sialyl-glucosyl ceramide (Gm 3) (Felding-Habermann et al., 1990; Hoffman-Ostenhoff et 
al., 1978). Gm 3 inhibits signal transduction by preventing EGF receptor dimerization 
and thus there is no activation of receptor-associated tyrosine kinase activity nor any 
activation of distal signals connected to mitogenesis (Hakomori, 1990).
A proliferative effect from ceramide may be facilitated by its conversion to sphingosine 
and subsequently by sphingosine kinase to sphingosine-1-phosphate (SPP) (Ghosh et 
al., 1990). SPP stimulated phospholipase D (PLD) which generated the potent mitogen 
phosphatidic acid (PA) from phosphatidylcholine (Fukami and Takenawa, 1992; Desai et 
al., 1992). Interestingly, in the presence of PMA, reduced levels of dihydrosphingosine 
(DHS, a sphingosine precursor) have been noted in human neutrophils with concomitant 
increases in ceramide levels (Wilson et al., 1988). The balance between generation and 
utilization of ceramide may be dependent on cell type and stage of activation. An 
alternative method by which proliferative signals may be prolonged may be invoked 
through PA. A cytoplasmic GTPase-activating protein (rasGAP), capable of converting 
active rasGTP to inactive rasGDP may be inhibited by PA provided PA has unsaturated 
fatty acid moieties such as arachidonic acid, which contains a 20 carbon chain with 4 cis 
double bonds (Tsai et al., 1989). Therefore ceramide may indirectly, through conversion 
to SPP, increase PA synthesis and prolong Ras activity. This presents an opportunity for 
modulation of PI3K activity as PI3K has been shown to be activated by Ras (Rodriguez- 
Viciana et al., 1994). Alternatively sphingolipids may alter T cell signalling due to the 
indirect activation of DAG kinase (DAGK) by sphingosine (Kanoh et al., 1990). Human 
PBMC and Jurkat T cell DAGK is predominantly located in the cytosol, although PMA 
can induce translocation of DAGK to the membrane where DAG is produced. As PMA 
can both activate PKC (Vance and Vance, 1991) and induce recruitment of DAGK, 
which decreases the levels of DAG following activation of DAGK by sphingosine 
(Kanoh et al., 1990), PKC activation may be indirectly controlled by sphingolipids. 
Therefore sphingolipids may exert a modulatory effect on elements of both the primary
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Fig. 1.9: In terrela tionsh ip  of Phospholipid and Sphingolipid
Signalling Pathw ays
Hydrolysis of membrane associated phospho- and sphingolipids generate signals which 
modulate each other through complex regulatory mechanisms
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Sphingolipid metabolism may be seen to be exceedingly complex with paradoxical effects 
between different cell types e.g. ceramide, respectively, had negative and positive effects 
on T cell and fibroblast growth (Felding-Habermann et al., 1990; Olivera et al., 1992). 
Assay conditions may also give rise to apparently contradictory results e.g. exogenously 
added SMase induced NFkB translocation through ASMase but not NSMase while lysate 
preparations showed NFkB was induced through both N- and ASMase (Wiegmann et 
al., 1994; Machleidt et al., 1994). The acylation of ceramide to glycosphingolipids, or its 
transacylation (exchange of one fatty acid for another) or deacylation to sphingoid bases 
(Vance and Vance, 1991) presents many possible mechanisms by which ceramide may 
influence cell biology. The suggested negative regulatory function of CAPK (Mathias et 
al., 1991; Liu et al., 1994) and CAPP (Wolff et al., 1994) concurs with the activation of 
SMase by the receptors TNFR (Wiegmann et al., 1994; Kim et al., 1991; Yang et al., 
1993) and Fas (Cifone et al., 1993) which have a negative role on cell viability. 
However the reported putative CD28-ASMase association (Boucher et al., 1995) would 
appear to be paradoxical due to the costimulatory role of CD28. So far, it is apparent that 
the effects of ceramide are context and cell type specific (Cifone et al., 1993; Yang et al., 
1993; Igarashi et al., 1989) and little is known about the effects of ceramide in resting T 
cells.
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1.6 Aims of the Project
The activation of T cells is highly regulated by processes, the identity and function of 
which are just emerging. Proximal signals generated from CD28 determine whether 
CD28 transduces anti-apoptotic, proliferative or activation messages to the T cell. Clearly 
T cells have stage specific sensitivity to costimulation and in the case of CD28, the most 
profound effects are seen on resting memory T cells where there is an absolute 
requirement for CD28 costimulation in order that high amounts of IL2 are produced from 
those T cells. Antigen-primed T cells however, also respond to CD28 derived signals, as 
is evident from their high levels of proliferation. In both these cases CD28 has effects 
beyond that seen by other costimulatory receptors such as CD2 or LFA-1.
The mechanism(s) by which CD28 transduces costimulatory signals are unclear, although 
part of the functional outcome of CD28 ligation may lie in promoting progression of cell 
cycling. Many mitogenic receptors functionally couple to PI3K while SMase also 
appears to be a candidate modulator of the growth of many cell types. For these reasons, 
it was decided to examine the effects of proximal signals associated with CD28 and 
sphingolipids which may affect T cell growth. The following parameters were analysed:
i) phosphorylation states of CD28 and associated molecules following CD28 
ligation
ii) identity of molecules associating with CD28
iii) possible protein tyrosine kinase(s) facilitating the recruitment of proximal
signalling elements to CD28
iiii) relationship between CD28 and sphingomyelinase
v) relationship between resting T cell costimulation and sphingomyelinase
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vi) possible interplay of CD28 and sphingomyelinase on distal targets of 
both
It was hoped that data arising from such experiments would provide clues to the identity 
of the effectors and mechanisms by which CD28 transduced signals lead to the activation 






Unless otherwise specified all laboratory reagents were purchased from Sigma (Poole, 
UK). Cell lines used included Jurkats, Chinese hamster ovary (CHO) K l, CD28 and 
CD80 expressing CHO transfectants as previously reported (Sansom et al., 1993). The 
antibodies used in the experiments were obtained from a variety of sources. OKT3 
(aC D 3), HB8784 (aC D 25) and L243 (aHLA-DR) were obtained from ATCC 
(Rockville, MD, USA). UCHM1 (aCD14) was received from Prof. P Beverley (ICRF, 
London, UK); 9.3 (aCD28) and BB-1 (aB 7-l) from Dr P Linsley and B U I2 (aCD19) 
from Dr I. McLennan (University of Birmingham, UK). Monoclonal aCD69 (Cat. No. 
M CA1442) was purchased from Serotec, Oxford, UK. W estern blotting primary 
polyclonal antibodies against fyn (Cat. No. sc-16; Santa Cruz; Autogen Bioclear UK Ltd, 
Wiltshire, UK), lck (donated by Dr C. Bebbington, Celltech, Slough, UK) and ZAP70 
(Cat. No. ZU06-271; TCS Biologicals, Bucks, UK) were acquired from various sources 
and JS14 (a p 8 5 a ) and 4G10 (a-phosphotyrosine) were donated by Dr M. Welham 
(University of Bath, UK). Secondary Western blotting goat a-mouse (P0447) /  a-rabbit 
(P0448) antibodies were purchased from Dako (Glostrup, Denmark). 15E8 (aCD28) 
was donated by Dr van Liev (Amsterdam, Netherlands) and the GST-c-Jun fusion 
PGEX construct was supplied by J. Woodget, Toronto. Restriction enzymes were 
purchased from Promega Ltd, Southampton, UK and X Hind III cut with EcoRI (Cat. 
No. 15612-013) markers to allow sizing of DNA fragments were purchased from Gibco 
BRL, Paisley, UK. X Hind III fragment sizes are 23130, 9416, 6557, 4361, 2322, 
2027, 564 and 125 bps. For following the migration of proteins under SDS-PAGE, 
prestained markers were used (Cat. No. 160-0305; Biorad Laboratories, Herts, UK). 
Enhanced chem ilum inescent (ECL) reagents (Cat. No. RPN2106) and 14C 
sphingomyelin (Cat. No. CFA566) were purchased from Amersham (Amersham 
International, Bucks, UK). 32P y-ATP was purchased from ICN (4500 Ci/  mmol, Cat. 
No. 38101X, ICN, California, USA). Nitrocellulose membrane used in Western blotting 
was purchased from Anderman and Co. (Cat. No. 401236, Schleicher and Schuell; 
Anderman and Co., Surrey, UK). The following reagents were purchased from the
suppliers indicated. PGNaseF (Cat. No. 704S; New England BioLabs, Herts, UK).
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Protein A Sepharose beads (Cat. No. 17-0974-01, Pharmacia Biotech, Herts, UK). 
Biotin and avidin D.HRP (Cat. No. SP01210; Vector Laboratories, Peterborough, U.K). 
Rabbit complement (Cat.No. MA CL3221; Cedarlane Laboratories, Newcastle upon 
Tyne). Heparin (5000U/ ml, Monoparin CP Pharmaceuticals). Lymphoprep (density 
1.077 g/ ml; Nycomed UK Ltd, Birmingham, UK).
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2.2 Generating Protein Tyrosine Kinase Transfectants
Plasmid preparation
Plasmids based on pFIO containing fyn, lck or ZAP70 cloned downstream of human 
cytomegalovirus promoter were received from Dr C. Bebbington, Celltech, Slough 
(appendix 1). Additionally these plasmids contained a xanthine-guanine phospho- 
ribosyltransferase (gpt) gene facilitating selection of cells transfected with these plasmids 
under the regulation of XMAT (appendix 3) provided guanosine was omitted from the 
media (Mulligan and Berg, 1981).
Spectrophotometric determination (at OD2 6 onm) of the concentration of the plasmid 
preparations revealed that fyn and lck plasmids were at an insufficient concentration to 
proceed with transfection of mammalian cells. In order to generate more fyn and lck 
vector electrocompetent E. coli Top 10F cells were transformed by electroporation with 
either fyn or lck plasmid. To a 2mm width electroporation cuvette (Biorad, Herts, UK) 
sitting in ice, a 40 pi aliquot of Top 10F cells was added with 10-20ng of plasmid and 
mixed gently. At a resistance of 200£2 and a capacitance of 25|iF, a potential difference 
of 2.5kV was discharged achieving a time constant of 3.5 ms. 950{xl of SOC (appendix 
6) was added to each cuvette and the cells were left at 37°C for 30 mins. Aliquots from 
50 -1 OOjxl were plated out on ampicillin-containing agar plates (appendix 6) and left at 
37°C overnight.
Several bacterial colonies were picked at random from the agar plates and grown
overnight in 5ml broth minicultures (appendix 6). Minipreps were prepared from each
using standard alkaline lysis protocols (Sambrook et al., 1989). Single restriction
enzyme digests were carried out and analyzed on a lx  TAE buffered 1% agarose-
ethidium bromide gel (appendices 4 and 5) to identify cultures carrying fyn or lck insert.
A 500 ml maxiprep was prepared from one positive culture of each using the above
method and the plasmid preparation was PEG purified (Sambrook et al., 1989). The
plasmid pellet was resuspended in MilliQ H2O and the presence and orientation of an
insert was verified by single restriction enzyme digests. The products of which were
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separated and visualized by an agarose-ethidium bromide gel. The concentration of the 
plasmids were measured by spectrophotometry at 260nm.
Transfection
CHO cells transfected with CD28 human cDNA as previously reported (Sansom et al., 
1993) were transfected with fyn, lck or ZAP70 expression vectors. 3 million CD28+CHO 
cells were washed in Hepes Buffered Saline (HBS, appendix 2) and resuspended in 5 
mis of HBS. To a 4mm width electroporation cuvette (Biorad, Herts, UK), a 175 |il 
aliquot of CD28+CHO cells was added with 5|ig of plasmid and mixed gently. At a 
capacitance of 125|iF, a potential difference of 350V was discharged, achieving a time 
constant of 3.5 ms. 1ml of glutamine free media (appendix 3) was added to each cuvette 
and the cells were left at room temperature for 4 mins. The cells were then transferred to 
cell culture flasks and selection was applied after one passage.
2.3 Cell Culture
Assays were carried out using the leukaemic T cell line Jurkat, purified resting T cells, 
CHO, CD28+CHO, CD80+CHO and PTK+CD28+CHO transfectants. Jurkats and T 
cells were cultured at l-2 x l0 6 cells/ ml in RPMI 1640 containing 10% FCS 
supplemented with penicillin and streptomycin (appendix 3).
CHO cells, CD28 and CD80 transfectant cells as previously reported (Sansom et al.,
1993) were cultured in glutamine free DMEM (Glu-) containing 10% FCS supplemented
with nucleosides and sodium pyruvate (appendix 3). PTK transfectants were grown in
Glu- media containing 10% FCS, sodium pyruvate, XMAT and nucleosides where
guanosine was replaced with uridine (appendix 3). Selection of transfected cells in
XMAT is based on the inhibition of purine synthesis by mycophenolic acid and the
conversion o f xanthine to XMP by the transfected gene product guanine
phosphoribosyltransferase (Mulligan and Berg, 1981) which provides the cells with an
alternative mechanism to generate GMP. Cells growing in XMAT were monitored
regularly using FACS analysis of CD28 surface staining and Western blotting for PTK
detection. The cells were passaged every 3 days by aspiration of the media followed by a
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PBS wash and a 5 min incubation with trypsin at 37°C. The cells were dislodged by 
tapping the flask and media was added to inactivate the trypsin. Up to 90% of the cells 
were removed and the remainder diluted to volume with fresh media.
Cell lines and clones were maintained as stock by cryogenic storage. Following 
harvesting of subconfluent cells, they were washed in medium and resuspended in 
medium containing 20% FCS and 10% DMSO. Aliquots at lx lO 6 cells/ ml were 
dispensed to freezing vials (Nunc) and transferred to storage at -80°C for 24 hours before 
indefinite storage in liquid nitrogen at -190°C.
Cell recovery from frozen was performed by rapid thawing under warm water and 
washing of the cells in medium, followed by gentle pelleting of the cells at 800 rpm for 5 
mins. The cells were resuspended in lOmls of media, prewarmed to 37°C, before being 
introduced to a culture flask and the volume of media was adjusted to the appropriate 
volume for culture.
2.4 Flow Cytometric Analysis
Flow cytometric analysis (FACS) was used to provide a relative quantitation of
constitutive and inducible antigen expression levels at the cell surface, thereby giving an
indication of how stimuli may affect a cell or why a cell may respond in a particular way
to a certain treatment. The analysis requires labelling of the surface antigen using specific
mAbs followed by detection using a fluorescent labelled antibody which binds the
primary antibody. When a sample is analyzed, the cells are directed through a LASER
light source in a single cell suspension. Depending on the physical properties of the cell
and the amount of antibody bound to the cell, the light is defracted to varying
proportions. Relative to the plane of the LASER, information may be collected on how
the light source is altered by forward scatter (FSC, related to cell size), side scatter (SSC,
related to cellular granularity) and fluorescence from the labelled antibody (FL1, in this
study used to assess surface antigen fluorescence levels and FL2, in this study used to
measure propidium iodide entry in to a cell). A Becton Dickinson FACStar was used to
record data using a 60mW LASER at 520nm for FL1 and 580nm for FL2.
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Typically 2xl05 cells were stained for relevant markers while cells in medium were used 
as a negative control. Supernatants from hybridoma cell lines contained antibody 
concentrations of approximately 10 |Lig/ ml. Cells harvested from culture were washed in 
an excess of PBS, pelleted at 1500rpm for 5 mins (Beckman GPR) and resuspended in 
50|li1 of primary antibody at 10ug/ ml. The cells were incubated at 4°C for 45 mins. 
Excess and unbound antibody was removed by washing the cells in PBS. The cells were 
pelleted and (as above) and the primary antibody labelled cells were secondarily labelled 
with 50jxl of 10|Xg/ ml polyvalent a-m ouse immunoglobulin conjugated fluorescein 
isothiocyanate (FITC) in the same manner as the primary antibody. Subsequently the 
cells were recovered and resuspended in 200|il of PBS before analysis. Normally 10000 
events were recorded as a representative sample. Data are presented as histograms with 
the percentage expression above negative controls indicated in brackets. The percentage 
represents the level of fluorescence greater than the fluorescence recorded on the 95th 
percentile of the control treatment.
Homogeneous expression levels of CD28 on PTK transfectants would facilitate the 
analysis of the effect of one PTK compared to another. PTK transfectants following 
expansion under XMAT selection were assessed by FACS for levels of CD28 surface 
expression. Twenty clones of each type of PTK transfectant with comparable CD28 
expression were directed into a 96 well flat bottomed plate at 1 cell/ well using a Becton 
Dickinson automatic cell deposition unit (ACDU) programme. The clones were 
expanded under XMAT selection where initially medium was added at 50|il/ well before 
transfer to 75 cm2 culture flasks for further expansion.
2.5 Generating CD28LOW Jurkats
Antibody labelling of CD28 on the cell surface of Jurkats provided a useful mechanism
by which CD28+ve cells could be removed from a Jurkat population. CD28+ve Jurkats
labelled with the aCD28 mAb 9.3 were removed from the population by three methods.
Firstly complement mediated lysis, secondly immunomagnetic depletion and thirdly by
FACS sorting to exclude CD28+ve cells. The treatments were performed sequentially
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such that following the recovery in cell number of a treated population, the population 
was further treated to remove residual CD28+ve Jurkats.
Complement mediated lysis of CD28+ve Jurkats was initially used to decrease CD28+ve 
cells from Jurkats. 5x l06 cells were labelled in 500jll1 of 9.3 (1 / 2000 dilution from 
ascites) for 40 mins at 4°C and subsequently washed in PBS. The cells were 
resuspended in 250|il of serum free medium and dispensed at 50pl/ well to a 96 well flat 
bottomed Petri dish. 1ml of ice cold water was added to lyophilized rabbit complement 
and the solubilized complement was filter sterilized. 50jll1/ well of complement was 
added to the aCD28 labelled cells. The cells were incubated for 1 hour at 37°C before 
addition of 100(il/ well of RIO medium (appendix 3). The cells were left overnight at 
37°C before expansion of the population for use in further CD28 depletion experiments. 
Following recovery of cell numbers, CD28 surface expression was assessed by FACS 
analysis. The cells were labelled Jurkat complement-treated cells Round 1-4. JcRl-4, 
depending upon how many rounds of complement treatment they had been subjected to. 
The complement mediated lysis of CD28+ve cells was performed four times before an 
alternative method was used to further decrease CD28+ve cells from the population.
Immunomagnetic depletion of CD28+ve Jurkats was subsequently used. 5x l06 cells 
from the final round of complement treated Jurkats were taken and labelled with murine 
aCD28 antibody and washed in PBS. The cells were resuspended in 250|il of medium 
and 25(0.1 of immunomagnetic sheep anti-mouse IgG beads (Dynal UK Ltd, 
Bromborough, UK) and rotated at 4°C for 2 hours. The CD28+ve cells were removed 
from the population by a magnet and the resulting population was resuspended in lOmls 
of medium and expanded before analysis by FACS for levels of CD28 surface expression 
on the treated population (labelled JMAG).
FACS sorting was used to further deplete the number of cells in a Jurkat population with
detectable CD28 surface expression. 2 x l0 5 cells from the population subjected to
magnetic depletion were stained for FACS analysis. Cells with low or no CD28
fluorescence were selected with a Becton Dickinson FACStar Plus ACDU programme.
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Cells incubated with the primary aCD28 mAb which had lower fluorescence than the 
negative control were directed into a 96 well flat bottomed flat bottomed microtitre plate 
and subsequently expanded. This method of selecting CD28 -ve/ low expressing Jurkats 
was repeated and the final population, labelled CD28 Negative Jurkats, 28N, was 
cryopreserved following FACS analysis of surface phenotype compared to the parental 
J16 population.
2.6 Western Blotting
Western blotting may be used to detect the presence of proteins to which an antibody has 
been developed. Protein detection is based upon the use of a primary antibody directed 
against an antigen which is detected by a secondary antibody targeted against the primary 
antibody. The relative level of protein is visualized in a reaction where the secondary 
antibody conjugated with a horse radish peroxidase (HRP) activity generates free radicals 
upon incubation with substrate e.g. hydrogen peroxide. The reaction products can 
expose X ray film. Proteins from cell lysates or immunoprecipitates which are separated 
by electrophoresis and transferred to a nitrocellulose membrane may be incubated with 
Western blotting antibodies and detection reagents in order to generate a record of the 
level of protein detected upon exposure of X ray film to the activated detection reagents.
Sample Preparation
For the detection of fyn, lck, ZAP70 and p85 proteins from cell lysates, 1 million cells 
were washed twice in serum free medium and lysed in 30|il of lysis buffer (appendix 4). 
The samples were incubated on ice for 40 mins before pelleting cytoskeletal and nuclear 
proteins at 14000rpm, 4°C for 6 mins (Beckman G15R). The post-nuclear supernatant 
(PNS) was mixed with an equal volume of loading buffer and boiled at 100°C for 10 
mins. The samples and 10|il of prestained markers were loaded on a 1mm thick SDS- 
PAGE gel comprising a 4% acrylamide stacking gel (to a depth of 1cm) and a 12% 
resolving gel. Samples were electrophoresed at 10mA through the stacking gel and 
20mA through the resolving gel under constant current in running buffer (appendix 4).
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Detection of tyrosine phosphorylation changes in OKT3-stimulated Jurkats was assayed 
in a similar manner, except before lysis the cells were incubated at 37°C from 0-30 mins 
with the aCD 3 mAb OKT3 or an irrelevant antibody L243 (aHLA-DR) at a final 
concentration of lOjig/ ml. The stimulations were carried out in lOjil of serum free 
RPMI and stopped by the addition of an equal volume of lysis buffer. The samples were 
precleared on ice and the PNS was mixed with 20|xl of loading buffer, boiled and 
separated on a 1mm thick 4% stacking/ 12% resolving gel.
Tranfer
Following electrophoresis the separated proteins were transferred from the gel to a 
nitrocellulose membrane. The proteins carry a net negative charge and so when a current 
is applied across them, they migrate from the negative to the positive electrode. The 
migrating proteins may be transferred to a nitrocellulose membrane placed between the 
gel and the positive electrode. A cassette was used to support a 'sandwich' of a foam 
(Scotchbrite) pad, two sheets of Whatman blotting paper, the gel, the membrane, two 
sheets of Whatman and a foam pad. All elements of the sandwich were presoaked in 
transfer buffer (appendix 4) before assembly and the cassette submerged in transfer 
buffer with the gel oriented to the negative electrode and membrane toward the positive 
electrode. A cooling coil with self-contained circulating fluid at 4°C was placed in the 
transfer tank to limit a rise in temperature which may adversely affect the structure of 
transferred proteins. Transfer was performed at 0.6A for 1.5 hours.
Subsequently the efficiency of transfer was assessed by staining the gel for half an hour 
in Coomassie stain with three half hour washes in destaining solution (appendix 2). This 
was performed on a rocking platform at room temperature. The gel was dried at 70°C for 
1 hour under vacuum on a gel drier (Biorad, Herts, UK)
Blotting
To prevent non-specific signals from arising, the membrane with the blocked by
incubation in lOOmls of blocking buffer comprising 5% w/v BSA and 0.01% w/v Na
azide in TBS for 3 hours on a rocking platform before being washed in lOOmls of TBS
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for lOmins. Primary antibody was diluted in a 10% v/v blocking buffer solution in TBS 
and membranes were incubated for 2 hours in 5mls of diluted primary antibody (final 
dilutions indicated in the results) with rocking. After which the membrane was washed 
for 10 min/ wash once in TBS, 3 x TBS with 0.1% v/v NP40 (TBSN) and once again in 
TBS. All washes were with lOOmls of TBS or TBSN. Secondary antibody was diluted 
in TBSN and the membranes was incubated in lOmls of this for a further 2 hours before 
washing as before. An additional TBS wash was performed as well and then the 
membrane was incubated with ECL reagents for 1 min. The membrane was drained of 
excess reagent and used to expose X ray film.
2.7 Immunoprecipitation of CD28
Precoupling aCD28 Antibody to Protein A Sepharose Beads
To isolate and enhance the detection of signalling molecules associated with CD28, CD28 
was immunoprecipitated using an antibody (15E8) immobilized on Protein A Sepharose 
beads. The beads supplied as a lyophilized powder were rehydrated according to the 
manufacturer's instructions and an equal volume of 80% PBS and 20% ethanol v/v 
storage buffer was dispensed to them. 1ml of a 50% v/v slurry of Protein A beads was 
washed gently in PBS three times before 200|ig of 15E8 was added to them and the 
volume adjusted to 1ml with PBS. The beads and antibody were left to bind by rotation 
at 4°C overnight. The first supernatant was retained and the beads were washed three 
times in PBS before resuspension in 0.5mls of storage buffer and stored at 4°C. The 
level of antibody binding to beads was found to be complete when antibody levels were 
assessed by Coomassie staining of SDS-PAGE separation of aliquots of the first 
supernatant and the precoupled beads.
Immunoprecipitation of Biotinylated CD28
Due to a paucity of antibodies suitable for detection of CD28 by Western blotting, an
alternative method was used to determine the ability of the precoupled 15E8: Protein A
beads to immunoprecipitate a protein matching the predicted molecular mass of CD28,
which was 44 kDa (Aruffo and Seed, 1987). Biotin reacts with amino groups on
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proteins and by immunoprecipitation of biotinylated protein, products may be visualized 
by SDS-PAGE separation and Western blotting. The blotting antibody, an avidin D and 
horse radish peroxidase (HRP) conjugate, served to bind biotin by an interaction between 
avidin D and biotinylated proteins and generate signals which exposed X ray film by an 
interaction between HRP and Amersham ECL reagents.
Typically CD28+CHO cells or as a negative control non-transfected CHO cells at 5x l06 
cells/ sample were biotinylated by washing in PBS.CM (PBS with O.lmM CaCl2 and 
ImM MgCl2 ), pelleted at 1500 rpm (Beckman) and resuspended in 0.5 ml PBS.CM. 
20pl of a freshly made 50 mg/ ml solution of biotin was added to the cells, mixed gently 
by swirling and incubated at room temperature for 2 hours. Subsequently the cells were 
washed three times in PBS, resuspended in 1ml of lysis buffer (appendix 4), incubated at 
0°C for 40 mins, before pelleting cytoskeletal and nuclear proteins at 14000 rpm for 2 
mins. The supernatant was precleared of cross-reactive proteins which may have bound 
Protein A by a 4°C, 30 min rotation with 20fxl of a 50% (vol/ vol) slurry of Protein A 
beads alone i.e. which had not bound antibody. The precleared supernatant was 
recovered and rotated overnight at 4°C with 15E8: Protein A beads. Subsequently the 
beads were washed four times in lysis buffer by centrifugation at 6500 rpm, 10 second 
pulses and the supernatant discarded. The beads were resuspended in an equal volume of 
loading buffer, boiled for 10 minutes and analyzed by Western blotting using avidin D. 
HRP at 5 |ig/ ml as the Western blotting antibody. Upon generation of a new batch of 
precoupled beads, a number of points (at 5x l06 cell equivalents) were incubated with a 
titration of precoupled 15E8: Protein A beads to optimize immunoprecipitation of the 
maximum level of CD28, as indicated in the results.
CD28 Immunoprecipitation Experiments
A number of experiments were performed by stimulation of CD28 using fixed
CD80+CHO cells where the ratio of stimulatory to stimulated cells was 1:3. CD28+CHO
cells, PTK transfected CD28+CHO cells or non-transfected CHO cells (as a negative
control) were stimulated by fixed CD80+CHOs or fixed CHOs for 5 mins at 37°C.
Subsequently the cells were lysed in 1ml of lysis buffer (appendix 4) and incubated over
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ice for 40 mins, before pelleting nuclear and cytoskeletal proteins and preclearing the 
solubilized proteins with 20 |il of a 50% v/v slurry of protein A beads. CD28 was 
immunoprecipitated by rotation of the precleared supernatants for two hours with 
precoupled 15E8: Protein A beads. The beads were washed four times in solubilization 
buffer before further treatment.
In order to assess changes in tyrosine phosphorylation of CD28 and/ or associated 
proteins, 2.5xl07 cells were stimulated by CD80+CHOs or CHOs. lOOfil of precoupled 
15E8: Protein A was used to immunoprecipitate CD28. The beads recovered after 
immunoprecipitation and washing were loaded in 50|il of loading buffer (appendix 4), 
before being boiled for 10 mins and analyzed by SDS-PAGE and Western blotting with 
an anti-phosphotyrosine primary antibody G418 at a 1/1600 dilution and secondary 
antibody goat a-mouse.HRP conjugate (Dako) at 1/ 20000 dilution.
Recruitment of p85 the regulatory subunit of PI3K was assessed in a similar manner to 
changes in tyrosine phosphorylation except lxlO 7 cells were stimulated and 40|LLl of 
15E8: Protein A beads were used to immunoprecipitate CD28 from the cell lysates. The 
primary antibody, JS14, directed against p85a of PI3K and was used at a dilution of 
1/2000 and secondary antibody goat a-rabbit.H RP conjugate (Dako) at 1/ 20000 
dilution.
In Vitro Kinase Assay
Changes occurring in tyrosine/ threonine/ serine phosphorylation were assessed by
performing in vitro kinase (IVK) reactions with CD28 immunoprecipitates. Cells were
stimulated and immunoprecipitated in a manner analogous to that performed in detection
of p85 recruitment to CD28. However after washing the immunoprecipitates the cells
were washed once in cold, i.e. without [32P y] ATP, kinase buffer (appendix 2), before
resuspension in 30|il of kinase buffer containing 2|iCi [32P y] ATP. The cells were
incubated at room temperature for 30 mins. The reaction was stopped by washing the
immunoprecipitates in kinase buffer containing 30mM EDTA. The samples were washed
twice more in this before resuspension in 20|nl of loading buffer and boiling of the
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samples for 10 mins. Proteins were separated by SDS-PAGE and following drying of 
the gel, phosphoproteins were visualized by autoradiography.
Deglycosylation of CD28 Immunoprecipitates
Following autoradiography of the products of a CD28 IVK assay, a number of proteins 
of different molecular weights were seen to have undergone increased phosphorylation 
due to CD80 stimulation. One of which, migrated as a broad band between 44-54 kDa. 
To determine whether the breadth of this band was associated with the protein being 
glycosylated, CD28 immunoprecipitates were treated with/ without PGNase F, a 
deglycosylation reagent which is an amidase capable of cleaving mannose and complex 
oligosaccharides from N-linked glycoproteins. CD28+CHOs (lx lO 7) were stimulated as 
in previous IVK assays with/ without CD80, subjected to an IVK reaction, followed by 
deglycosylation of the reaction products by PGNaseF. Subsequent to termination of the 
IVK reaction of CD28 immunoprecipitates and the removal of unbound/ excess label by 
washing in kinase buffer the samples were washed twice in RIPA buffer:
RIPA buffer: 1 % v/v Triton X 100
0.5% w/v sodium deoxycholate 
0.1% w/v SDS 
150mM NaCl 
50mM Tris.HCl pH8 
ImM Na orthovanadate
and protease inhibitors
10 fig/ ml leupeptin 
10 |ig/ ml aprotinin 
1001ig / ml soybean trypsin inhibitor
once in RIPA with 1M NaCl, twice in RIPA and once in buffer D:
buffer D: 0.1% v/v Triton X I00 
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150mM NaCl 
50mM Tris.HCl pH8 
ImM Na orthovanadate
and protease inhibitors as above
The immunoprecipitates were resuspended in 20|nl buffer D and incubated for 10 mins at 
100°C to denature them. 2.5|il of 10X G7 buffer (manufacturer supplied) and 2.5fxl of 
10% v/v NP40 were added to the denatured samples. Each sample was incubated with 
PGNaseF at 1000U for 1 hour at 37°C. PGNaseF was supplied at 500U/ |il where 1U 
is defined as the amount of enzyme required to remove >95% of the carbohydrate from 
10|ig of denatured RNase B in a lOfil reaction at 37°C in 1 hour. An equal volume of 
loading buffer (appendix 4) was added to each point which were then boiled for 10 mins 
at 100°C before analysis by SDS-PAGE and autoradiography.
2.8 Modulation of Costimulation by Sphingomyelinase/ C2 Ceramide 
Preparation of Purified Resting T cells
50 mis of blood from healthy volunteers was collected in heparinized tubes (0.1 % v/v of
5000U/ ml) and diluted with an equal volume of PBS. Peripheral blood mononuclear
cells (PBMCs) were separated from whole blood by aliquoting in the following
proportions, 25mls of the blood and PBS mixture onto 15mls of a lymphoprep gradient
(density 1.077 g/ ml) and centrifuged without a brake for 30 mins at 1500 rpm (Mistral
2L). Serum (top layer) was aspirated and the buff layer collected. This layer which
comprised PBMCs was washed three times in RPMI containing 10% FCS. The cells
were counted using a Neubauer haemocytometer and added to plastic Petri dishes at a
dilution of no more than 2.5xl06 cells/ ml in medium. The cells were incubated at 37°C
for 1 hour to remove adherent cells such as monocytes. The non-adherent cells were
carefully removed, pelleted and resuspended in 500|il each of mAbs against activated T
cells (L243, HLA-DR at lOpg/ ml), monocytes (UCHM1, aCD14 at lOjxg/ m l) and B
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cells using I O j l l I  of aCD19 (BU12, a 1/10 dilution from ascites). The cells were rotated 
for 1 hour at 4°C and then washed in PBS before resuspension in 500p.l of medium. 
50jil of immunomagnetic sheep anti-mouse IgG beads were added to the cells which 
were rotated for another hour at 4°C before addition of lOmls media and removal of 
antibody labelled cells using a magnet. The cells were washed, counted and analyzed by 
FACS. Typical preparations were >95% CD3+ve.
Proliferation Assays
The effects of different stimuli on cell growth may be examined using a proliferation 
assay. A dividing cell synthesises a copy of its DNA before mitosis and so requires 
nucleotides to facilitate DNA replication. Thymidine is one of the nucleotides required in 
DNA synthesis and the level of 3H thymidine incorporation into cellular DNA is 
proportional to the amount of proliferation occurring. Analysis of the effect of various 
reagents on T cell proliferation may be performed by supplying each point with 3H 
thymidine and allowing time for variations in the uptake of thymidine between treatments 
to become manifest before harvesting the assay and assessing the relative levels of 
radioactivity associated with one treatment compared to another. Thus the effect of one 
treatment compared to another on proliferation can be assessed.
The use of CD80+CHO cells to provide a costimulatory ligand requires fixing of the cells
to prevent high background counts due to their proliferation. Fixing kills the cell
preventing further metabolism but allows the presentation of surface markers to occur i.e.
the interaction of CD80 on CD80+CHOs with CD28 on T cells is not prevented by fixing
the CD80+CHOs. Cells were fixed by washing harvested transfectants twice in PBS and
resuspension of 5 x l0 6 cells in 1ml of 0.025% v/v glutaraldehyde (in PBS). The cells
were incubated at room temperature for 2 mins with occasional swirling to ensure
adequate resuspension of the cells. The cells were washed twice in medium to remove
excess glutaraldehyde and resuspended at the required concentration for the assay.
Control wells of fixed CD80+CHOs with T cells were included in assays to ensure that
the levels of thymidine incorporation recorded were not attributable to transfectant
proliferation and that proliferation of T cells arose from cells of a resting phenotype.
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Typically a proliferation assay was performed by the addition of 5x104 resting T cells 
with 1.7xl04 fixed CD80+CHO and aCD3 mAb at 10jj,g/ ml in RPMI medium. To 
determine whether the proliferation response of T cells to SMase or C2 ceramide was 
dependent upon the type of primary stimulus, the assay was duplicated but aCD3 mAb 
was replaced by PM A at 40ng/ ml as the primary stimulus. Sample volumes were 
adjusted to 200|il with lx  RPMI and aliquoted to a well in a 96 well flat bottomed 
microtitre plate. Treatments were performed in triplicate and for the last 8 hours of 
culture ljiC i of 3H thymidine (5 Ci/ mmol, Cat. No. 2406605, ICN) was added to each 
well. Following this the cells were harvested onto glass fibre filters, separated into tubes 
with 500|xl of scintillation fluid (Wallac, Optiscint HiSafe) and the radioactivity was 
measured using a (3 liquid scintillation counter.
The effects of various reagents as indicated in the results, were assessed in proliferation 
assays. The concentrations listed in the results refer to the final concentration of reagent 
in each well. All samples were equalized for vehicle at a concentration equivalent to the 
highest dose of reagent under analysis.
Viability Assay
In order to determine the effect of a reagent on cell viability in the proliferation assays, 
cells were analyzed for their ability to exclude propidium iodide (PI) from entry in to the 
cell. Cells which loose membrane integrity cannot exclude PI and show increased 
fluorescence (FL2) due to excitation of PI at 580nm i.e. mortality is proportional to FL2.
Cell viability was assessed using replicate plates from proliferation assays, except that 3H
thymidine was omitted. The triplicate points from each treatment were combined and PI
was added to a final concentration of lOjig/ ml. Each treatment was analyzed by FACS
and the data were recorded as FL2. Typically 10000 events were recorded as a
representative sample. In the case of experiments where fixed CD80+CHOs were
included, to avoid high background FL2 from the dead fixed cells, these cells were
excluded from viability analysis on the basis of their larger size (FSC). By excluding the
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very large FSC data from the analysis, little background data due to CD80+CHOs was 
recorded.
Surface Marker Changes
To analyze the effect of reagents upon T cell phenotype the surface expression of CD25 
and CD69 were assessed. Experimental conditions comparable to those for the 
proliferation assays were used except coated aCD 3 mAb was used as the primary 
stimulus where the effects of aCD3 stimulation were analyzed. Soluble antibody would 
have been inappropriate due to interference with subsequent FACS assessment of CD25 
and CD69 expression levels.
Typically a 24 well flat bottomed culture dish was coated in lOOjxl of lOjig/ ml aCD3 
mAb for 4 hours at 37°C (or overnight at 4°C). Excess antibody was removed and the 
wells were washed twice by the gentle pipetting of 1ml PBS in and out of the well. 
l xlO6 T cells and 3.3 xlO5 CD80+CHOs/ well were dispensed in 1ml of RPMI. The 
effect of SMase/ C2 ceramide on surface marker expression were determined by addition 
to replicate cultures. Over 4 days the treatments examined were costimulated cells with 
medium, 7.5x1 O'5 U/ ml SMase, 30|oM C2 ceramide and 0.3% v/v ceramide vehicle 
(ethanol). Daily one well/ treatment was harvested, taking care not to scrape the coated 
aCD3 mAb off the bottom of the well. The cells were washed in PBS and divided into 3 
equal aliquots for FACS analysis. One point was the negative control i.e. not stained 
with a primary antibody and the remaining two points were stained with 50|il of primary 
antibodies against CD25 and CD69 at lOjxg/ ml. All treatments were secondarily stained 
with 50|il of lOjig/ ml goat a-mouse polyvalent FITC conjugate. Fluorescence data were 
recorded as FL1 where 10000 events were recorded as a representative sample.
To assess whether the primary stimulus for T cell proliferation regulated the effects of 
SMase/ C2 ceramide on T cell phenotype, a replicate assay was performed where the 
aCD3 mAb stimulus was replaced with PMA. PMA was added directly to the wells in a 
soluble form at a final concentration of 40ng/ ml. All other conditions were comparable
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to the assay where aCD3 mAb was the primary stimulus. FL1 data were collected on 
CD25 and CD69 surface expression.
2.9 Sphingomyelinase Assay
Sphingomyelinase has been reported to be activated by receptors with opposing function 
e.g. CD28 (Boucher et al., 1995; Chan and Ochi, 1995) and Fas (Cifone et al., 1993). 
Sphingomyelinase generates ceramide and phosphocholine by the hydrolysis of 
sphingomyelin, a ubiquitous animal membrane component (Vance and Vance, 1991). An 
assessment of the degree of SMase activation was performed based on the detection of 
phosphocholine levels in aqueous cell extracts (Wiegmann et al., 1994). Stimulated cell 
lysates, incubated with 14C sphingomyelin, may have their radiolabelled products 
detected by scintillation.
CD28+CHOs were incubated in serum free glutamine free medium at 37°C for 2 hours to 
prevent serum-induced enzyme activation. 5 million cells in 100|il aliquots of serum free 
medium were stimulated by 1.7xl06 fixed CD80+CHOs or untransfected CHOs. At the 
relevant time points the reactions were stopped by immersion of the eppendorf in liquid 
nitrogen, addition of 1ml of ice cold PBS and centrifugation at 2000rpm, 4°C (Heraeus 
Biofuge Fresco) for 15 seconds. The cell pellet was washed twice in PBS and once in a 
buffer A:
Buffer A 10%v/v Nonidet P-40
1 jig/ml leupeptin 
l|ig/ml pepstatin 
ImM PM SF
Following centrifugation as before, the pellet was resuspended in 200|il of the same 
buffer on ice for 15 mins. The samples were pelleted at 13000rpm for 5 mins and 37|il 
of the supernatant was saved. The supernatant was incubated for 2 hours at 37°C in 
ASMase reaction buffer:
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ASMase reaction buffer, pH 4.5 250mM Na acetate, pH 4
ImM EDTA, pH 5
containing 1.1 pC i/ ml 14C sphingomyelin in a final reaction volume of 50pl. 
Phosphocholine was extracted from the samples by chloroform: methanol extraction 
(2:1). 800|il of chloroform: methanol were added to each sample with 300pl of H2O. 
The samples were vortexed and centrifuged at 13000rpm. 200pl of aqueous phase were 
added to vials to which 5mls of scintillation fluid were added before counting. A time 
course of CD80+CHO-induced enzyme activation of ASMase in responding cells was 
plotted as percentage increase in activity above the levels obtained through stimulation in 
the absence of CD80 i.e. with non-transfected CHOs.
In assessment of the neutral (N) and acidic (A) SMase activity in S. aureus SMase a 
comparable protocol was followed. To assess ASMase activity, enzyme aliquots were 
diluted in 5 0 | l l 1  ASMase reaction buffer, pH 4.5 and to assess NSMase activity enzyme 
aliquots were diluted in 50pl NSMase reaction buffer pH 7.4:









0.2% v/v Triton X-100
protease inhibitors as for buffer A
containing 1.1 pCi/ ml 14C sphingomyelin in a final reaction volume of 50pl. Following
a 2 hour incubation at 37°C, phosphocholine was recovered by chloroform: methanol
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extraction. A dose response of NSMase and ASMase activity in S. aureus SMase was 
plotted and compared against a simultaneous experiment using boiled S. aureus SMase.
2.10 Modulation of JNK Activity by Sphingomyelinase/ C2 Ceramide
JNK activation can be detected as a phosphorylation of c-Jun, a substrate of the JNK 
family members (Verheij et al., 1996). Lysates from stimulated cells incubated with a 
fusion protein GST.c-Jun, comprising the amino acids 5-89 of the N terminus of c-Jun, 
may reveal a differential ability between reagents to modulate JNK activity. An in vitro 
kinase reaction utilizing glutathione agarose beads (GAB) to immobilize the substrate 
facilitates the detection of radioactive phosphate utilized by JNK family members to 
phosphorylate GST.c-Jun. The products may be visualized by SDS-PAGE and 
autoradiography.
Induction of GST.c-Jun
25 mis of liquid broth medium containing 50pg/ ml ampicillin (LBamp, appendix 6 ) was 
inoculated from a thawed stock of E.coli transfected with a vector containing an isopropyl 
p-D-thiogalactopyranoside (IPTG)-inducible promoter regulating the expression of 
GST.c-Jun. The inoculum was shaken overnight at 37°C. Two flasks of 400mls LBamp 
were inoculated with 12 mis each of the culture and grown for 2-3 hours until the 
OD6oonm reached 0.6 to 0.8 but not more than 0.9. 2mls of culture were removed for 
continued growth without induction. Expression of GST.c-Jun was induced by addition 
of 0.4mM IPTG and continued growth for 3-5 hours at 37°C. A shorter time induces 
less protein but the protein may be more soluble. 1 ml of uninduced and induced culture 
were transferred to separate eppendorfs, pelleted, resuspended in 80jil of loading buffer 
(appendix 4) and boiled for 10 mins. The samples were resolved by SDS-PAGE and the 
gel Coomassie stained to determine the presence of an induced protein in the IPTG treated 
culture.
Each of the 400ml induced cultures were pelleted at 4°C, 4000rpm for 20mins and the 
pellet resuspended in 1 0 ml lysis buffer by pipetting up and down.
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The lysates were combined and stored overnight at -20°C before sonication for 40 secs. 
The samples were sonicated three more times with a 1 min interval on ice between each 
sonication. The samples were pelleted at lOOOOrpm, 4°C for 10 mins and 2ml of a 50% 
slurry of presoaked GABs (in PBS) were added to the supernatant. The mixture was 
rotated for 2 hours at 4°C, before gentle pelleting of the beads for 15 secs at 1200 rpm. 
A 2 min interval was allowed for the beads to settle before aspirating the supernatant. 
The beads were washed once in lysis buffer (as above) by rotation at 4°C for 5 mins and 
washed (without rotation) again in lysis buffer, three times in PBS containing 2mM 
EDTA, three times in PBS and once in storage buffer.
GAB storage buffer: 50mM Hepes pH 7.4
50mM NaCl 
50% v/v glycerol
The final wash in storage buffer was performed for 1 min at 1200rpm and an interval of 
at least 10 mins was allowed before careful aspiration of the supernatant. The beads were 
transferred to two eppendorfs at 500jxl beads/ eppendorf and an equal volume of storage 
buffer was added to each eppendorf. The beads were stored at -20°C ready for use 
where 10pl of the 50% v/v bead slurry were used.
Measuring GST.c-Jun Phosphorylation
Initially the sensitivity of the newly made batch of GST.c-Jun beads to stimuli was 
assessed. Stimulation with/ without a combination of 5ng/ ml PMA and ljiM  ionomycin
(Cat. No. 407950, Calbiochem) was used to determine whether the old and new batches
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of GST.c-Jun beads could detect JNK activation. Furthermore as ceramide had been 
reported to stimulate JNK activation (Verheij et al., 1996), a dose response of C2 
ceramide on the new beads was made. To account for a vehicle effect on JNK activity, 
the concentration of the vehicle was standardized at 0.5% v/v ethanol in all C2 ceramide 
treated samples. lxlO 7 Jurkats were stimulated for 20 mins at 37°C before being pelleted 
at 1500rpm and 4°C, washed in PBS, repelleted and lysed in 1ml of lysis buffer 
(appendix 4). Lysates were stored on ice for 40 mins before pelleting nuclear and 
cytoskeletal protein at 14000rpm for 6  mins at 4°C. The supernatants were rotated with 
I O jllI  of GST.c-Jun beads for 2 hours at 4°C. The beads were washed three times in 
lysis buffer, leaving 1 min after each centrifugation to allow the beads to settle before 
aspirating the supernatant, and once in JNK kinase buffer (appendix 2). The beads were 
resuspended in 3 5 jll1  of kinase buffer containing 2p,Ci of 32P y-ATP and incubated at 
37°C for 30 mins. The reaction was stopped by the addition of 40p,l of loading buffer 
and boiling for 10 mins. The samples were separated by SDS-PAGE, the gel dried and 
the degree of c-Jun phosphorylation visualized by autoradiography. Subsequently the gel 
was rehydrated by immersion in 750mM Tris.HCl pH 8 . 8  for 10 mins before being 
Coomassie stained to determine protein loading.
After validating the new batch of beads JNK activity was assessed in resting T cells 
under a variety of stimuli. lxlO 7 resting T cells were stimulated for 20 mins at 37°C by 
combinations of PMA (40ng/ ml), aCD3 mAb (diluted 1/100 from ascites), 3.3xl0 6 
fixed CD80+CHOs, 7 .5x l0 ’ 5 U/ ml SMase, 30(xM C2 ceramide or 0.3% v/v ethanol. 
Following stimulation the resting T cell samples were lyzed and treated as for analysis of 
JNK activity in Jurkats.
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Chapter 3
Generation of Cell Lines 
to Assess CD28 Signals
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CD28 has been demonstrated to be reliant on tyrosine phosphorylation to transduce its 
costimulatory effect on IL2 secretion (Vandenberghe et al., 1992). It may be possible 
that the TCR and CD28 share the same PTKs in transducing their proximal signals, as 
neither receptor has intrinsic kinase activity. An analysis of if and what PTKs were 
involved in CD28 signalling was made by constructing a T cell model. A CHO cell line 
was chosen which had previously been transfected with, and expressed, CD28 (Sansom 
et al., 1993). The fibroblastic CHO cell line was used because it is not of haematopoietic 
origin and therefore CHO transfectants would be unlikely to have elements which would 
substitute for the function of one or other of the TCR-activated PTKs. Therefore the 
contribution of individual PTKs to CD28 signalling could be assessed. Thus a 
CD28+CHO cell line was used as the parental cell line for a number of transfections with 
vectors expressing fyn, lck or ZAP70 cDNA in order to determine what contribution each 
of these PTKs might make to CD28 signalling.
Another approach adopted to identify how CD28 might transduce its costimulatory 
function was through the generation of a CD28 negative T cell line. It was hoped that 
this would be the basis for a T cell model with many of the functions and responses of a 
resting T cell remaining but without the CD28-initiated signals. This model would be 
useful in assessing which regions of the intracellular domain of CD28 were involved in 
recruitment/ activation of various effectors to CD28 subsequent to transfections with 
CD28 cytoplasmic domain mutants.
3.1  Plasmid Maxipreparation and Orientation of Fyn and Lck Vectors
In order to transfect the parental CD28+CHO cell line with PTKs, a number of plasmids 
which expressed fyn, lck or ZAP70 were prepared for transfection. Maxipreparations of 
lck and fyn plasmid DNA were performed from E.coli transfected with the vectors. The 
DNA preparations were analyzed by restriction digestions to confirm whether or not there 
were i) fragments of a size compatible with a fyn or lck cDNA insert in the vector and ii) 
whether the insert was correctly oriented. Figure 3.1a shows the result obtained for each 
plasmid after various restriction enzyme digests were performed and the products 
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Fig. 3.1: In sert and O rientation Digests and M aps of Lck and Fyn Vectors
a) 1 jig of lck and fyn vectors were digested by restriction enzymes (REs) as indicated 
and the reaction products were separated by TAE ethidium bromide agarose gel 
electrophoresis using lpg of EcoRl cut ^Hindlll DNA marker to determine product size.
b) A representation of the RE sites on each of the vectors with inserts of fyn (1.626 kb) 
and lck (1.55 kb) cDNA in sense orientation within a gpt.EE6 (6.652 kb) vector are 
illustrated above. Heavy bars on the plasmid indicate cloning site with REs used to 
excise the insert indicated. Numbers before other REs indicate cut site on plasmid.
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Lck
The presence of an insert in the plasmid was determined by digestion with EcoRl or 
Hindm. Both of these had a unique restriction site in the lck insert rather than the vector. 
The expression vector alone without insert was 6.65 kb long and with lck cDNA was 
8.20 kb long (fig 3.1b). Digests of unique sites, therefore, by either EcoRl or Hindlll 
should and did yield a linear 8 . 2  kb fragment.
To analyze the direction in which the cDNA insert lay in the vector, it would be useful to 
find a restriction site within the insert which was considerably asymmetric with respect to 
the length of the site i.e. more 5' than 3' or vice versa. To perform a single digest, 
thereby avoiding complications in digest efficiency by using non-optimal buffers/ 
conditions for different restriction enzymes, it would also be useful to have a second site 
of the same enzyme in the vector as well as the insert. The BamHl site served this 
purpose and if the cDNA was oriented in the sense direction i.e. read 5' to 3' with respect 
to the direction of the promoter activity, then it was predicted that 486 b and 7.71 kb 
fragments would be produced. If in the anti-sense version, the expected products would 
be 1.526 kb and 6.676 kb long.
Figure 3.1a (lane 2) showed a sub-8.2 kb fragment (which could be either sense or anti­
sense) and an absence of any other discernible band. Critically, it was the absence of the 
1.526 kb band which indicated that lck was oriented correctly. If this band had been 
present it would indicate, that an anti-sense cDNA insertion was present. Its absence was 
not due to assay insensitivity, as a digest performed on fyn vector yielded a 1 . 6  kb 
product which was easily visible (see lane 5). In fact, although it is hard to see, there 
was a band of ~ 0.5 b which was visible to the eye (in the lck BamHl digest), although 
rather weak in intensity. As signal strength is proportional to the mass of DNA present it 
was not surprising that the smaller band was weak in signal intensity.
The undigested plasmid showed rather an intense signal which was not well resolved.
This could be due to well overloading and so an incapacity of the agarose gel to properly
sieve such a relatively high mass of DNA.
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Fyn
To check the fyn expressing plasmid for correct size, a unique restriction site was found 
that could be cut by the restriction enzyme T thlll I (fig. 3.1b). Figure 3.1a illustrated 
two points about the plasmid. Namely a linear plasmid of predicted 8.274 kb could be 
detected from this digest. And as the restriction site lay in the insert rather than the 
plasmid, there was an insert within the plasmid. Unlike the lck vector, the fyn vector had 
two H indlll sites flanking the insert. Therefore a H indlll digestion with of the fyn 
vector would reveal a 1.6 kb fyn insert sized fragment and a 6.7 kb plasmid sized 
fragment. This was indeed the case.
To orientate the insert a digest was performed with Apal which lies acentrically within the 
fyn cDNA insert and has one other site within the plasmid. The predicted fragment sizes 
were; sense 2.578 kb and 5.696 kb
antisense 2.282 kb and 5.992 kb
From the markers used, it was possible to see that the critical determinant would have 
been the smaller fragment which if the cDNA was oriented in a sense fashion would lie 
above the level of the 2.3 kb marker and vice versa for the anti-sense version. Lane 7 
(fig. 3.1a) showed fyn to be oriented in sense, as the lower marker lies above the level of 
the 2.3 kb marker with a position that could correspond to a 2.6 kb fragment.
Therefore, it appeared that the plasmids were correctly oriented to express the PTKs and 
were available, in sufficient quantities, to attempt transfection of CD28+ve CHO cells.
3.2 Detection of Fyn, Lck and ZAP70 in CD28+CHO Cells
To establish cell lines expressing one of the PTKs involved in CD28 signalling,
CD28+CHO cells were transfected with the PTK vectors. Following transfection the
populations were expanded under XMAT selection. Detection of fyn, lck and ZAP70 in
the transfectants was determined by Western blotting (fig 3.2a-c). Primary and
secondary antibodies were titrated to determine optimum dilutions for specific detection
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of the PTKs without contributions from non-specific molecules which may cross react 
with the blotting antibodies. In the detection of lck (fig. 3.2b) and ZAP70 (fig. 3.2c) 
many non-specific bands appeared when either the primary or secondary antibody 
concentration was increased. In the case of lck two bands between 56 and 60 kDa were 
detected. This is consistent with a reported retardation in electrophoretic mobility of 
activated lck, whereby the inactive form may be seen at 56 kDa and the activated form at 
60 kDa (August and Dupont, 1994a). It was difficult to say with any certainty whether 
the upper band was indeed an lck gene product as a similar band was apparent in the 
CHO control at some dilutions. ZAP70 (fig. 3.2c) and fyn (fig. 3.2a) showed 
transfectant specific products migrating at approximately 70 and 59 kDa respectively. 
These results are consistent with previous reports detailing the migration of fyn, lck and 
ZAP70 under SDS-PAGE at respectively 59, 56-60 and 70 kDa (Mustelin, 1994). A 
compromise between strength of signal and specificity was reached by using antibody 
dilutions at:
Protein Detected Exposure Primary Dilution Secondary Dilution
Fyn 3 mins 1/500 1/30000
Lck 3 mins 1 / 2 0 0 1/30000
ZAP7070 30 secs 1 / 1 0 0 0 1/30000
In subsequent blots for fyn, lck or ZAP70, the conditions listed in the above table were 
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Fig. 3.2a: O ptim ization of Fyn Detection in Fyn T ransfectants
CD28+CHO cells were transfected with a vector expressing Fyn cDNA. Following 
expansion, lxlO6 Fyn transfectants (FI) or CHOs (C)/ lane were lysed and analyzed by 
SDS-PAGE separation, transfer to a membrane and Western blotting. Primary (rabbit 
derived aFyn polyclonal antibody) and secondary (goat a-rabbit antibody) antibody 
concentrations were titrated to determine optimum signal detection. Arrow indicates 
position of p59fyn. A representative experiment of n=3 is shown.
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Fig. 3.2b: O ptim ization of Lck Detection in Lck T ransfectants
CD28+CHO cells were transfected with a vector expressing lck cDNA. Following 
expansion lxlO6 lck transfectants (L) and CHOs (C)/ lane were lysed and analyzed by 
SDS-PAGE separation, transfer to a membrane and Western blotting. Primary (rabbit 
derived aLck polyclonal antibody) and secondary (goat a-rabbit antibody) antibody 
concentrations were titrated to determine optimum signal detection. Arrows indicate 
positions of putatively activated p60lck (upper) and inactive p56lck (lower). A 
representative experiment of n=3 is shown.
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Fig. 3.2c: Optim ization of ZAP Detection in ZAP T ransfectants
CD28+CHO cells were transfected with a vector expressing ZAP cDNA. Following 
expansion lxlO6 ZAP transfectants (Z) and CHOs (C)/ lane were lysed and analyzed by 
SDS-PAGE separation, transfer to a membrane and Western blotting. Primary (rabbit 
derived aZAP polyclonal antibody) and secondary (goat a-rabbit antibody) antibody 
concentrations were titrated to determine optimum signal detection. Arrow indicates 
position of pVO2^ .  A representative experiment of n=3 is shown.
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3 .3  Expression Levels of Fyn and Lck Protein in Clones
While clonal populations of cells facilitate experimental reproducibility, achieving clonal 
populations of cells with the desired characteristics may be difficult. However to assess 
the contributions of PTKs, without variation arising from a polyclonal population, 
transfectants were screened by Western blotting in order to attempt the identification of 
clones with detectable and preferably high levels of PTK expression. Initially the PTK 
transfected CD28+CHOs were stained with a primary aCD28 mAb and secondary FITC 
conjugated antibody for FACS analysis. The cells which had homogeneously high 
expression of CD28 were directed in to a 96 well microtitre plate by a Becton Dickinson 
ACDU application at 1 cell/ well for 20 clones. Subsequently these were expanded under 
XMAT selection before analysis by Western blotting.
Fyn transfectant clones showed (fig. 3.3a) that only clone 1 (F1CC) had relatively high 
expression of fyn with clones 18 and 19 showing some fyn expression although at a 
lower level. Lck transfected clones did not show (fig. 3.3b) detectable lck expression 
although the uncloned "LCC" populations did. Due to the limited number of fyn 
transfectants and the absence of clonal lck transfectants expressing easily detectable levels 
of PTKs, further attempts to isolate PTK clones were not performed.
In conclusion F1CC, LCC and Zap+CD28+CHO (ZCC uncloned) cell populations were 
deemed to have sufficiently high levels of PTK expression to differentiate them from the 
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Fig. 3.3: Expression Levels of a) Fyn and b) Lck in T ransfected
C D 28+ve CHO Clones
Above is representative example of twenty CD28+CHO clones transfected with a) fyn or
b) lck expression vectors which were expanded and Western blotted for levels of fyn and 
lck protein expression. lxlO6 cell equivalents/ lane were analyzed. The arrows in a and 
b represent respectively the migration positions of p59fy° andp56lck. A representative 
sample of n=2 is shown.
L9 L10 J16 CHO IgG
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3.4 Development of a CD28LOW J16 line
In order to develop a better understanding of the role of CD28 and the signals controlling 
costimulation in T cells, a T cell line which could act as a parental cell host for CD28 
intracellular domain mutants was developed. The Jurkat subclone, J16, was subjected to 
various treatments to deplete the population of CD28 expressing cells. The first type of 
treatment was by labelling the cells with aCD28 mAb followed by complement mediated 
lysis. Following recovery of live cells and their expansion the process was repeated four 
times. Figure 3.4 shows CD28 expression in the parental line J16 and after the fourth 
round of complement treatment, where the cell type is labelled JcR4. Following 
expansion the population of cells were labelled again with aCD28 mAb and incubated 
with magnetic beads carrying anti-mouse immunoglobulin. Then the population was 
exposed to a magnet to deplete the population of CD28 positive cells further (fig. 3.4, 
JMAG). Finally the population of cells not removed by the magnet were expanded and in 
two consecutive rounds sorted by FACS for cells showing a comparable level of 
fluorescence (FL1) to the negative control. FL1 was proportional to the level of CD28 
expression and the negative control had not been labelled with aCD28 antibody. The 
level of CD28 expression following the second round of selection of CD28-ve cells by 
FACS using an ACDU programme, labelled 28N (for CD28 Negative 116s). is illustrated 
in figure 3.4. A marked decrease from 98.9% to 24.6% of the population showed CD28 
expression between the J 16 and 28N cell lines.
3.5 Phenotype of a CD28LOW Jurkat Cell Line
To assess whether or not the strategy which depleted CD28 from the cell surface of 
Jurkats was specific to depleting CD28, the parental cell line, J16, and the CD28LOW line, 
28N, were assessed for the level of other surface markers. The cells were stained for 
FACS analysis with antibodies against a range of membrane proteins. The overlapping 
histograms in figure 3.5 allow a comparison of the level of expression between J 16 and 
28N for the surface markers. In fact the two cell lines had comparable expression of 
CD2, CD3, CD4, CD7, CD8 , CD25, CD48 and LFA-3. The only marked difference 
between the two populations was the level of expression of CD28 which was far lower in 








Fig. 3.4: G eneration of a CD28-ve/ Low T cell Line.
aCD28 mAb labelling of cells followed by complement mediated lysis (JcR4), magnetic 
depletion of cells binding aCD28 (JMAG) and selection of CD28 -ve cells by FACS 
(28N) generated a CD28 low T cell line, 28N, from J16 Jurkats. A histogram shows the 
level of CD28 expression assessed by FACS at each stage of treatment. The percentage 
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Fig. 3.5: Com parison of Surface M arkers between J16 and a CD28LOW
J16 Line, 28N
2xl05 J16s (filled grey histograms) or 28Ns (lines) were fluorescent stained for surface 




To analyze the role of PTKs in CD28 signalling, a number of cell lines were developed. 
PTK+CD28+CHO cells would facilitate an analysis of different effects between one PTK 
and another in the phosphorylation of CD28 or associated substrates of CD28. In 
addition PTK transfectants would be useful in analyzing the possible contribution PTKs 
make in the recruitment of other signalling molecules to CD28. The Jurkat CD28LOW 
cell line, 28N, might be useful in assessing the role of CD28 cytoplasmic mutants or 
CTLA4 if they were transfected into 28N.
The use of clonal populations in biological responses facilitates reproducible results due 
to the homogeneity of biochemical signalling within such a population compared to a 
mixed population. In this chapter, 20 clones of fyn and lck CD28+CHO transfectants 
were screened by Western blotting following their expansion under selection. It was 
noted that one clone of the fyn transfectants expressed markedly greater levels of fyn 
protein and two others expressed moderate amounts of fyn. In contrast, of the lck clones 
tested, none expressed a level of lck detectable by Western blotting. Thus the non-clonal 
population (LCC) was designated as the more useful cell line for future experiments. 
Due to the lack of a high or even detectable level of lck in the clonal populations, it was 
decided that as the non-clonal ZAP70 population expressed clearly detectable levels of 
protein specific to the ZAP70 gene, that it might be excessively costly in time to attempt 
to find a clone which may/ not express greater levels of ZAP70. And so a non-clonal 
population, ZCC, was used in analysis of the function of ZAP70 in CD28 signalling.
It is interesting to note that despite expansion of newly transfected cells and later clones 
under selection none of the lck clones and few of the fyn clones expressed detectable 
PTK. Therefore while the cells had to express the gpt gene to proliferate under XMAT 
selection (Mulligan and Berg, 1981), it was apparent that the expression of a PTK cDNA 
insert was not necessarily concomitant with expression of a selectable marker gene.
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To assess the level of protein expression from transfected genes Western blotting was 
employed. The primary antibody, raised against the gene product and the secondary 
antibody, which had the primary antibody as a substrate, determined the specificity of 
Western blotting. Crossreactive molecules to primary antibodies induce the appearance 
of bands in Western blots which are not specific to the expressed transfected gene 
product. The secondary antibody functions to regulate the level of signal. Therefore 
where specificity is problematic, provided that the target signal is the most intense, 
primary and/or secondary antibody concentrations may be lowered until only the 
strongest signal is visible. Further the length of time a film is exposed to signal (from 
the enhanced chemiluminescent source of emission) determined signal strength, and 
apparent specificity, in a manner analogous to the secondary antibody.
In order to attempt further analysis of CD28 signals and provide information on the type 
of interaction(s) transducing costimulatory signals, a CD28LOW T cell line was 
developed. This CD28LOW T cell was intended to be a host for subsequent transfection 
of CD28 cytoplasmic mutants. Alternatively CTLA4 might be transfected into the cell 
line. A variety of methods were used to develop a CD28 -ve T cell line, all based upon 
deletion of cells reactive to aCD28 mAb from the population. A cell line with markedly 
lower CD28 expression was achieved and denoted 28N. However throughout the CD28 
deletion strategy, it became apparent that the reductions in CD28 surface expression were 
not necessarily permanent and given time may return, perhaps to levels comparable to the 
parental line, J16. Therefore after expansion of the 28N population and checking that 
CD28 expression was still low, a number of vials were cryopreserved and the remainder 
were further expanded and rapidly used. Phenotypically 28N had slight differences from 
J16 in CD48 and CD2 expression and except for the large difference in CD28 expression, 
both populations had comparable expression of other surface markers. Whether or not 
differences in response of 28N arise solely from its lower expression of CD28, rather 
than small changes in CD48 and CD2 was not investigated. Due to the partial nature of 
the difference in expression between 28Ns and J 16s of these latter two surface markers, 
it would seem more likely that differences in response between the two cell lines would
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arise from the distinctly lower surface expression of CD28 on 28N compared to those of 
CD28 on J16.
In conclusion a number of cell lines of the required phenotype were successfully 
generated. For example the clonal fyn+CD28+CHO cell line, F1CC, expressed 
detectable levels of fyn and CD28, the uncloned transfectants LCC and ZCC expressed 
detectable levels of lck and ZAP70 respectively as well as CD28, while 28N had 
depleted levels of CD28. Further, a Western blotting assay had been optimized such 
that specific detection of fyn, lck or ZAP70 expression in the PTK was possible. 
Monitoring of the level of CD28 expression in the cell line 28N was performed by 
FACS. Therefore it was possible to conclude that the cellular models required were 
ready for use and so assays were devised to assess the effect of ligating CD28, by one 
of its natural ligands, CD80.
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Chapter 4
Analysis of Proximal Signals of CD28
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The mechanism by which CD28 transduces costimulatory signals is not known despite 
growing interest in the field. Studies attempting to identify proximal signalling molecules 
involved in CD28 costimulatory pathways are obscured by a number of issues. For 
example the action of an inhibitor herbimycin A in ablating CD28 costimulation of IL2 
production (Vandenberghe et al., 1992; Lu et al., 1994) has lead to the belief that protein 
tyrosine kinases are important in transducing CD28 proximal costimulatory signals. 
However because herbimycin A is directed against sulphydryl (SH) moieties (Uehara et 
al., 1989), it may be suggested that it lacks specificity. Therefore the role of PTKs in 
CD28 signalling remains to be investigated. Interpretation of the results of other studies 
addressing the contribution of PTKs by analysis of PTK mutant cell lines e.g. JCaM l, 
which is lck negative, also presents difficulties because T cells possess a number of 
PTKs from the src, syk and EMT families and these may have functional redundancy. 
For example Lu et al demonstrated phosphorylation of a p i 10 protein with and without 
contributions from lck in Jurkats and JCaM ls respectively (Lu et al., 1994) following 
CD28 ligation. Thus it is difficult to determine whether lck was the kinase capable of 
phosphorylating p i 10 in the lck+ve Jurkat or whether an alternative PTK had substituted 
the role of lck. An alternative method to study the contribution of individual elements of 
CD28 signalling is needed. One theoretical possibility would be to transfect resting T 
cells with kinase inactive PTKs and determine which combination of these regulates 
CD28 signalling. However this is not yet possible due to difficulties in resting T cell 
transfection whereupon they show low survival rates. Transfection of activated T cells or 
Jurkats is possible e.g. with IL2 promoter constructs (Stein et al., 1994; Boucher et al., 
1995; Crooks et al., 1995) but may not supply accurate information on the costimulatory 
requirements of resting T cells due to differences in biochemical signalling pathways 
from resting T cells. For example inhibition of PI3K activity by incubation of resting T 
cells in wortmannin inhibits IL2 production despite costimulation, but wortmannin has no 
effect or possibly augments IL2 production in Jurkats and T cell blasts (Ward et al., 
1995; Ueda et al., 1995). Therefore the use of "activated" T cells in studies attempting to 
analyze the transduction pathways arising from CD28 in resting T cells may be of limited 
use.
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This chapter attempted to overcome some of these problems and in order to analyze 
interactions with CD28 during signal transduction, individual PTKs were expressed in 
CHO cells expressing CD28 (CD28+CHOs) and assessed for their contribution to CD28 
signalling. We analyzed immunoprecipitates of CD28 for tyrosine (tyr), serine (ser) and 
threonine (thr) phosphorylation changes in response to stimulation with and without 
CD80. Attempts were also made to analyze the effect of lck on PI3K recruitment to 
CD28 and in addition due to reports that CD28 costimulatory function may be replaced by 
ASMase in murine splenic T cells (Boucher et al., 1995; Chan and Ochi, 1995), CD28 
was examined for its capability to stimulate ASMase.
4.1 Immunoprecipitation of CD28
In order to determine the effect of ligating CD28 in the absence of contributory signals 
from other receptors and to optimize the sensitivity of detection of CD28-associated 
signals, CD28 was immunoprecipitated from CHO transfectants. In order to verify the 
procedure and due to a paucity of aCD28 antibodies suitable for Western blotting, CD28 
and other cell surface proteins were initially labelled with biotin. Labelled CD28+CHOs 
or control CHOs were lysed, incubated with aCD28: Protein A-Sepharose, subjected to 
SDS-PAGE and Western blotted with an HRP.avidin D conjugate directed against biotin 
and the products were visualized using ECL reagents. This process yielded a broad band 
of approximately 44-54 kDa from CD28+CHOs, but not from non-transfected CHO cells 
(fig. 4.1). A second band at -70  kDa of weaker intensity was also apparent and this may 
be an associated surface protein or a partially reduced CD28 dimer. The nature of this 
high molecular weight molecule was not investigated further although it is unlikely that it 
was a CD28 dimer due to the molecular weight which was not consistent with an 
expected molecular weight of 8 8  to 108 kDa for a CD28 dimer. Thus, as a result of 
transfecting CHO cells with CD28, a product of 44-54 kDa could be immunoprecipitated 
from these cells. This is in agreement with previous findings that CD28, while predicted 
to be expressed as a protein of molecular weight 23 kDa from the gene sequence (Aruffo 
and Seed, 1987) becomes heavily glycosylated (Aruffo and Seed, 1987; Hara et al., 
1985) accounting for the breadth of the band immunoprecipitated.
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CHO Cell Type
Fig. 4.1: A B road 44 - 54 kDa Band Can Be Im m unoprecipitated from
C D 28+CH O  Cells But Not from  P aren ta l CHO Cells
Precoupled aCD28: Protein A Sepharose beads immunoprecipitated a broad band of ~ 
44-54 kDa from biotinylated cells transfected with CD28, but not where cells did not 
express CD28. 5-60pl of aCD28: Protein A Sepharose beads were titrated against 5 
million cells/ lane, CD28 was immunoprecipitated and Western blotted with Streptavidin. 
HRP. A representative experiment of n=3 is shown.
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To optimize the sensitivity of immunoprecipitates, a titration of aCD28: Protein A beads 
against a fixed number (5 million) of biotinylated CD28+CHO cells was performed. The 
optimum ratio of antibody precoupled beads to cell number was determined from 
experiments such as this and in the preparation used in figure 4.1 was 40|il of beads for 5 
million cells. Thus for subsequent experiments, depending on the cell number required, 
the volume of beads could be altered to maximize signals associated with CD28.
4.2 Establishing a Tyrosine Phosphorylation Assay
In order to establish an assay to detect tyrosine phosphorylation by Western blotting 
which could subsequently be used to assess the tyrosine phosphorylation status of CD28, 
changes in tyrosine phosphorylation occurring after ligation of CD3 were assessed, as 
CD3 has been reported to undergo tyrosine phosphorylation upon stimulation (Rudd et 
al., 1994; Straus and Weiss, 1993; Irving and Weiss, 1991). Lysates from 1 million 
Jurkats, stimulated by aCD3 mAb and lysed after incubation periods between 0 and 30 
mins, were assessed for changes in tyrosine phosphorylated proteins on the Western 
blotted lysates. It was found that in Jurkats there was some constitutive tyrosine 
phosphorylation (fig. 4.2) of -29 , 35, 44, 53, 63, 67, 85, 90 and 120 kDa proteins. 
Stimulation through CD3 rapidly increased both the overall level of tyrosine 
phosphorylation and induced the appearance of specific tyrosine phosphoproteins at -23 
kDa and between 46 and 120 kDa. In addition some phosphotyrosine proteins 
disappeared during stimulation e.g. an 85 kDa protein. An increase in tyrosine 
phosphorylation was apparent 10 seconds after stimulation of CD3, peaking at 1-2 
minutes. Thereafter a gradual decline was evident although there was still a greater level 
of tyrosine phosphorylation at 30 minutes post-stimulation than in the resting Jurkats. 
The tyrosine phosphorylation profile observed from Jurkat lysates following CD3 
stimulation concurs with that observed in other reports (Irving and Weiss, 1991). These 
tyrosine phosphorylated molecules represent substrates of tyrosine kinases associating 
with the TCR such as CD3 and TCR£, kinases and adapter molecules facilitating TCR 
signal transduction. For example 23 kDa CD3e and CD38 have been reported to become 
tyrosine phosphorylated following TCR stimulation (Straus and Weiss, 1993) and the 40
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kDa molecule may represent tubulin while the kinases fyn, lck and ZAP70 which are 
negatively regulated upon tyrosine phosphorylation by p50csk are of 59, 56-60 and 70 
kDa respectively (McFarland et al., 1992). However the identity of these molecules was 
not further investigated because we were not trying to establish the identity of CD3- 
stimulated phosphotyrosine proteins and this experiment served to demonstrate that we 
were capable of detecting phosphotyrosine proteins by Western blotting. The changes in 
various phosphoproteins also served to establish that the detection was specific as 
stimulation through an irrelevant antibody (L243, directed against HLA-DR proteins, lane 
9) did not show a comparable increase in tyrosine phosphorylation at 30 minutes post­
stimulation compared to the level induced by the aCD3 mAb (lane 8 ) .  In conclusion we 
established an assay capable of measuring changes in tyrosine phosphorylation which 
could then be used in CD28 assays.
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Fig. 4.2: L igated CD3 M odulates Tyrosine Phosphorylation in Ju rk a ts
lxlO6 Jurkats/ lane were stimulated with aCD3 mAb (10|ig/ ml) for the indicated time 
periods at 37°C where 10“ and 30” referred to seconds and other time points were in 
minutes. The point 30’ was stimulated by an irrelevant antibody. Following stimulation, 
lysates were analyzed for changes in tyrosine phosphorylation by Western blotting with 
4G10. A representative experiment of n=3 is shown.
* *
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4.3 The Effect of Fyn, Lck and ZAP70 on Tyrosine Phosphorylation of 
CD28 Immunoprecipitates
We next attempted to examine the effect of the PTKs fyn, lck and ZAP70 on modulating 
the tyrosine phosphorylation of CD28 and associated molecules following stimulation by 
CD80 (B7). CD28+CHO cells were stimulated with/ without CD80, CD28 was 
immunoprecipitated from lysates and following SDS-PAGE, Western blotted with the 
primary mAb 4G10 for phosphotyrosine proteins. Figure 4.3 illustrates that the levels of 
tyrosine phosphorylation associated with CD28 immunoprecipitates were generally 
greater in the presence of a PTK transfected into CD28+CHO cells, although none of the 
increases in tyrosine phosphorylation appeared specific to the ligation of CD28. Indeed 
the increases in tyrosine phosphorylation in the presence of PTKs did not appear specific 
either in that most of the substrates phosphorylated appeared to be present in 
CD28+CHOs, albeit tyrosine phosphorylated to a lower ex ten t. Jurkats showed similar 
tyrosine phosphorylation patterns to PTK+CD28+CHO cells. It would appear then that 
little/ no increase in CD28 tyrosine phosphorylation is facilitated without the presence of 
additional signals e.g. PTKs in agreement with the lack of an intrinsic PTK activity of 
CD28 (Aruffo and Seed, 1987).
In the presence of T cell PTKs, irrespective of stimulation with or without CD80, there
was an overall higher level of tyrosine phosphorylation associated with CD28
immunoprecipitates. Previous reports have described the induction of phosphotyrosine
proteins such as the T cell expressed plOOVav (Nunes et al., 1994) and p62, an adapter
protein (Nunes et al., 1996) following CD80 stimulation of CD28. There was no
evidence that a 100 kDa band was induced in our experiments in Jurkats although it may
be possible that a 62 kDa protein was present in the fyn transfectant immunoprecipitates
independent of CD80-CD28 interaction. However due to strong signals from the reduced
heavy chain immunoglobulin band at -55 kDa, it is difficult to decipher whether the 62
kDa protein is part of the immunoglobulin band or present due to fyn activity. Despite
the lack of inducible changes in tyrosine phosphorylation recorded in CD28
immunoprecipitates, Jurkat lysates (lane 13) stimulated with an aCD 3 mAb (OKT3)
demonstrated that tyrosine phosphorylation could be observed. Overall the results from
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these experiments were disappointing and did not reveal specific, kinase-dependent 
phosphotyrosine changes in CD28 immunoprecipitates.
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Fig. 4.3: Effect of Fyn, Lck or ZAP on Tyrosine Phosphorylation of
CD28 Im m unoprecipitates +/- CD80 Stim ulation
2.5x107 cells/ lane were stimulated with (+) CD80+CHO or with CHO (-) at a ratio of 
3:1 for 5 mins at 37°C. Following immunoprecipitation with aCD28:Protein A beads, 
changes in tyrosine phosphorylation were assessed by SDS-PAGE separation and 
Western blotting. CHO, Chinese hamster ovary; CC, CD28+CHO; F1CC, fyn+CC 
(clone 1); LCC, lck+CC; ZCC, ZAP+CC; lxlO6 Jurkats were stimulated with OKT3 
(10pg/ ml as a positive control) for 2 minutes and the lysate was analyzed. A 
representative experiment of n=3 is shown.
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4.4a The Effect of Fyn, Lck and ZAP70 on the Phosphorylation of CD28 
Immunoprecipitates
We next examined whether fyn, lck or ZAP70 could either facilitate the association of
other kinases with CD28 or functionally associate themselves with CD28. CD28+CHOs,
Jurkats, CHOs or PTK transfected CD28+CHOs were stimulated for 5 mins at 37°C with
or without CD80 and PTK-modulated phosphorylation of CD80-stimulated CD28 was
assessed. CD28 was immunoprecipitated and subjected to a [32P y] ATP in vitro kinase
(IVK) reaction. The reaction products were separated by SDS-PAGE and the dried gel
was used to visualize the products which had incorporated 32P y by autoradiography.
Interestingly, both fyn and lck specifically enhanced phosphorylation of CD28
immunoprecipitates in response to CD80-CD28 interaction (fig. 4.4a), a result which
contrasted with that observed in analysis of tyrosine phosphorylation changes (fig. 4.3).
Three substrates in lck or fyn transfectants (LCC or F1CC) appeared to show increased
levels of phosphorylation and these migrated at approximately 44, 85 and 110 kDa. It
was found that lck and fyn transfectants but not ZAP70 transfectants were capable of
demonstrating a CD80-induced increase in phosphorylation of CD28 immunoprecipitates
(fig 4.4a). In particular the result for lck transfectants when stimulated by CD80 was
most marked. Strikingly, Jurkats showed a similar pattern of phosphoprotein banding to
that seen with lck and fyn transfectants. In addition in Jurkat cells, two bands at 56-60
kDa, which were not apparent in CHO transfectants, underwent a CD80-induced increase
in phosphorylation. These may have represented lck because upon activation lck
becomes more heavily phosphorylated and appears as a pair of protein bands at 56 and 60
kDa (August and Dupont, 1994a). For the ZAP70 transfectants (ZCC) there was no
increase in either constitutive or CD80-induced levels of phosphorylation beyond that
seen in the parental cell line CD28+CHO. Thus the presence of ZAP70 did not facilitate
increased phosphorylation of proteins associating with CD28. However, since direct
precipitation of ZAP70 followed by assessment of kinase activity was not performed, we
cannot at this stage exclude the possibility that the kinase was defective. Support for the
hypothesis that fyn and lck but not ZAP70 mediate increased phosphorylation of CD28
immunoprecipitates could further be provided by a confirmation of an intact kinase
activity of ZAP70. However the data suggest that fyn and lck, but not ZAP70, could
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facilitate an increase in the phosphorylation of proteins corresponding to the molecular 
weights of CD28 and PI3K subunits, when CD28 was ligated by CD80, although the 
identity of these proteins is not proven. These data also concur with a report (Raab et al.,
1995) which demonstrated lck and fyn, but not ZAP70, were sufficient to associate with 
CD28 immunoprecipitated in vitro kinase activity, although they did not address the 
effects of ligating CD28 with either ligands or antibody. In conclusion it would appear 
that fyn and lck are capable of associating with CD28 signal transduction and that fyn or 
lck either directly tyrosine phosphorylate CD28 and associated substrates or alternatively 
recruit ser/ thr kinases which phosphorylate CD28. Furthermore assuming equivalent 
levels of PTK expression in the cell lines, lck more than fyn had the greater capability to 
inducibly phosphorylation of CD28.
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Fig. 4.4a: Effect of Fyn, Lck or ZAP on Phosphorylation of CD28 Im m unoprecipitates +/- CD80 Stim ulation
lxlO7 cells/ lane were stimulated with CD80+CHOs (+) or CHOs (-) at a ratio of 3:1 responders to activators, for 5 mins at 37°C. 
CD28 was immunoprecipitated and IPs were subjected to IVK analysis. Cell lines as in figure 4.3. A representative experiment 
of n=3 is shown.
4.4b-c Fyn, Lck, ZAP70 and CD28 Expression in Cell Lines
In order to assess whether the differential phosphorylation of CD28 by the PTKs fyn, lck 
or ZAP70 may have been an artefact arising from variation in either PTK or CD28 
expression, control experiments were performed to analyze their levels of expression.
To analyze CD28 expression, FACS assessment of CD28 surface expression was 
employed. Figure 4.4b illustrated that CD28 expression was comparable between cell 
lines. Therefore the lower level of inducible changes seen with ZCC (compared to LCC 
and F1CC) could not be attributed to depleted levels of CD28.
To determine whether variation in PTK expression may have accounted for the difference
in response shown in figures 4.3 and 4.4a, Western blotting was used to determine levels
of PTK expression. Figure 4.4c demonstrated that PTK expression was heterogeneous
between cell lines, relative to the level observed in Jurkats. When fyn expression was
assessed, two bands at ~ 59 and 63 kDa were apparent in a blot of fyn transfectant lysates
whereas only one band was present in the CHO control at ~ 63 kDa. Therefore the lower
band at 59 kDa was specific to fyn and while this was apparent in the fyn transfectant, it
was absent from the Jurkat lysate and CHO control. Therefore Jurkats did not express a
protein migrating at the same molecular weight as the transfectant. However it is possible
that fyn may be differently processed in Jurkats and therefore may migrate at a different
rate under SDS-PAGE. Lck expression was markedly lower in the transfectants (LCC)
than in Jurkats and ZAP70 expression appeared to be, like fyn, higher in transfectants
than Jurkats. All transfectants showed gene products (indicated by arrow heads) at the
expected molecular weights, respectively 59, 56 and 70 kDa for fyn, lck and ZAP70,
which were clearly distinguishable from background cross reactive products. As ZAP70
and fyn expression in transfectants was relatively high compared to the levels observed in
J16s, its was interesting that lck, expressed to a lower level in transfectants compared to
J16s, should facilitate the most intense phosphorylation of CD28 associated substrates.
It was therefore concluded that given the levels of expression as determined by Western
blotting, lck was the most potent kinase tested for the recruitment of kinase activity to
CD28 immunoprecipitates. The apparent lack of a role for ZAP70 is consistent with its
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known role in TCR signalling and requirements for binding to CD3 and £ subunits 
bearing an IT AM motif (Hatada et al., 1995) from the literature, however we were unable 
to rule out a defective kinase activity. Nonetheless these data strongly support a role for 
lck in recruiting p85/ p i 10 molecules to CD28 which are possibly PI3K, as well as 
causing the phosphorylation of a 44 kDa band which is probably CD28.
4.5 Deglycosylation of CD28
In order to attempt identification of the phosphoprotein migrating in the range 44-54 kDa 
which may have been CD28, immunoprecipitated CD28 was treated by a deglycosylating 
agent, PGNase F. While CD28 has a predicted molecular weight from nucleotide 
sequence data of 23 kDa (Aruffo and Seed, 1987) as a monomer, the mature protein has 
five potential N-linked glycosylation sites (Asn-Xaa-Ser/ Thr) (Aruffo and Seed, 1987). 
Thus as a mature protein CD28 under reducing conditions is reported to migrate as a 
broad band at -44-54 kDa (Aruffo and Seed, 1987; Hara et al., 1985). Figure 4.5 shows 
that in lck+CD28+CHOs, stimulated by CD80, the phosphorylation state of a broad 44- 
54 kDa band, increased. Treatment with a deglycosylating agent, PGNase F, caused the 
disappearance of this band (top arrow) and the appearance of a 23 kDa band (bottom 
arrow) without affecting the migration rates of other phosphoproteins associated with 
CD28. Thus it seemed likely from this data and the information above that this broad 44- 
54 kDa band was CD28 and this concurred with data from a report (Hutchcroft et al., 















Fig. 4.4b: Levels of CD28 Surface E xpression  on T ran sfec tan ts  and
Ju rk a ts  and B7 on B7+ C H O s
2 x l0 5 cells were fluorecent labelled with aCD28 (9.3) or aB7 (BB1) mAbs before 
FACS analysis. Cell samples analyzed were paired with the cell lines in fig 4.4a; fyn 
(FCC), lck (LCC), ZAP (ZCC), CD28 (CC) and J16 Jurkats. Figures in brackets 
indicate the percent of cells showing expression above 95% of the -ve control. CD80 
(B7) expression relative to cells stained without the primary antibody is also shown in the 
top diagram.
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Fig. 4.4c: Levels of Fyn, Lck and ZAP in T ransfectants and Ju rk a ts
lxlO6 cells/ lane were lysed, their proteins separated by SDS-PAGE and Western blotted 
for fyn, lck or ZAP indicated by arrow heads. Jurkats (J), CHOs (C), fyn (FI), lck (L) 




Fig. 4.5: Deglycosylation of CD28 A ltered Its E lectrophoretic  M obility
lxlO7 Lck transfectents were stimulated with CD80+CHOs (B7) (+) or CHO controls (-) 
at a ratio of 3:1 responders to stimulators for 5 min at 37°C. CD28 immunoprecipitates 
were subjected to IVK reactions before treatment +/- PGNaseF, a deglycosylation agent. 
Products were visualized after SDS-PAGE separation by autoradiography. Upper arrow 
indicates position of untreated CD28, lower arrow deglycosylated CD28. A 
representative experiment of n=2 is shown.
4.6a Detection of p85, the Regulatory Subunit of PI 3-kinase
In order to determine the identity of the -85 kDa protein in figure 4.4a, cellular lysates 
from CHO cells were used to optimize a Western blotting assay directed against p85, the 
regulatory subunit of PI3K (Ward et al., 1992). Figure 4.6a demonstrates that it was 
found possible to detect an 85 kDa protein in CHO cell lysates in addition to a number of 
other proteins which cross-reacted with the Western blotting antibody. However these 
bands migrated at different rates under SDS-PAGE and were easily distinguished from 
p85. Ultimately a dilution was decided upon of primary a-p85 antibody at 1/2000 and 
secondary antibody at 1/20000. This was an attempt to minimise non-specific 
contributory signals while maintaining the intensity of the p85 signal, although 
background signals were not ablated entirely. Thus the detection of p85 was made 
possible.
4.6b Effect of CD80 on Recruitment of PI 3-kinase to CD28
To investigate whether or not the 85 kDa protein observed to be phosphorylated by the 
ligation of CD28 by CD80 (B7) in the presence of lck or fyn (see fig. 4.4a) was p85, 
CD28 was immunoprecipitated from cell lines following stimulation by CD80 and the 
presence or absence of p85 was determined by Western blotting. Figure 4.6b showed a 
CD80-induced recruitment of p85 (see arrow) to Jurkats but not to a CD28LOW T cell 
line, 28N. This was consistent with a previous finding of p85 recruitment to CD28 
which could be induced by CD80 in Jurkats (Ward et al., 1995). In CHO cells it was not 
possible to convincingly detect p85 and this may be due to assay insensitivity. Controls 
for CD28 expression detected more CD28 expression in transfectants than Jurkats and 
therefore limited CD28 was not a cause of assay insensitivity. Lck expression in 
transfectants however had diminished and therefore this was likely to have contributed to 
the difficulty of detecting p85 recruitment to CD28 should this occur in CHO 
transfectants.
4.7 Effect of CD28 Ligation on Acidic Sphingomyelinase Activation
A number of studies have suggested an association between CD28 ligation and ASMase
activation (Boucher et al., 1995; Chan and Ochi, 1995). In order to examine whether this
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may occur in CHOs, fixed CD80+CHOs were used to stimulate CHOs and CD28+CHOs 
before measurement of endogenous ASMase activity. Lysates from stimulated cells were 
incubated with 14C sphingomyelin and the release of labelled phosphocholine due to 
activation of endogenous ASMase was measured by scintillation counting. It was 
demonstrated (fig. 4.7) that CD80-CD28 interaction could activate ASMase rapidly, 
facilitating a 1.7 fold increase in phosphocholine release at 3 mins, above the levels 
obtained where parental CHO cells were used to stimulate CD28+CHOs. Activation of 
ASMase in CD28+CHOs would indicate that CD28 can activate ASMase independent of 
lck/ fyn contributions. This may indicate that alternative intracellular molecules contribute 
to CD28-derived costimulation independent of PTKs. The low level activation of 
ASMase demonstrated here concurs with data from other studies where a maximal 3 fold 
activation of endogenous ASMase in T cell lines was seen (Edmead et al., 1996; Chan 
and Ochi, 1995). The slightly higher levels of activation observed in those studies may 
possibly be attributed to the use of T cells rather than CHOs whereby the majority of T 
cells which express CD28 and associated signalling effectors may have a greater capacity 
than transfected CHOs to interact with ASMase. Currently it is not known how CD28 
activates ASMase but as ASMase is lysosomal, interaction between CD28 and ASMase 
would involve the translocation of one signalling entity to the other or the activation of 
intermediate molecules. These experiments are suggestive of a CD28-SMase interaction 
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Fig. 4.6: a, O ptim ization of p85a Detection
lxlO6 cells/ point were lysed, their proteins separated by SDS-PAGE and p85 detection 
optimized by titrating a-p85 (1') and goat-a-mouse (2') antibodies against the transferred 
proteins. Numbers parallel to 1' and 2' relate to inverse of antibody dilution factored at 
10'3 e.g. 2 was a 1/2000 dilution and 25 was a 1/25000 dilution.
b, Effect of CD80 on R ecruitm ent of p85a to CD28 in T ransfectants 
lxlO7 cells/ lane were stimulated by CD80 (+) or CHO (-) at 37°C for 5 mins at a ratio of 
3:1 responders to stimulators and CD28 was immunoprecipitated from lysates. Proteins 
were separated by SDS-PAGE and subjected to ap85 Western blotting. Cells lines as 
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Fig. 4.7: Effect of CD28 on Acidic Sphingom yelinase Activity
ASMase activity was measured in CD80 stimulated CHOs and CD28+CHOs (CC). 
5 x l 0 6 responder cells were stimulated at 37°C by CD80+CHOs at a ratio of 3:1 
reponders to CD80+CHOs. Samples were lysed, incubated with 14C sphingomyelin and 
the release of labelled phosphocholine by endogenous ASMase activity was determined 
by scintillation. Data are presented as phosphocholine release relative to control CHO 




The experiments in this chapter attempted to address the possibility of interaction between 
CD28, a costimulatory receptor with no intrinsic kinase activity and the proximal 
signalling molecules fyn, lck, ZAP70, PI3K and ASMase. Analysis of changes in 
tyrosine phosphorylation, tyr/ ser/ thr phosphorylation, PI3K recruitment and ASMase 
activation in response to ligation of CD28 by CD80 were performed and suggested that 
the kinases examined made unequal contributions to CD28 signalling.
Tyrosine phosphorylation changes of CD28 immunoprecipitates assessed by Western 
blotting with the anti-phosphotyrosine mAb, 4G10, revealed small/ no changes in the 
tyrosine phosphorylation state of CD28 immunoprecipitates following stimulation by 
CD80. A number of possibilities may account for the low level of increase in tyrosine 
phosphorylation associated with CD28, despite previous reports of the importance of 
tyrosine phosphorylation to the costimulatory capability of CD28 (Lu et al., 1994; 
Vandenberghe et al., 1992). These include an incapacity of 4G10 to recognise the 
conformation of tyrosine phosphorylated moieties present on CD28 in CHO cells 
however more likely is that only small levels of tyrosine phosphorylation occur and 
detection of these changes were beyond the sensitivity of the assay employed. 
Phosphotyrosine changes in this study (fig. 4.3) and others (August and Dupont, 1994b; 
Hutchcroft and Bierer, 1994; Parry et al., 1997) has not been easily detected following 
CD28 ligation compared to phosphorylation overall (fig. 4.4a) and (Boussiotis et al., 
1996; Parry et al., 1997). W hile CD80 did not induce increases in tyrosine 
phosphorylation, increases in tyr/ ser/ thr phosphorylation were observed and this 
suggests that the kinases were not constitutively activated as inducible changes in 
activation were observed in figure 4.4a for fyn and lck transfectants. For the ZAP70 
transfectant no inducible changes were observed in either tyrosine or tyr/ ser/ thr 
phosphorylation. Therefore it is possible that the kinase was inactive or alternatively is 
not utilized by CD28. In order to address these points further investigation could be 
carried out by performing respectively W estern blotting with alternative anti-
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phosphotyrosine antibodies and immunoprecipitating more CD28 to overcome assay 
insensitivity. However the difficulty in detecting changes in tyrosine phosphorylation 
associated with stimulation of CD28 was addressed partly by the use of increased cell 
numbers in the tyrosine phosphorylation assays where 25 million cells/ lane were 
analyzed compared to 1 0  million cells/ lane when phosphorylation was measured by in 
vitro kinase analysis. Additionally in vitro kinase assays on directly immunoprecipitated 
lck/  fyn/ ZAP70 kinases to assess the degree of activation or the possibility of activation 
of the kinases could be performed. The necessity of tyrosine phosphorylation in 
contributing to costimulation has yet to be demonstrated unequivocally. Some studies 
have also demonstrated small tyrosine phosphorylation changes following CD28 
stimulation (August and Dupont, 1994b; Lu et al., 1992), although others have recorded 
no tyrosine phosphorylation changes in the absence of additional stimulation from TCR/ 
CD3-like signals (Hutchcroft and Bierer, 1994; Hutchcroft et al., 1996; Nunes et al.,
1996) or crosslinking of CD28 (Hutchcroft and Bierer, 1994; Hutchcroft et al., 1996). 
The results demonstrated here are consistent with the consensus arising from the data 
available and suggest that only limited tyrosine phosphorylation of CD28 and substrates 
occurs following its ligation.
The phosphorylation of CD28 immunoprecipitates following stimulation by CD80 was
more marked when measured by IVK analysis than for tyrosine phosphorylation, as
measured by Western blotting with the mAh 4G10. Accordingly data from IVK analysis
suggests if the tyrosine phosphorylation data did indeed represent low level changes,
most of the phosphorylation of CD28 immunoprecipitates occurred on ser/ thr residues.
This possibility could be investigated by thin layer chromatographic analysis using
phosphorylated tyr/ ser/ thr standards to compare against phosphoproteins from CD28
immunoprecipitates with and without stimulation by CD80. If ser/ thr phosphorylation of
CD28 was revealed, it would imply that because lck is a tyrosine kinase, it was recruiting
a ser/ thr kinase to phosphorylate CD28 rather than directly phosphorylating CD28. This
would provide information on the nature of phosphorylation reactions associated with
CD28 signal transduction and suggest which types of residue on the intracellular domain
of CD28 may be responsible for transducing costimulatory signals. One such study
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demonstrated a marked increase in tyrosine phosphorylation following antibody 
stimulation of CD28 (Hutchcroft et al., 1996), although data from Parry et al 
demonstrated comparable levels of ser and thr phosphorylation following CD80-CD28 
interaction (Parry et al., 1997). This may reflect differences in the residues 
phosphorylated between antibody and natural ligand. The low level of inducible tyrosine 
phosphorylation (fig. 4.3) and the more marked level of tyr/ser/ thr phosphorylation (fig 
4.4a) is in agreement with the lack of tyrosine phosphorylation of CD28 and the marked 
increase in ser/ thr phosphorylation following CD28-CD80 interaction observed by Parry 
et al (Parry et al., 1997). It is possible to suggest that differences between the levels of 
tyrosine phosphorylation and tyr/ ser/ thr phosphorylation may be due to ser/ thr 
phosphorylation. Further characterization of ser/ thr interactions with CD28 is required.
However an alternative interpretation of the tyrosine phosphorylation data presented in
figure 4.3 is that the low level changes of tyrosine phosphorylation following CD28
ligation do not reflect the necessity of tyrosine phosphorylation to CD28 signal
transduction. A number of observations support the suggestion that PTKs are necessary
for CD28 costimulation. For example PTKs are known to be rapid signalling effectors
and therefore could provide CD28 with the capability to interact rapidly with distal
effectors. Furthermore mutation of the tyrosine residue in the PI3K docking site
Y191MNM of CD28 to phenylalanine ablates PI3K binding (Prasad et al., 1994) and IL2
production (Pages et al., 1994) where PI3K activation subsequent to CD28 ligation by
CD80 has been demonstrated to be necessary for activation of human resting T cells
(Ward et al., 1995; Ueda et al., 1995). Therefore this PI3K-CD28 interaction is
necessary for some of the costimulatory capability of CD28 to be fulfilled and so PTKs
are required to phosphorylate Y191 to facilitate PI3K binding to, and activation by,
CD28. Additionally a role for lck in CD28 signalling has been suggested by the
diminished production of IL2 in lck -ve Jurkats (Lu et al., 1994) under PMA, ionomycin,
CD28 stimulation. However as both fyn and lck interact with the TCR (Boussiotis et al.,
1996; McFarland et al., 1992) and CD28 (August and Dupont, 1994a; Raab et al., 1995;
Hutchcroft and Bierer, 1994) it can be difficult to determine the contribution these PTKs
make to one pathway or another. Furthermore the phosphorylation of CD28 following
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ligation by CD80 (fig. 4.4a) varied depending on the cell line, suggesting that CD28 may 
possibly show selectivity between different PTKs in signal transduction. While lck more 
than fyn demonstrated a capacity to induce increases in phosphorylation of CD28 
immunoprecipitates, ZAP70 transfectants did not. This may be due to differential 
recruitment and/  or activation of these PTKs by CD28. Alternatively it may be the case 
that ZAP70, although detectable by Western blotting was not expressed as a kinase which 
could be activated. A further control to assess this possibility may be performed by IVK 
analysis of immunoprecipitated PTKs which would reveal if all three kinases could be 
activated. Interestingly similar experiments performed by Raab (Raab et al., 1995) also 
found that despite expression of ZAP70, which in an IVK assay was found to be active, 
ZAP70 transfectants did not stimulate CD28 phosphorylation while lck or fyn could 
(Raab et al., 1995). One reason why this may occur may reside in the lack of an IT AM 
sequence on the intracellular domain of CD28 which has been shown to be necessary for 
ZAP70 activation following TCR ligation (Hatada et al., 1995). Thus lck is the best 
candidate to date for transducing CD28 signals.
Following ligation of CD28 by CD80 in the fyn and lck transfectants increased
phosphorylation of three bands was observed. These migrated under reducing conditions
as proteins of molecular weights 44, 85 and 110 kDa which coincide with the molecular
weights of CD28 (Aruffo and Seed, 1987; Hutchcroft et al., 1996; Parry et al., 1997)
and the regulatory and catalytic subunits of PI3K respectively (Ward et al., 1992). This
is highly consistent with the possibility that ligation of CD28 by CD80 leads to increased
phosphorylation of proteins demonstrated to be CD28 and PI3K in other studies (Lu et
al., 1994; August and Dupont, 1994b; Parry et al., 1997). Strong support for the
possibility that the broad 44 kDa band was CD28 is derived from deglycosylation data
(fig. 4.5) where deglycosylation of CD28 immunoprecipitates resulted in an altered
electrophoretic mobility of only one band from 44 kDa to 23 kDa. The breadth of this
band may be accounted for by considerable glycosylation of CD28 on 5 glycosylation
sites on its extracellular domain (Aruffo and Seed, 1987). This shift in molecular weight
demonstrated in this study following deglycosylation concurs with nucleotide sequence
data which predicts CD28 to exist as a 23 kDa molecule (Aruffo and Seed, 1987) and is
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in agreement with another study (Hutchcroft et al., 1996) demonstrating a similar altered 
electrophoretic mobility of a band present in CD28 immunoprecipitates. This data would 
support the possibility that the broad 44 kDa band observed in figure 4.4 was indeed 
CD28.
The relationship between CD28 ligation by CD80 and PI3K activation may be
investigated by analysis of D3 phosphoinositol lipid production following CD80
stimulation of CD28 as demonstrated by Ward et al (Ueda et al., 1995). The experiments
in figure 4.6b demonstrated that following CD80 stimulation of CD28 in Jurkats, there
was an inducible recruitment of p85 to CD28 in agreement with data from other reports
indicating CD28 ligation leads to the recruitment of PI3K (Ward et al., 1995; Stein et al.,
1994; Ueda et al., 1995; Prasad et al., 1994; Pages et al., 1994; Ward et al., 1993; Cai et
al., 1995; Pages et al., 1996). This would suggest that the inducibly phosphorylated
bands migrating at 85 and 110 kDa observed in figure 4.4b may have been PI3K,
although additional support for this hypothesis may be supplied by Western blotting
against the p i 10 subunit of PI3K. In CHO transfectants attempts to identify the smaller
molecule as the regulatory subunit of PI3K by immunoblotting were hampered for a
number of reasons, although the primary cause was likely to be the transient expression
of PTK gene product. Over a number of passages it became evident that the
phosphorylation response of the lck transfectants following CD80-CD28 interaction
decreased. This may be seen when comparing the phosphorylation response of early
transfectants (figure 4.5, lanes 1 and 2) with that of highly passaged transfectants (lanes
3 and 4). The phosphorylation experiments represented in figures 4.3 and 4.4 utilized
early lck transfectants, which when Western blotted had demonstrable lck expression,
whereas the later passaged lck populations (figure 4.5 lanes 3 and 4 and 4.6b) had
undetectable lck expression. Therefore the usefulness of a mixed population of
transfectants was limited by time. Possible reasons for the decrease in PTK expression
over time include a greater rate of proliferation of non transfected cells or transfected cells
not expressing the PTK. Another problem concerning the specific detection of p85 was
the relatively high degree of cross-reactivity between the primary anti-p85 antibody
(JS14) and other proteins present in both CHO cellular lysates (figure 4.6a) and CD28
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immunoprecipitates (figure 4.6b). It would be interesting to repeat these experiments 
with fresh transfectants and different blotting antibodies against p85.
The activation of ASMase following ligation of CD28 by CD80 demonstrated in figure
4.7 is in agreement with previous data (Boucher et al., 1995; Edmead et al., 1996; Chan
and Ochi, 1995) indicating a possible role for ASMase in CD28 costimulation. However
the functional relevance of ASMase activity in resting human T cells has yet to be
determined. Although there is little understanding of the mechanism by which CD28 and
ASMase interact, a number of observations suggest areas of future research which may
provide information on the identity/ mechanism of effectors participating in the interaction
of CD28 and ASMase. Accordingly ASMase is known to be localized to lysosomes
(Spence, 1993) and recent data indicates that the level of expression of CD28 on the cell
surface is in part regulated by degradation in lysosomes (Cefai et al., 1998). Thus an
opportunity for CD28 and ASMase interaction is provided when CD28 translocates to
lysosomes. If lysosomes represent the location of interaction, the question of how
ASMase interacts with CD28 still remains. Currently there is no data on this subject but
one may suggest an interaction between CD28, ASMase and one or more intracellular
effectors interacting with the tyrosine residue Y191. This suggestion arises from a CD28
cytoplasmic mutant Y191F which showed persistent surface expression with markedly
reduced intracellular localisation of CD28 (Cefai et al., 1998). Therefore molecules
interacting with Y191 facilitate the translocation of CD28 from the membrane to
lysosomes. A number of candidate molecules exist which can bind the phosphorylated
Y191 residue including p72 itk, which is reported to negatively regulate CD28/ T cell
function (Liao et al., 1997); PI3K which is proposed to be necessary for costimulation of
resting human T cell activation ie IL2 production (Ward et al., 1995; Ueda et al., 1995;
Ward et al., 1993) and the adapter protein GRB2 (Schneider et al., 1995a), which may
facilitate interactions between CD28 and the small G proteins Racl and Cdc42 (Kaga et
al., 1998a) ultimately leading to activation of kinase cascades eg involving PAK1 and
MEKK1 (Kaga et al., 1998a) and so the activation of the AP-1 transcriptional promoter
site of the IL2 gene. Of these possible effectors which may/ may not interact in CD28-
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ASMase signalling, preliminary data are available on an interaction between CD28 and 
PI3K in the regulation of CD28 surface expression. Accordingly a significant proportion 
(one third) of the lysosomally-targeted internalized CD28 associates with PI3K (Cefai et 
al., 1998).
In conclusion we demonstrated that lck transfectants markedly phosphorylated molecules 
likely to be CD28 and corresponding with the molecular weight of PI3K subunits in 
response to CD80-CD28 interaction. Deglycosylation of CD28 immunoprecipitates 
resulted in a specific alteration in the molecular weight of only one molecule from a broad 
44 kDa band to a more defined band of 23 kDa, consistent with the migration of CD28 
before and after deglycosylation (Hutchcroft et al., 1996). Fyn transfectants 
demonstrated a similar phosphorylation of CD28 substrates, although to a less intense 
degree than lck, despite higher levels of expression of fyn than lck relative to the levels of 
these kinases in Jurkats. This suggests that CD28, at least in our CHO transfectant 
model, may utilize lck in preference to fyn in CD28 transduction pathways. By contrast 
ZAP70 appeared to contribute nothing to CD28 phosphorylation and it may be suggested 
that this is either because it was not utilized by CD28 or that it was expressed as a 
defective kinase. We also demonstrated the recruitment of p85, the regulatory subunit of 
PI3K to CD28 following CD28 ligation by CD80 in Jurkats and the activation of ASMase 
following CD80-CD28 interaction in CD28+CHOs. The data presented here represent 
new findings in that an inducible contribution to CD28 signalling due to the presence of 
lck or fyn, without contribution from other T cell specific effectors, has not previously 
been demonstrated and that activation of ASMase by CD28 independent of fyn/ lck 
suggests that alternative, PTK-independent CD28 signalling pathways exist.
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Chapter 5
The Effect of Sphingomyelinase or C2 Ceramide 
on Resting T cell Proliferation,
Viability and Surface Marker Expression
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Resting T cells are known to require two signals to mount an effective immune response. 
The previous chapter attempted to define some of the proximal signalling elements 
downstream of CD28 involved in transducing the costimulatory effects of CD28. One 
such element, acidic sphingomyelinase(ASMase), was suggested to be responsible for 
the costimulatory effects of CD28 (Boucher et al., 1995; Edmead et al., 1996; Chan and 
Ochi, 1995), although it was evident from proliferative levels that even at an optimal 
dose, ASMase did not show a quantitatively similar response to CD28 stimulation. This 
suggests that the costimulatory function of CD28 may be facilitated by ASMase and 
additional signals. This chapter attempts to analyze the effects of sphingomyelinase 
activity on resting T cells by examining the proliferation, activation and viability of 
costimulated T cells. All viability data are paired with the proliferation figures preceding 
them.
5.1 Assessment of Acidic and Neutral Sphingomyelinase Activity in 
Staphylococcus aureus Sphingomyelinase
In order to define whether the activity of SMase, derived from Staphylococcus aureus, 
had a neutral or an acidic pH optimum, as at least two SMases exist with different pH 
requirements (Spence, 1993), SMase was assessed for its capability to release 
phosphocholine from sphingomyelin under acidic or neutral reaction conditions. 
Dilutions of SMase were incubated with 14C sphingomyelin at 37°C for 2 hours and the 
release of radiolabelled phosphocholine was measured by scintillation. Figure 5.1 
demonstrates that SMase comprises both acidic and neutral SMase activities which 
released comparable levels of phosphocholine.
5 .2  The Ability of Sphingomyelinase, C2 Ceramide or Phosphocholine 
to Costimulate the Proliferation of Resting T cells
To determine whether SMase or its products were capable of replacing CD28-derived 
signals as a costimulus for resting T cell proliferation, T cells were stimulated by aCD3 
mAb and fixed CD80+CHOs , SMase, C2 ceramide or phosphocholine. Proliferation 
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Fig. 5.1: N eutral and Acidic Sphingom yelinase Activities of
S taphylococcus au reus Sphingom yelinase
Neutral and acidic SMase activity in S. aureus SMase was assessed. Titrations of SMase 
were incubated in neutral or acidic reaction buffers with 14C sphingomyelin. The release 
of radiolabelled phosphocholine was subsequently measured. The effect of denaturation 
of the enzyme preparation on SMase activity was assessed in a parallel assay with boiled 
(BLD) SMase. Data are derived from a single determination at one sample/ dilution.
121
60000 n
5 0 0 0 0 -
4 0 0 00  -
2  30000  -u
20000  -  
10000 -  
0  -
Fig. 5.2a: The Ability of CD80 or Sphingom yelinase to Costim ulate
Resting T cell Proliferation
Resting T cells were left unstimulated, or incubated with aCD3 (1/ 100 dilution of 
ascites) alone or in the presence of fixed CD80 cells or increasing concentrations of 
SMase for 72 hours. bSMase vehicle was present at a concentration equivalent to 1U/ ml 
bSMase. Proliferation was measured by 3H-thymidine incorporation (CPM). Data are 
the triplicate mean of a single representative experiment of n=3 (SD indicated by 
horizontal bars).
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Fig. 5.2b: The Ability of CD80 or C2 Ceram ide to Costim ulate Resting
T cell Proliferation
Resting T cells were left unstimulated or incubated with aCD3 mAb (1/ 100 dilution of 
ascites) alone or in the presence of fixed CD80 cells or increasing concentrations of C2 
ceramide for 72 hours. Proliferation was measured by 3H-thymidine incorporation 
(CPM). Data are the triplicate mean of a single representative experiment of n=3 (SD 
indicated by horizontal bars).
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Fig. 5.2c: The Ability of CD80 or Phosphocholine to Costim ulate
Resting T cell Proliferation
Resting T cells were left unstimulated, or incubated with aCD3 (1/ 100 dilution of 
ascites) alone or in the presence of fixed CD80 cells or increasing concentrations of 
phosphocholine (PC) for 72 hours. Proliferation was measured by 3H-thymidine 
incorporation (CPM). Data are the triplicate mean of a single representative experiment of 
n=3 (SD indicated by horizontal bars).
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While CD80 and aCD3 costimulation of resting T cells induced a significant proliferative 
response, neither a range of SMase (fig. 5.2a), nor C2 ceramide (fig. 5.2b) nor 
phosphocholine (fig. 5.2c) titrations could costimulate resting T cell proliferation. This is 
in contrast to previous suggestions that a SMase activity was sufficient to induce at least 
some of the proliferative response which CD28 ligation caused (Boucher et al., 1995; 
Chan and Ochi, 1995). Therefore CD80 but not SMase, C2 ceramide nor 
phosphocholine was capable of costimulating resting T cells under the conditions 
employed in this study.
5 .3  Effect of Sphingomyelinase or C2 Ceramide on Unstimulated 
Resting T cell Viability
In order to assess whether the inability of SMase or C2 ceramide to costimulate T cell 
proliferation was due to their toxicity i.e. a capacity to cause cell death, the viability of 
unstimulated resting T cells was assessed following incubation in medium, SMase or C2 
ceramide using a propidium iodide (PI) exclusion assay. Cells which have intact 
membranes prevent PI from entering the cell and therefore how low/ -ve fluorescence 
compared to cells with damaged membranes ie dead/ dying cells. Both SMase at 7.5 x 
lO-5 U/ ml and C2 ceramide (fig. 5.3) decreased the viability of resting T cells. At 50|iM 
C2 ceramide, 63.1% of the cells were positive for FL2 compared to 4.63% of 
unstimulated T cells, although some of this effect was attributable to its vehicle ethanol 
which caused 25.3% of the population to lose viability. SMase induced 22.4 % of the 
population to lose viability. SMase and C2 ceramide reduce unstimulated resting T cell 
viability and this concurs with other reports where C2 ceramide reduced cell viability, 
possibly through apoptosis (Wolff et al., 1994; Gulbins et al., 1995; Jarvis et al., 1994).
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Fig. 5.3: Effect of Sphingom yelinase/ C2 C eram ide on V iability of
U nstim ulated T cells
Resting T cells (2 x 105/ point) were left unstimulated (medium) or incubated with 
ceramide, its vehicle (ethanol) or SMase and analyzed by FACS for viability. Propidium 
iodide (PI, 10|ig/ ml, FL2) uptake which is proportional to cell mortality was used to 
assess the effect of treatments on viability. Figures in brackets indicate the percent of 
cells showing mortality relative to the control where 4.68% of the cells did not exclude 
PI. A representative experiment of n=3 is shown.
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5 .4  Ability of Sphingomyelinase or C2 Ceramide to Modulate 
Costimulated Resting T cell Proliferation and Viability
To assess the effect of SMase and its products on T cells receiving costimulation, aCD3, 
CD80 stimulated cultures of resting T cells were incubated with/ without titrations of 
SMase, C2 ceramide and phosphocholine for 72 hours. Proliferation was measured by 
3H thymidine incorporation and from duplicate cultures viability was assessed by PI 
exclusion using FACS analysis. It was found that SMase from 5x l0 -5 to 5x l0 -3 U/ ml 
decreased or ablated the proliferation of costimulated resting T cells (fig. 5.4a) 
independent of any effect of the vehicle. The vehicle was added to culture at a dilution 
corresponding to the highest titre of SMase. At concentrations of lxlO -5 U/ ml SMase 
and lower, little or no decrease in proliferation of costimulated resting T cell cultures was 
observed relative to the vehicle control. In summary concentrations of SMase in excess 
of 5 x lO 5 U/ ml decreased proliferation.
Interestingly the viability data (fig. 5.4b) showed that at concentrations of SMase at 5x10- 
5 U/ ml there was no decrease in viability. Thus the decrease in proliferation observed at 
5xl0 -5 U/ ml was not caused by death of the culture overall. Between 5xl0 -5 U/ ml and 
lxlO -4  U/ ml no or little increase in cell death was observed (data not shown). At lxlO ' 3 
U/ ml and above cell death increased up to 56.6% from 16.2% where SMase was not 
added to the culture. However for costimulated T cells SMase could, at certain 
concentrations, decrease proliferation without increasing cell death.
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Fig. 5.4a: The Effect of Sphingom yelinase on the P ro lifera tion  of
Resting T cells Stim ulated by aC D 3, CD80
Resting T cells were left unstimulated, or incubated with aCD3 (1/ 100 dilution of 
ascites) in the presence of fixed CD80 cells with or without (bSMase vehicle at a 
concentration equivalent to lxlO-2 U/ ml bSMase) increasing concentrations of bSMase 
for 72 hours. Proliferation was measured by 3H-thymidine incorporation (CPM). Data 
are the triplicate mean of a single representative experiment of n=3 (SD indicated by 
horizontal bars).
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Fig. 5.4b: Effect of Sphingom yelinase on the Viability of Costim ulated
T cells
aCD3, B7 stimulated resting T cells (2 x 105/ point) were incubated for 72 hours with/ 
without SMase and analyzed by FACS for viability. Propidium iodide (PI, lOjug/ ml, 
FL2) uptake by the cells, which is proportional to cell mortality, was measured by 
FACS. Figures in brackets refer to the percent of cells showing positive fluorecence i.e. 
beyond the level recorded in the viable portion of the costimulated T cell sample. These 
data are paired with the data in figure 5.4a.
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C2 ceramide also caused a dose dependent inhibition of proliferation (fig. 5.4c) where 
costimulated T cell proliferation was ablated by the addition of lOOpM C2 ceramide. 
Costimulated cell viability was resistant to the effects of C2 ceramide (fig. 5.4d) and only 
at IOOjiM  C2 ceramide, the highest concentration employed in this assay (and the one 
which ablated proliferation) was a marginal reduction in viability observed. While 
costimulated T cells had 20.5% death, the samples with the addition of 100|iM C2 
ceramide had 24.3% death. C2 ceramide, like SMase, could reduce proliferation without 
promoting a loss in viability of the costimulated T cell population.
5.4e Ability of Phosphocholine to Modulate Costimulated T cell 
Proliferation
An analysis of the capability of the other metabolite of sphingomyelin, namely 
phosphocholine, to alter costimulated T cell proliferation was made by a 3H thymidine 
incorporation assay. Following 72 hours of costimulated culture, phosphocholine could 
be seen to have had negligible effect on costimulated T cell proliferation. Figure 5.4e 
illustrates the lack of effect of the highest concentration of phosphocholine, which was 
representative of a titration from 10-100fiM phosphocholine. Phosphocholine, unlike 
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Fig. 5.4c: The Effect of C2 Ceram ide on the Proliferation of Resting T
cells Stim ulated by aC D 3, CD80
Resting T cells were left unstimulated, or incubated with aCD3 (1/ 100 dilution of 
ascites) in the presence of fixed CD80 cells with or without increasing concentrations of 
C2 ceramide for 72 hours. Proliferation was measured by 3H-thymidine incorporation 
(CPM). Data are the triplicate mean of a single representative experiment of n=3 (SD 
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Fig. 5.4d: Effect of Ceram ide on the Viability of C ostim ulated T cells
aCD3, CD80 stimulated resting T cells (2 x 105/ treatment) were incubated for 72 hours 
with/ without ceramide and analyzed by FACS for viability. Propidium iodide (PI, 10pg/ 
ml, FL2) uptake, proportional to cell mortality, was measured by FACS. Figures in 
brackets indicate the percent of cells with FL2 levels greater than costimulated T cells. 
These data are paired with figure 5.4c.
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Fig. 5.4e: The Effect of Phosphocholine on the Proliferation of
Resting T cells Stim ulated by aC D 3, CD80
Resting T cells were left unstimulated or incubated with aCD3 (1/ 100 dilution of ascites) 
in the presence of fixed CD80 cells with or without increasing concentrations of 
phosphocholine (PC) for 72 hours. Proliferation was measured by 3H-thymidine 
incorporation (CPM). Data are the triplicate mean of a single representative experiment of 
n=3 (SD indicated by horizontal bars). The highest dose of PC was representative of its 
effect at any dose from 10-lOOpM.
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5 .5  Acidic Denaturation of SMase
In order to check that the effect of the SMase preparation supplied was based on 
enzymatic activity, its physical properties and ability to limit proliferation were assayed 
before and after denaturation. Denaturation was performed by incubation of an aliquot 
of SMase for 10 minutes in concentrated hydrochloric acid, and subsequent neutralization 
with sodium hydroxide. Aliquots were reserved for analysis of physical properties by 
SDS-PAGE (fig. 5.5a) or by their effects on proliferation of costimulated T cells (fig. 
5.5b).
In the untreated lane, i.e. no acid denaturation, two bands were visible at -40  and 32 kDa 
(see lower arrows, fig. 5.5a), possibly representing entities within the SMase preparation 
responsible for its acidic and neutral activity. The Swiss protein bank predicts a 
molecular weight of 37.3 kDa for SMase from its amino acid sequence although in a 
review of SMases from different species widely varying molecular weights were reported 
from 23 and 34 kDa for bacterial SMase to 70-120 kDa for human SMases (Spence, 
1993). The reason for the wide variation in molecular weights of SMases was unknown 
although glycosylation was suggested as a mechanism contributing to the existence of 
proteins migrating at different rates (Spence, 1993) and S. aureus SMase has two 
glycosylation sites (Swiss protein data bank). The appearance of a single protein band 
following denaturation concurs with the suggestion that SMase readily forms aggregates 
(Spence, 1993). An early report detailing the purification of p haemolysin (Wadstrom 
and Mollby, 1971), found to be composed of SMase activity, showed the presence of 
molecules of 33 and 38 kDa which is comparable to that illustrated for SMase (fig. 5.5a, 
lane 1 ).
A site sensitive to acid cleaving was found (Swiss Protein data bank) carboxyl to proline
residue 261 in the mainly polar but uncharged sequence HNSTWDP2 6 1 QSNSI. This
may create an opportunity for electrostatic interactions to form an agglutinate. Therefore
the single higher molecular weight product may represent an agglutinate of the other two
species. Subsequent analysis of the ability of denatured SMase to modulate proliferation
(fig. 5.5b) showed that the denatured SMase had little effect on proliferation beyond that
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of the SMase vehicle. However the same concentration of native, i.e. non-denatured, 
SMase ablated proliferation. It would appear then that a component of the SMase 
preparation sensitive to acidic denaturation was responsible for decreased proliferation of 




Fig. 5.5a: D enaturation of Sphingom yelinase by C oncentrated
H ydrochloric Acid
Equal aliquots of bSMase were denaturated (+) or not (-) by a 10 minute incubation with 
concentrated HCI followed by neutralization with NaOH. lpg was analyzed by SDS- 
PAGE and and the products were visualized by immersion of the gel in Coomassie Blue 
protein stain. Lower arrows indicate positions of non-denatured bSMase and upper 
arrow position of single denatured product. A single determination was performed.
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Fig. 5.5b: Effect of D enatured Sphingom yelinase on the Proliferation of
Resting T cells Stim ulated by aC D 3, CD80
Resting T cells were left unstimulated or incubated with aCD3 (1/100 dilution of ascites) 
in the presence of fixed CD80 cells, or with SMase vehicle at a concentration equivalent 
to 7.5 x 10'5 U/ ml, SMase or denatured (D)SMase for 72 hours. Proliferation was 
measured by 3H-thymidine incorporation (CPM). Data are the triplicate mean of a single 
experiment (SD indicated by horizontal bars).
137
5 .6  Ability of Sphingomyelinase or C2 Ceramide to Alter the Viability 
and Proliferation of Blasts and Jurkats
To determine whether SMase could inhibit the proliferation of T cells with different 
proliferative requirements, 3H thymidine incorporation assays were performed following 
the incubation of T cell blasts and Jurkats with/ without SMase for 24 hours. The effect 
of C2 ceramide on Jurkat proliferation and viability was also examined following the 
incubation of Jurkats in C2 ceramide over 24 hours to determine whether SMase and C2 
ceramide had similar effects. Preliminary data (fig. 5.6a) illustrates that SMase did not 
reduce the proliferation, nor viability (fig. 5.6c), of T cell blasts and figure 5.6b shows 
the same was observed for Jurkats. As SMase could not alter the proliferation nor the 
viability of T cells with minimal proliferation requirements even at a concentration which 
caused 56.6% death of costimulated T cells (fig. 5.4b), it would appear that SMase has a 
stage specific effect.
Of interest however was the effect of C2 ceramide on the proliferation (fig. 5.7a) and 
viability (fig. 5.7b) of Jurkats. These preliminary data indicate that C2 ceramide effected 
a dose dependent proportional increase in mortality and loss of proliferation. Although 
the mechanism by which the Jurkats died was not analyzed, it may be due to apoptosis as 
ceramide has been reported to induce apoptosis (Verheij et al., 1996; Gulbins et al., 
1995; Cifone et al., 1993; Higuchi et al., 1996). At 75|iM  C2 ceramide, there is 98% 
mortality of Jurkats (fig. 5.7b) and a similar decrease in proliferation could be observed 
(fig. 5.7a). While the proliferation of costimulated T cells was inhibited in the presence 
of C2 ceramide (fig. 5.4c), their viability was affected very little (fig. 5.4d), unlike 
Jurkats (fig. 5.7b) or unstimulated T cells (fig. 5.3). Therefore C2 ceramide appeared to 
induce two types of effect. The first which could be seen in costimulated resting T cells 
was that of inhibiting proliferation. The second effect which was the reduction of cell 
viability was only manifest in T cells not receiving primary or costimulatory signals i.e. 
Jurkats and unstimulated resting T cells. Therefore it would appear that C2 ceramide may 
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Fig. 5.6a+b: Effect of SM ase on the Proliferation of T cells Blasts and 
Ju rk a ts
a) T cell blasts or b) Jurkats were incubated with/ without increasing concentrations of 
bSMase for 24 hours. 0.03% v/v bSMase vehicle was included at a concentration 
equivalent to lxlO-2 U/ ml bSMase. The highest dose of bSMase used in the assay is 
shown as a representative example. Proliferation was measured by 3H-thymidine 
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Fig. 5.6c: Effect of SMase on the Viability of T cell Blasts and  Ju rka ts
T cell viability +/- SMase was assessed by a PI exclusion assay. 2x10^ i) blasts or ii) 
Jurkats/ point were incubated with/ without SMase for 24 hrs. PI (lOjig/ ml) uptake, 
proportional to cell mortality, was measured as FL2. Figures in brackets indicate the 
percent of cells recorded with greater FL2 than the control. These data are paired with 
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Fig. 5.7a: The Effect of C2 Ceram ide on the Proliferation of Ju rk a ts
Jurkat T cells were incubated with or without increasing concentrations of C2 ceramide 
for 24 hours. All concentrations were equalized for vehicle dilutions. Proliferation was 
measured by 3H-thymidine incorporation (CPM). Data are the triplicate mean of a single 
representative experiment of n=3 (SDs were less than 5%).
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Fig. 5.7b: Effect of C2 Ceram ide on the Viability of Ju rk a ts
The effect of C2 ceramide on Jurkat viability after a 24 hour incubation was assessed by 
FACS analysis. All treatments were equalized for vehicle content at 1% v/v ethanol. 
Propidium iodide (10pg/ ml) was used to assess cell viability by their ability to exclude 
the dye. PI uptake was recorded as FL2. Bracketed figures indicate the percentage 
mortality. These data are paired with figure 5.7a.
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5.8-10  Effect of Sphingomyelinase/ C2 Ceramide on the Biology of 
Costimulated T cells Receiving Different Primary Stimuli
In order to examine the mechanism(s) by which SMase/ C2 ceramide may inhibit the 
proliferation of aCD 3, CD80 costimulated T cells, costimulated T cell proliferation, 
viability and phenotype were assessed in the presence or absence of SMase/ C2 ceramide. 
Analysis of the surface expression of proteins associated with T cell activation, CD25 and 
CD69 (Damle et al., 1992), were used to assess changes in phenotype arising from 
SMase/ C2 ceramide treatment of T cells. To assess whether or not the primary stimulus 
required for resting T cell activation and proliferation determined a differential sensitivity 
to SMase/ C2 ceramide, a parallel series of assays was performed where aCD3 mAb 
was replaced with PMA as the primary stimulus. CD80 was used as the costimulus in 
both sets of experiments.
5 .8  Proliferation
The effect of using different primary stimuli in CD80 costimulated T cell proliferative 
responses to SMase/ C2 ceramide was examined. CD80 and aCD 3/ PMA costimulated 
resting T cells were incubated with or without SMase/ C2 ceramide and their proliferation 
was measured by 3H thymidine incorporation over a time course. Figure 5.8a showed 
that aCD3, CD80-stimulated T cell proliferation increased up to day 3 and thereafter the 
level of thymidine incorporation declined slowly. 7.5xl0 -5  U/ ml SMase or 30|iM C2 
ceramide decreased cell proliferation up to day 2. Afterwards the costimulated T cell 
cultures showed a parallel increase in cell numbers under SMase/ C2 ceramide compared 
to medium although the maximum levels of proliferation were suppressed due to the 
initial inhibition.
A maximum level of proliferation under PMA, CD80 costimulation of resting T cells was
recorded at day 2. Subsequently proliferation decreased proportionally with time. The
maximum level of proliferation induced by aCD3 or PMA was comparable. Control
populations, i.e. resting T cells stimulated in the presence of aCD3 mAb, PMA or CD80
alone or aCD3, CHO showed little or no proliferation (<1000 cpm, data not shown). C2
ceramide, over all the days tested, induced a decrease in proliferation of PMA+CD80
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stimulated T cells (fig. 5.8b). The effect of SMase on PMA+CD80 stimulated T cells 
was not consistent with that observed under aCD3, CD80 stimulation and only apparent 
up to the second day of the proliferation assay. Thereafter the culture, under 
PMA+CD80 stimulation, was not sensitive to the anti-proliferative effects of SMase.
C2 ceramide consistently inhibited proliferation of resting T cells irrespective of whether 
the primary stimulus was aCD3 mAb or PMA. PMA stimulated T cells did not show 
continued sensitivity to inhibition of their proliferation in the presence of SMase, whereas 
aCD3 stimulated T cells did. Therefore PMA induced a resistance to the effects of 
SMase but not to the effects of C2 ceramide, whereas aCD3 stimulated T cells which 
reached peak proliferative levels more slowly than PMA stimulated T cells were 
susceptible to inhibition of their proliferation in the presence of SMase or C2 ceramide. 
This observation bears some similarity to the differential sensitivity of blastic or Jurkat T 
cell proliferation to SMase and C2 ceramide, whereby blasts and Jurkats were insensitive 
to inhibition of proliferation by SMase (fig. 5.6a and 5.6b respectively) yet sensitive to 
inhibition by C2 ceramide (fig 5.7a). In summary C2 ceramide inhibited the proliferation 
of costimulated T cells, irrespective of their primary stimulus up to the second day post 
stimulation of resting T cells. Thereafter changes in proliferation were parallel to those 
occurring in the presence of medium. Where PMA, rather than aCD3, was the primary 
stimulus for proliferation, only a transient decrease in proliferation due to SMase was 
observed. This was evident on the second day of the assay and thereafter comparable 
levels of proliferation were shown by SMase and medium in PMA, CD80 stimulated T 
cells. The inhibition of the proliferative response of costimulated T cells to C2 ceramide 
was independent of the type of primary stimulus, but the inhibition of proliferation of 
costimulated T cells by SMase was only maintained where the primary stimulus was 
aCD3 rather than PMA. Possible reasons for the differential sensitivity of PMA or 
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5 .8 : Effect of Sphingom yelinase or C2 C eram ide on the P ro liferation  of
aC D 3 or PMA Costim ulated Resting T cells
(a) aCD3, CD80 or (b) PMA (40ng/ ml), CD80 resting T cells were incubated in 
medium or with C2 ceramide (C2, 30|iM) or SMase (bSM, 7.5x10-5 U/ ml) for 4 days. 
Proliferation was measured from the second to the fourth day by 3H -thym idine 
incorporation (CPM). Data are the triplicate mean from a representative experiment of 
n=3 (SD indicated by horizontal bars).
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5 .9  Viability
To examine whether the reduction of costimulated T cell proliferation by SMase/ C2 
ceramide was due to cell death, viability of aCD 3 (fig. 5.9a) or PMA (fig. 5.9b) 
stimulated T cell populations was analyzed in the presence or absence of SMase/ C2 
ceramide by a PI exclusion FACS assay. There was no correlation between the effects of 
SMase/ C2 ceramide on viability with their negative effects on proliferation. In only one 
case (fig. 5.9biii, day 3) did SMase reduce viability, from 12% without SMase to 
27.1% with SMase, and this was not paralleled by an inhibition of proliferation on that 
day in PMA, CD80 stimulated T cells (fig. 5.8b). Therefore the reductions in 
proliferation caused by SMase/ C2 ceramide were not an artefact of cell death. It may 
then be possible to suggest that SMase and C2 ceramide modulate cell division. It may 
also be possible that they inhibit cellular activation. To examine the latter possibility, the 
effects of C2 ceramide and SMase were examined on surface markers which were 
associated with T cell activation.
5.10 CD25 and CD69 Expression
As SMase/ C2 ceramide could inhibit proliferation it may be possible that they down 
regulate T cell activation. In order to examine this possibility the expression of CD25 and 
CD69 were examined by FACS analysis over the course of a proliferation assay. 
Unstimulated T cells or cells stimulated by CD80 with aCD3 or PMA with or without 
SMase/ C2 ceramide were examined for surface expression of CD25 and CD69 by 
FACS. Preliminary data (fig. 5.10a+b) illustrates that CD25 and CD69 respectively 
underwent delayed upregulation due to SMase/ C2 ceramide. CD25 expression was 
limited at day two by a decrease in the number of cells expressing CD25 which was 
33.6% in aCD3, CD80 costimulated T cells and 19 or 20.6% where SMase/ C2 ceramide 
were added. By day 4 post-stimulation the difference between treatments is less. While 
all show comparable intensity of expression, there are more cells expressing CD25 in the 
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Fig. 5.9a: Effect of Sphingom yelinase or C2 C eram ide on the Viability
of Resting T cells Stim ulated by aC D 3, CD80 O ver a Time Course
The viability of aCD3, CD80-stimulated T cells in the presence of i) medium, ii) 30jiM 
ceramide or iii) 7.5 x 10'5 U/ ml SMase was assessed by FACs analysis over a 4 day 
period. Overlapping histograms show levels of propidium iodide (PI, 10pg/ ml, FL2) 
uptake which is proportional to cell mortality. Figures in brackets indicate the percent of 
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Fig. 5.9b: Effect of Sphingom yelinase or C2 C eram ide on the Viability
of Resting T cells Stim ulated by PMA, CD80 Over a Time Course
The viability of PMA+ CD80-stimulated T cells in the presence of i) medium, ii) 30jiM 
ceramide or iii) 7.5 x 10*5 U/ ml SMase was assessed by FACs analysis over a 4 day 
period. Overlapping histograms show levels of propidium iodide (PI, 10|ig/ ml, FL2) 
uptake which is proportional to cell mortality. Figures in brackets indicate the percent of 
cells showing positive FL2 above control. Data are paired with figure 5.8.
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CD69 upregulation underwent a similar delay due to SMase/ C2 ceramide whereby at day 
1, 55.2% of aCD3, CD80 costimulated T cells expressed CD69, an increase of almost 
ten fold compared to unstimulated T cells. While the intensity of expression was not 
affected SMase/ C2 ceramide showed 41.9 and 37.4% of the population to have 
upregulated CD69 expression. Four days later, more (42.5%) of the C2 ceramide treated 
cells expressed CD69 and slightly less (26%) of the SMase-treated T cells expressed 
CD69 than the costimulated T cells which had undergone a decrease in intensity and the 
number of cells (29.9) showing positive fluorescence relative to the levels observed on 
day 1.
Figure 5.10c shows the effect of SMase/ C2 ceramide on CD25 and CD69 surface 
expression under PMA+CD80 stimulation of resting T cells. When PMA was the 
primary proliferative stimulus both the intensity of expression and the number of cells 
expressing either CD25 or CD69 was more rapidly upregulated than where aCD3 mAb 
was the primary stimulus. Nearly all the cells under PMA stimulation (94.5%) showed 
positive staining for CD25 while only 33.6% of aCD 3 mAb stimulated T cells had 
increased expression. For CD69 expression on day 1, PMA induces over 90% of the 
cells to express CD69 while when aCD3 mAb was the primary proliferation stimulus, 
55.2% of the cells had upregulated expression. Finally while PMA induced a more rapid 
and profound increase in CD25 and CD69 expression, neither SMase nor C2 ceramide 
modulated PMA induced changes in expression. PMA appeared to be a more effective 
stimulus for T cell activation than aCD3 mAb and caused T cells to become insensitive to 
the effects of SMase on proliferation and SMase/ C2 ceramide on the expression of 
activation markers CD69 and CD25.
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Fig. 5.10a: Effect of SM ase/ C2 Ceram ide on CD25 Expression on a C D 3 , 
CD80 C ostim ulated T cells
Resting T cells were stimulated with aCD3, CD80 as a stimulus and CD25 surface 
expression was measured by FACS over a 4 day period post stimulation in the presence/ 
absence of 7.5xlO"^U/ ml SMase/ 30|iM ceramide. Changes in expression are 
represented by the histograms depicted and the percentage of cells showing positive 
expression is indicated in brackets. Control is the level of CD25 observed on 
unstimulated resting T cells. Data are paired with figure 5.8.
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Fig. 5.10b: Effect of SM ase/ C2 Ceram ide on CD69 Expression on a C D 3 , 
CD80 Costim ulated T cells
Resting T cells were stimulated with aCD3, CD80 as a stimulus and CD69 surface 
expression was measured by FACS over a 4 day period post stimulation in the presence/ 
absence of 7.5x10"^U/ ml SMase/ 30p,M ceramide. Changes in expression are 
represented by the histograms depicted and the percentage of cells showing positive 
expression is indicated in brackets. Control is the level of CD69 observed on 




i) CD25 Day 2
SM ase (92.5)
C eram ide (90.9) 
M edium  (94.5) 
C ontro l (5.27)
FL1 height
ii) CD69 Day 1
SM ase (89.1)
C eram ide (90.3)
M edium  (92.8) 
C ontro l (5.77)
F L l height
Fig. 5.10c: The Effect of SM ase/ C2 Ceram ide on CD25 and CD69 
Expression in PMA+CD80 Stim ulated Resting T cells
Resting T cells were stimulated with PMA, CD80 as a stimulus and CD25 and CD69 
surface expression was measured by FACS over a 4 day period post stimulation in the 
presence/ absence of 7.5x10"^U/ ml SMase/ 30pM C2 ceramide. Changes in expression 
are represented by the histograms depicted and the percentage of cells showing positive 
expression is indicated in brackets. Control is the level of CD25 or CD69 observed on 




The experiments conducted in this chapter attempted to analyze the costimulatory 
requirements of resting human T cells. It was found that resting human T cells could 
proliferate in response to a primary stimulus of aCD3 mAb or PMA and a costimulus of 
CD80 (fig. 5.2), but not to either primary stimulus or the costimulus alone. This is in 
agreement with the experiments of a number of other authors (Ward et al., 1995; Ueda et 
al., 1995; Hara et al., 1985; Krummel and Allison, 1996; Walunas et al., 1996; Damle et 
al., 1992; Sansom et al., 1993; Krummel and Allison, 1995) who found CD28 was 
necessary to costimulate T cell proliferation
The role of SMase and C2 ceramide in costimulation was also examined. Neither SMase
nor C2 ceramide could costimulate the proliferation of resting human T cells cultured with
aCD3 mAb (fig. 5.2), in contrast to their effect on splenic murine T cells (Boucher et al.,
1995; Chan and Ochi, 1995) where a two to five fold increase in proliferation was
observed beyond the level achieved by stimulating with aCD3 mAb or PMA alone. This
difference in response between murine and human T cells supports the data revealing
different biological responses from T cells originating from different species e.g. murine
T cells may become activated independent of PI3K (Truitt et al., 1995; Ni et al., 1996)
while human T cells have a requirement for PI3K to proliferate and become activated
(Ward et al., 1995; Ueda et al., 1995). In our study we observed that in addition to C2
ceramide not costimulating T cell proliferation, it reduced the viability of T cells not
receiving costimulation e.g. unstimulated resting T cells (fig. 5.3) and Jurkats (fig. 5.7b)
which both showed a dose responsive decrease in viability due to C2 ceramide.
Interestingly neither Jurkat or T cell blast viability nor proliferation were affected by
SMase (fig. 5.6). Thus T cell responses to SMase and C2 ceramide were not equal
where T cells were of an “activated” phenotype. Furthermore a differential sensitivity to
a SMase- rather than a C2 ceramide-induced inhibition of proliferation displayed by
costimulated T cells was dependent on the primary stimulus. While aC D 3, CD80
stimulated T cell proliferation was inhibited by SMase/ C2 ceramide equally (fig. 5.8a)
PMA, CD80 costimulated T cell proliferation was only transiently sensitive to inhibition
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by SMase whereas C2 ceramide-inhibited proliferation did not recover to the levels 
obtained with controls (fig. 5.8b).
Human T cells of, or approaching, an activated phenotype appear resistant to a SMase- 
induced inhibition of proliferation, yet sensitive to C2 ceramide. While T cell blast and 
Jurkat proliferation and viability were unaffected by SMase, Jurkat viability was 
markedly decreased by C2 ceramide. In addition the PMA, CD80 but not the aCD3, 
CD80 costimulated T cells were only transiently sensitive to a SMase-induced inhibition 
of proliferation. Accordingly when activation marker expression was analyzed, it was 
found that CD69 and CD25 expression were more rapidly increased where PMA rather 
than aCD3 mAb was the primary stimulus in a costimulation assay (fig. 5.10). Thus the 
phenotype of PMA, CD80 stimulated T cells resembled that of an activated cell and as 
such became less sensitive to SMase as was observed for T cell blasts and Jurkats. This 
would have the effect of limiting the exposure of PMA, CD80 stimulated T cells to 
second messengers such as C2 ceramide generated by extracellular enzymes such as 
SMase (Spence, 1993). Clearly activated T cells are sensitive to C2 ceramide-induced 
cell death as C2 ceramide was capable of killing Jurkats (fig. 5.7b) and therefore limiting 
the deleterious effect of agents such as SMase would be beneficial to cell viability. 
However costimulated T cell viability was not compromised by C2 ceramide, although 
proliferation was (fig. 5.9). Anti-apoptotic effects due to PMA against ceramide-induced 
(apoptotic) death or CD28-induced expression of the survival factor bcl-xL (Boise et al.,
1995) may provide the mechanism by which costimulated T cells survive death caused by 
SMase/ C2 ceramide.
The transient susceptibility of PMA, CD80 stimulated T cells and the resistance of T cells
of an activated phenotype e.g. Jurkats and blasts to reductions in proliferation due to
SMase may be a mechanism of enhancing cell survival when long term exposure to PMA
results in the down regulation of PKC activity (Zhang et al., 1990). When this occurs,
an anti-apoptotic effect of PKC would be lost over time (Haimovitz-Friedman et al.,
1994) and so the change in susceptibility to SMase may be necessary to maintain cell
viability. While PMA may antagonize ceramide mediated apoptosis, it was also apparent
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that the viability of PMA, CD80-stimulated T cell cultures was not reduced by C2 
ceramide. This would indicate that perhaps CD28 more than TCR derived signals 
regulate costimulated T cell survival.
Following the observation that a SMase/ C2 ceramide reduction in costimulated T cell 
proliferation was not simply due to cell death, an assessment of T cell activation state 
revealed that C2 ceramide and SMase delayed the upregulation of the early activation 
marker CD69 and the IL2R, CD25. This delay in the activation of T cells was dependent 
on aCD3 as a primary stimulus, rather than PMA, suggesting substrates for C2 ceramide 
exist upstream of PKC. One such target of C2 ceramide might be Ras, as dominant 
negative Ras ablated a ceramide-induced apoptotic response (Gulbins et al., 1995) 
showing that Ras and ceramide can functionally interact and blocking Ras activity leads to 
T cell inactivation (Williams, 1996) i.e. lack of IL2 secretion. As Ras interacts with 
molecules involved in cytoskeletal rearrangement such as Racl and Cdc42 (Qiu et al.,
1995), modulation of Ras or for example Racl or Cdc42 may provide a mechanism for 
C2 ceramide to inhibit CD69 and CD25 transport to the cell surface.
However as C2 ceramide inhibited costimulated T cell proliferation irrespective of the 
type of primary stimulus, an additional target for C2 ceramide down stream of PKC 
seems likely. One element involved in negative regulation of cell cycling is the 
retinoblastoma protein (RbP) which when dephosphorylated decreases c-Myc levels 
(Cooper and Whyte, 1989). Concordantly, C2 ceramide has also been demonstrated to 
limit c-Myc levels (Wolff et al., 1994), an effect prevented by okadaic acid (Wolff et al.,
1994). The ceramide activated protein phosphatase, CAPP, is also inhibited by okadaic 
acid (Dobrowsky and Hannun, 1992) and it may be that C2 ceramide activates CAPP 
causing the dephosphorylation of RbP thereby limiting cell cycling through decreasing c- 
Myc levels. Indeed C6 ceramide has been demonstrated to dephosphorylate RbP and 
induce cell cycle arrest (Dbaibo et al., 1995) and this may be the mechanism by which C2 
ceramide inhibits T cell proliferation.
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Despite the differences in response of resting T cells to SMase/ C2 ceramide in the 
presence of CD3 or PKC signals with respect to surface marker expression, there was 
little difference in the effect of C2 ceramide in its ability to reduce proliferation from either 
primary stimulus. Therefore while some activation events e.g. upregulation of CD25 
may be differentially sensitive to SMase/ C2 ceramide depending upon the primary 
stimulus delivered, the proliferative response of the T cells did not discriminate between 
C2 ceramide signals in the presence of CD3 or PKC derived pathways. This might 
suggest that the proximal signals may be more relevant to activation of T cells and signals 
distal to PKC control proliferation. Alternatively it may also imply that a target for C2 
ceramide regulating T cell proliferation is present in CD28 signal transduction pathways 
or in both distal TCR pathways and CD28 pathways. To further analyze what role C2 
ceramide and SMase may play in T cell signalling, the activation of JNK in resting T cells 




Role of Sphingomyelinase and C2 Ceramide 
in JNK Activation 
in T cells
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The c-Jun terminal kinase (JNK) family members can phosphorylate c-Jun, a component 
of a heterodimeric transcription factor, API, which is involved in activation of the IL2 
gene promoter (Granelli-Pipemo and Nolan, 1991). JNKs function to stimulate the 
transcriptional activation of c-Jun by phosphorylation of serine residues (Ser63 and 
Ser69) in the transactivation domain of c-Jun (Faris et al., 1996). c-Jun upregulates its 
own expression by interacting with the c-jun promoter (Faris et al., 1996). In addition 
JNKs also upregulate c-Fos expression by phosphorylation of the ternary complex factor 
p62TCF (Elk-1) which binds the c-fos promoter (Faris et al., 1996). T cells receiving 
proliferative and activation stimuli are capable of inducing API formation (Su et al., 
1994; Faris et al., 1996; Granelli-Pipemo and Nolan, 1991). The available evidence 
would indicate that JNK is involved in promoting, rather than inhibiting, T cell activation 
(Faris et al., 1996; Su et al., 1994; Granelli-Pipemo and Nolan, 1991) and that the 
generation of API is jointly dependent on signals derived from TCR and CD28 pathways 
(Su et al., 1994; Faris et al., 1996; Rincon and Flavell, 1994) to facilitate the 
translocation of c-Jun from cytoplasm to nucleus (Su et al., 1994; Minden et al., 1995). 
In contrast JNK may also be activated by ligation of TNFR1, a receptor delivering 
apoptotic signals to cells (Verheij et al., 1996). Therefore the role of JNK in cells is 
unclear.
Ceramide has also been shown to induce JNK activation (Verheij et al., 1996; Gulbins et 
al., 1995; Kyriakis et al., 1994). Due to the role of API in promoting IL2 transcription 
(Granelli-Pipemo and Nolan, 1991) and the activation of JNK by cellular stress (Verheij 
et al., 1996), JNK may be a sensitive and pivotal element in determining cellular 
behaviour. While SMase has been suggested to be an effector of CD28 costimulatory 
function in blasts and Jurkats (Boucher et al., 1995; Chan and Ochi, 1995) it was not 
costimulatory in resting T cells (Chapter 5, fig. 5.2a). Therefore a study was designed to 
examine whether a SMase or C2 ceramide derived modulation of JNK activity might 
provide an explanation of the mechanism by which SMase/ C2 ceramide could alter T cell 
responses.
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6.1 Induction of GST.c-Jun Expression
In order to measure JNK activity, a substrate for JNK was expressed in a bacteria (E. 
coli) using an IPTG-sensitive promoter to express a GST.c-Jun fusion construct. The c- 
Jun residues provided the substrate for JNK and the GST domain provided a mechanism 
to immobilise c-Jun by a GST interaction with glutathione agarose beads (GAB). 
Following growth of the cells with or without IPTG, the cells were harvested, lysed and 
proteins separated by SDS-PAGE were visualized by Coomassie staining. Figure 6.1 
demonstrated that the GST.c-Jun vector could be induced to upregulate expression of a 
protein of -36  kDa when the vector promoter was stimulated by IPTG corresponding to 
the predicted molecular weight of GST.c-Jun. Subsequently this protein was 
immobilized on GAB and so an immobilised substrate for the assessment of JNK activity 
was prepared.
6.2 Ability of C2 Ceramide to Activate JNK in Jurkats
In order to determine whether it was possible to detect JNK activation using the GST.c- 
Jun fusion protein, Jurkats were incubated for 20 mins with or without C2 ceramide or 
PMA/ ionomycin stimuli. Figure 6.2a illustrates the effect of PMA/ ionomycin or C2 
ceramide-stimulation of Jurkats on the phosphorylation of c-Jun. PMA/ ionomycin 
stimulated JNK activity, and this supports previous findings (Su et al., 1994), where 
PMA and the calcium ionophore, A23187 were used in the report mentioned. Figure 6.2 
also demonstrated that C2 ceramide, in a dose dependent manner, showed increasing 
stimulation of JNK activity independent of its vehicle. Protein loading controls (fig. 
6.2b) indicated equal loading between wells, except for the 'OLD' beads which had a 
lower titre of protein than the NEW beads. This would account for the lower level of c- 
Jun phosphorylation recorded in lanes 1+2 compared to 3+4 in figure 6.3a. It was 





Fig. 6.1: Ability of IPTG  to Induce G ST.c-Jun Expression
E.coli cells containing an IPTG-inducible GST.c-Jun PGEX expression construct were 
incubated with/ without 400|iM IPTG for 4 hours. Cell lysates were separated by SDS- 
PAGE and proteins were visualized by Coomassie staining. Arrow indicates a -36 kDa 
protein found to be upregulated under IPTG induction and corresponding to the predicted 
molecular weight of GST.c-Jun.
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Fig. 6.2: A ctivation of JN K  by PM A/ Ionomycin or Ceram ide
a) Jurkats (5xl06 cells/ lane) were analyzed for JNK activity under stimulation through 
medium (-); PMA(40ng/ ml) and ionomycin (lfiM) (+); vehicle (ethanol, V) or various 
concentrations of ceramide (10-50|iM). All lanes in the ceramide stimulations were 
equalized for ethanol content to be equivalent to 50|iM ceramide. b) Lanes as (a), 
Coomassie blue stained gel, control for protein loading.
161
6.3 Ability of Sphingomyelinase or C2 Ceramide to Modulate JNK 
Activity in Stimulated Human Resting T cells
In an attempt to account for the effects of SMase and C2 ceramide in limiting the 
proliferation of primary T cells, JNK activity in human resting T cells was assessed. 
Resting T cells were left unstimulated or stimulated with CD80 and/  or PMA or aCD3 
mAb. The effects of SMase, C2 ceramide or its vehicle, ethanol compared to medium on 
JNK activation were assessed for each of the treatments in a 20 mins stimulation at 37°C 
of resting T cells. Figure 6.3a+b illustrates the degree of c-Jun phosphorylation recorded 
(upper panels) and the levels of protein associated with each sample (lower panels). It 
may be seen that the greatest stimulation of JNK activity was attributable to PMA (fig. 
6.3b, upper panel, lane 1 to 8). Figure 6.3a (upper panel) shows that neither aCD3 mAb 
(lane 9) nor CD80 alone (lane 5) stimulated JNK activation beyond the level obtained in 
unstimulated T cells in medium (lane 1). Small variations in the level of c-Jun 
phosphorylation were apparent although these were paralleled by variation in protein 
loading (lower panel fig. 6.3a). Surprisingly in contrast to the effect of C2 ceramide in 
Jurkats, SMase/ C2 ceramide had little effect on modulating the level of JNK activation in 
each treatment relative to medium in resting T cells. A combination of CD80 and aCD3 
mAb stimulation lead to a greater activation of JNK, supporting the idea that either signal 
alone was an insufficient activation and / or proliferation stimulus (Thompson et al., 
1989; Damle et al., 1992), although the greater degree of JNK activation may be an 
artefact of protein loading. By far the strongest stimulus for JNK activation was PMA 
(fig. 6.3b) which seemed insensitive to modulation by other stimuli including CD80. At 
40ng/ ml the concentration of PMA may have been high enough to maximally activate 
JNK as in a previous report PMA at 10ng/ ml required additional stimuli such as aCD28 
mAb to activate JNK in Jurkats (Su et al., 1994). In conclusion there was no correlation 
between the effect of SMase/ C2 ceramide on modulation of JNK activity and their effect 
on inhibition of proliferation in costimulated T cells. Costimulation of T cells resulted in 
a possibly greater activation of JNK by aCD3, CD80 stimulation while PMA strongly 
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Fig. 6.3: E ffect o f S phingom yelinase  o r C2 C eram id e  on c -Jun
Phosphorylation in Resting T cells Stim ulated with CD80 and aC D 3/ PMA
Resting T cells (lxlO 7 cells/ lane) were incubated for 20 min at 37°C with a) medium 
(alone), fixed CD80+CHOs (3.3xl06 / lane, B7) or aCD3 mAb (1/100 dilution from 
ascites) or b) PMA (40ng/ ml), PMA-B7 , aCD3-B7 or non-transfected fixed CHOs 
(CHO). Each treatment (except CHO and B7 alone) was carried out in quadruplicate with 
one point of each being incubated with medium (M), 30pM ceramide (C2), 0.3% v/v 
ethanol (A) or 7.5 x 10‘5 U/ ml SMase (SM). b, last lane, fixed B7+CHOs alone were 
assessed for JNK activity. JNK activity, represented by the degree of c-Jun 
phosphorylation (see arrow heads), was measured following incubation of cell lysates 
with immobilized GST.c-Jun and IVK assay. Lower panels in a and b indicate controls 
for protein loading as measured by Coomassie Blue staining.
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6 .4  Discussion
An examination of the effects of SMase/ C2 ceramide on JNK activation in costimulated 
T cells was made. Following the preparation of a JNK substrate and successful 
establishment of an assay to measure JNK activation, it was found that although JNK 
could be activated by a combination of aCD3, CD80 signals (fig. 6.3), neither SMase 
nor C2 ceramide modulated the degree to which JNK was activated. This was surprising 
because in Jurkats, C2 ceramide, without additional stimuli, proved a strong stimulus for 
JNK activation (fig. 6.2). By contrast C2 ceramide altered the phosphorylation of c-Jun 
little in resting T cells under a variety of signals associated with proliferation and in 
unstimulated T cells, suggesting that either the effects of SMase/ C2 ceramide in T cells 
were negatively regulated relative to modulation in Jurkats or alternatively resting T cells 
lacked a signalling element (or critical titre thereof) present in Jurkats. Despite this 
possibility PMA was a strong stimulus for JNK activation in resting T cells (fig. 6.3b) in 
agreement with a PMA-induced activation of JNK in primary hepatocytes (Minden et al.,
1995) and PMA+ionomycin stimulated JNK activation in Jurkats (fig. 6.2) and (Su et 
al., 1994). One study demonstrated that suboptimal levels of PMA (10ng/ ml) synergize 
with aCD28 mAb in stimulation of JNK activity (Su et al., 1994) indicating that the 
strong stimulation observed in this chapter was likely due to a dose effect. Alternatively 
the difference in the level of JNK activity observed with PMA compared to aCD3 mAb 
may be due to negative regulatory elements upstream of PKC and downstream of CD3.
Some data have suggested that CD28 untilizes ASMase/ C2 ceramide as a costimulatory
signal (Boucher et al., 1995; Chan and Ochi, 1995) for T cell proliferation and NFkB
activation. If CD28 does transduce costimulatory signals through SMase then the
stimulation of CD28 and CD3 or SMase/ C2 ceramide and CD3 would be expected to
have a similar effect on JNK activation. No modulation of c-Jun phosphorylation due to
SMase/ C2 ceramide was observed in resting human T cells (fig. 6.3). In addition as
demonstrated in chapter 5, figure 5.2, SMase/ C2 ceramide did not replace CD28 as a
costimulus for T cell proliferation. These observations would lead to the suggestion that
SMase/ C2 ceramide modulate alternative substrates to inhibit T cell proliferation. In fact
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the JNK family member p38, independent of c-Jun phosphorylation, induced c-jun 
expression in response to UV-irradiation (Hazzalin et al., 1996). As SMase and C2 
ceramide have been implicated in stress responses e.g. facilitating apoptosis following 
ligation of TNFR (Higuchi et al., 1996) or in stress-induced apoptosis (Verheij et al.,
1996) it may be suggested that C2 ceramide preferentially activates the stress responsive 
JNK family member p38, while another member of the JNK family p54 JNK, may be a 
substrate for effectors of proliferative stimuli. For example p54 JNK activity correlated 
closely with c-Jun associated kinase activity in U937 cells (Kyriakis et al., 1994). It 
would be interesting to examine whether the response of p38 and p54 JNK isolated from 
resting T cells following stimulation by C2 ceramide revealed differences in activation.
A mechanism by which C2 ceramide may decrease proliferation through cell death, as in
the case of Jurkats (Chapter 5, figure 5.7) is by apoptosis. Although costimulated T cell
cultures did not show a reduction in viability due to SMase/ C2 ceramide, it is possible
that the assay was measuring the viability of C2 ceramide-insensitive 'survivors'.
Accordingly apoptosis through Fas- or TNFR-stimulation was paralleled by an increase
in SMase activity and Jurkats were sensitive to ceramide-induced apoptosis (Cifone et al.,
1993). This may occur through Ras as dominant negative mutant, N17 Ras, decreased
Fas or ceramide induced apoptosis, indicating a common apoptotic pathway is shared by
ceramide and Fas (Gulbins et al., 1995). Alternatively a study on TNFR1 identified
different effectors for three functions arising from TNFR ligation (Liu et al., 1996). The
Fas-associated protein with death-domain, FADD, was found to mediate apoptosis
independent of JNK activity (Liu et al., 1996). Similarly we observed that ceramide did
not stimulate JNK activation in resting T cells (fig. 6.3), but did decrease the proliferation
of costimulated T cells (chapter 5, fig. 5.2). A complex of the TNFR1 and the TNFR1-
associated death domain protein, TRADD, associated with two other transducers.
TNFR-associated protein 2, TRAF2, and receptor-interacting protein, RIP, were found
to mediate NFkB and JNK activation although the mechanism of JNK activation was not
known. Various dominant negative mutants elucidated that these three events could occur
independently of one another and expression of the NFkB component c-Rel, and to a
lesser extent RelA, had an anti-apoptotic effect (Liu et al., 1996). In agreement with this
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was the survival of costimulated T cells (chapter 5, fig. 5.4), unlike unstimulated (fig. 
5.3) or activated T cells (fig. 5.7), which were insensitive to ceramide-induced apoptosis 
possibly through an anti-apoptotic effect of CD28-induced NFkB nuclear translocation 
(Granelli-Pipemo and Nolan, 1991). Thus it could be hypothesised that receptors which 
functionally associate with SMase determine the final outcome of increased intracellular 
levels of ceramide or more specifically that CD28 possibly diverts C2 ceramide into 
inducing NFkB translocation, thus protecting the cell from apoptotic effects which C2 
ceramide may otherwise induce.
This study established an assay to assess JNK activation. JNK was found to be activated
beyond the levels observed in unstimulated T cells by either PMA alone or possibly under
costimulation by aCD 3, CD80. Surprisingly despite the modulation of activation
markers CD25 and CD69 demonstrated in the previous chapter (fig. 5.10), neither SMase
nor C2 ceramide limited or modulated JNK activity in resting T cells. Paradoxically C2
ceramide effected a far greater stimulation of JNK activity in Jurkats indicating stage
specific differences in the regulation of pathways between ceramide targets and JNK
activation. Therefore it may be suggested that a ceramide induced activation of JNK in
Jurkats partially accounts for its costimulatory capacity in activated T cells such as
demonstrated in murine splenocytes (Boucher et al., 1995; Chan and Ochi, 1995).
Accordingly data from other studies have indicated synergistic activation of JNK
following ligation of CD3 and CD28 in Jurkats (Su et al., 1994; Faris et al., 1996) and
furthermore only under multivalent crosslinking of CD28 was c-Jun expression
increased, while there was no evidence of synergy between CD3 and CD28 derived
signals in upregulating c-Jun expression in resting murine T cells (Chatta et al., 1994).
These data suggest that c-Jun phosphorylation and expression, contributing to API
formation, is more highly regulated in resting T cells than Jurkats. What is evident from
these studies is that it is not clear which factors determine the context of signals such as
those generated by SMase/ C2 ceramide in deciding cell fate. While some clues have been
provided e.g. from N17 Ras mutants in Fas signalling, and NFkB activation, it remains
to be determined at what stage, if at all, different ceramide-induced signalling pathways
relate to signals from receptors associated with anti-apoptotic, proliferative and gene
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activation effects. These may be at a proximal stage in signalling e.g. Ras or a distal stage 





An assessment of the role of the signal transduction elements p59fyn, p56lck, p70ZAP7° 
and sphingomyelinase which are putatively associated with CD28-mediated costimulation 
of resting T cell activation was made in this study. In order to analyze the individual 
contribution of each of the PTKs to CD28 signalling, cell models were prepared of CHO 
cells expressing CD28 and either fyn, lck or ZAP70. The responses of PTK transfectants 
to stimulation by CD80 , a natural ligand of CD28, were assessed. It was found that in 
CD28 immunoprecipitates of stimulated cells the PTKs caused little modulation of 
tyrosine phosphorylation in response to CD80. However analysis of overall 
phosphorylation revealed greater changes. Fyn and lck could increase the 
phosphorylation of molecules likely to be CD28 and possibly PI3K, whereas ZAP70 
could not, in response to a CD80-CD28 interaction. It may be concluded that CD28 
showed selectivity in activation of distinct families of PTKs and that the ligation of CD28 
by CD80 resulted in the activation of lck and fyn. Furthermore while the tyrosine 
phosphorylation of CD28 and associated molecules was apparently not influenced to a 
large extent by fyn or lck, tyrosine/ serine/ threonine phosphorylation was sensitive to, 
and increased by, the action of fyn and lck. In light of the marked increase in 
phosphorylation of CD28 immunoprecipitates by fyn and lck, it is probable that other 
kinases are recruited to CD28 through lck and fyn-mediated interactions if the small 
changes in tyrosine phosphorylation were not an artefact of the primary antibody used in 
Western blotting. The identity of such kinases are not known although they are unlikely 
to be either PI3K or PKC because inhibition of their activity by wortmannin and Ro-31 
respectively did not alter the phosphorylation of CD28 (Parry et al., 1997). Therefore it 
still remains an open question which kinase facilitates the profound alteration in 
phosphorylation of CD28. Further work on the role of fyn and lck in recruitment of, or 
interaction with, adapter molecules such as p62 (Nunes et al., 1996) and GRB2 
(Schneider et al., 1995a) shown to associate with CD28 following respectively CD80 or 
aCD28 mAb stimulation may be helpful.
Although fyn and lck delivered similar modulatory signals to CD28, they induced a
different level of phosphorylation of CD28 immunoprecipitates. As lck was expressed to
a lower level than fyn in transfectants relative to the level found in Jurkats, it would be
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possible to conclude that the lck-induced greater levels of phosphorylation of CD28 
immunoprecipitates, demonstrated lck to be more capable of transducing CD28- 
associated signals than fyn in CHO transfectants. This conclusion is supported by one 
study also showing that greater phosphorylation of CD28 was attributable to lck rather 
than fyn (Raab et al., 1995) and other data ascribing fyn a negative role in T cell function. 
For example in anergized T cells fyn associates with TCR£ and subsequent costimulation 
causes fyn dissociation and replacement by lck (Boussiotis et al., 1996). Support for a 
divergent function between fyn and lck may be deduced from data demonstrating fyn -ve 
cells to be resistant to Fas-induced death (Atkinson et al., 1996) while the lck -ve Jurkat 
line, JCam l, was not (Gonzalez-Garcia et al., 1997). Therefore fyn, not lck, transduces 
apoptotic signals from Fas while fyn is also capable of association with Fas (Atkinson et 
al., 1996). In conclusion the roles of fyn and lck appear to be different and this may be 
reflected in the preferential activation or recruitment of lck above fyn by CD28 which 
results in lck facilitating greater phosphorylation responses from CD28 following CD80 
stimulation which was observed in this study.
The role of SMase in CD28 signalling was also assessed. Initially it was noted that 
CD80-stimulated CD28 activated endogenous ASMase activity independently from T cell 
PTKs. Therefore the contribution ASMase might make to CD28 signalling could be 
different from that transduced by activation of lck or fyn. In agreement with the paradigm 
that resting T cells require two signals to proliferate and become activated, this study 
demonstrated that together aCD3 mAb and CD80 stimulation of resting T cells induced 
their proliferation while neither stimulus alone could induce proliferation. However 
despite the reported costimulatory ability of ASMase/ ceramide (Boucher et al., 1995; 
Chan and Ochi, 1995), we found resting T cell proliferation was not costimulated by 
SMase or either of the products of sphingomyelin hydrolysis i.e. C2 ceramide or 
phosphocholine. Therefore in resting human T cells, unlike splenic murine T cells, 
SMase/ C2 ceramide were not sufficient as a costimulatory stimulus.
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The effect of SMase, C2 ceramide and phosphocholine on costimulated T cell 
proliferation was analyzed in order to assess whether they modulate costimulation. It was 
observed that SMase/ C2 ceramide but not phosphocholine reduced costimulated resting T 
cell proliferation. This occurred without an apparent increase in cell death indicating that 
the reduction in proliferation was not simply due to a fatal perturbation of the plasma 
membrane due to the action of hydrolytic SMase on membrane localized sphingomyelin 
nor disruption of the membrane from the passage of C2 ceramide across the membrane. 
Therefore SMase/ C2 ceramide had the capability to inhibit costimulated T cell 
proliferation or alternatively to mediate the death of a susceptible proportion of the T cell 
population.
When the role of SMase in modulating 'activated' T cell proliferation was analyzed, 
surprisingly it was found to have no effect on the proliferation nor viability of T cell blasts 
and Jurkats. This would indicate that SMase has stage specific effects and only inhibits 
the response of resting T cells. In support of this conclusion is the transient sensitivity to 
SMase of resting T cells costimulated by PMA, CD80. Accordingly the rapid 
upregulation of the early activation marker CD69 and the later activation marker CD25 
when PMA was the primary proliferation stimulus indicated that PMA, CD80 
costimulation lead to those T cells gaining an activated phenotype. Therefore in a similar 
manner to Jurkats and T cell blasts, when PMA, CD80 costimulated resting T cells 
showed maximum expression of CD69, they became insensitive to SMase-derived 
inhibition of their proliferation.
Conversely the inhibition of Jurkat or costimulated resting T cells proliferation in the
presence of C2 ceramide was not transient. In fact C2 ceramide decreased Jurkat or
unstimulated resting T cell viability and in Jurkats the cell death caused by C2 ceramide
was proportional to the reduced proliferation levels. The lack of sensitivity to SMase of
activated T cells and the contrasting sensitivity to C2 ceramide by both activated and
resting T cells leads to the hypothesis that activated T cells become resistant to SMase to
limit the deleterious affects of C2 ceramide. In the case of Jurkats this is of particular
importance as unlike costimulated T cells, Jurkats die in the presence of C2 ceramide. A
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mechanism for activated T cells to become SMase-insensitive is not known, although it 
may be at the level of a change in membrane composition. It could be suggested that the 
survival of costimulated T cells, even of an activated phenotype i.e. PMA, CD80 
stimulated resting T cells, was due to the induction of survival factors such as bcl-XL by 
CD28 (Boise et al., 1995; Mueller et al., 1996) whereas Jurkats and unstimulated resting 
T cells die in response to C2 ceramide, possibly through apoptosis, due to a lack of 
survival factors.
In a comparison of the effect of either aCD3 mAb or PMA as a primary stimulus on the 
response of costimulated T cells to SMase/ C2 ceramide, a delay in upregulation of CD69 
and CD25 expression was only apparent where aCD3 mAb was the primary stimulus. 
This demonstrates that SMase/ C2 ceramide modulate not only the proliferative responses 
of T cells but also those associated with T cell activation. In addition the insensitivity of 
PMA stimulated T cells leads to the conclusion that elements between CD3 and PMA act 
as targets for C2 ceramide. A TCR stimulated Ras activation or rise in Ca2+i may 
represent targets of C2 ceramide. Indeed dominant negative Ras can inhibit ceramide- 
induced apoptosis (Gulbins et al., 1995) and CTLA4, which like C2 ceramide, inhibits 
CD25 and CD69 expression, as well as IL2 secretion (Krummel and Allison, 1996), 
shows increased surface expression due to raised Ca2+i levels (Linsley et al., 1996). If 
C2 ceramide were involved in either Ras-induced apoptosis or Ca2+i mobilization, it 
would provide a mechanism for C2 ceramide to limit T cell activation.
Despite the dependency of SMase on the primary stimulus to determine the longevity of
its effect on inhibition of costimulated proliferation, there was no difference in the
inhibition of proliferation where C2 ceramide was included in culture. PMA/ aCD 3
mAb- CD80 stimulated proliferation of resting T cells was inhibited equally by C2
ceramide. Therefore targets of C2 ceramide which facilitate the inhibition of proliferation
are distal to PKC in the costimulatory pathway and separate from the signalling element
which SMase/ C2 ceramide modulates in delaying activation marker upregulation. A
possible target for C2 ceramide which is involved in activation of the IL2 gene by
formation of a heterodimeric transcription factor, A PI, is c-Jun (Granelli-Pipemo and
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Nolan, 1991). When c-Jun phosphorylation was examined, it was found to be unaffected 
by SMase/ C2 ceramide although PMA or possibly aC D 3, CD80 could induce its 
phosphorylation. Thus c-Jun did not represent a target for the C2 ceramide-induced 
inhibition of proliferation and neither SMase/ C2 ceramide inhibit the activation of JNK. 
Thus alternative targets for SMase/ C2 ceramide, distal to PKC activation, exist which 
inhibit proliferation.
In conclusion despite intensive efforts extended by many laboratories there still remains, 
due a highly complex system of regulating T cell immune responses, many questions 
regarding the mechanism by which CD28 transduces its costimulatory signals. 
Determination of effector function in CD28 signalling is complicated by the existence of 
elements with apparent functional redundancy e.g. the ligands CD80 and CD86, the use 
of lck and fyn by CD28 and by effectors with altered function dependent on the activation 
state of a cell e.g. PI3K is not required for IL2 production in T cell blasts while it is in 
resting T cells (Ueda et al., 1995). These issues may be resolved by adopting a matrix 
approach to experiments to determine which of the possible interactions involved in 
CD28 costimulatory function occur. Rather than mitogenic stimulation, where little is 
known about the receptor-specificity of the mitogen, rigorous definition of the activation 
status of the cells and stimulation through carefully defined and specifically relevant 
receptors may, in the long term, be more informative.
7.1 Future Work
The data presented here provide a number of areas for further investigation. For example
lck rather than fyn may be a more significant effector in CD28 proximal signalling as this
study demonstrated a greater capability of lck, compared to fyn, to phosphorylate CD28
immunoprecipitates. Thin layer chromatography may be utilized to determine whether
fyn and lck differentially phosphorylate CD28 or its substrates, possibly facilitating
different outcomes following recruitment and activation of the two kinases to CD28.
Furthermore as CD28 cycles between the plasma membrane and lysosomes (Cefai et al.,
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1998), the latter may represent a signalling site for CD28. It would be interesting to 
determine whether fyn or lck are recruited to lysosomes and whether ligation of CD28 
induces preferential recruitment of one kinase more than another. This may be 
determined by Western blotting CD28 immunoprecipitates from cellular lysates and 
lysosomal fractions. Increasing amounts of data have linked CD28 signalling with 
association with adapter molecules eg p62 (Nunes et al., 1996), plOO Vav (Nunes et al.,
1994) and small G proteins Cdc42, Rac (Kaga et al., 1998a; Kaga et al., 1998b). These 
cellular effectors may provide a mechanism by which fyn and lck have putatively 
divergent function in CD28 signalling and IVK analysis of PTK immunoprecipitates from 
CD28 immunoprecipitates may be sensitive enough to reveal putative differences in 
utilization of very early signalling molecules following ligation of CD28. Both lysates 
and lysosomes might be analyzed for differences in Cdc42, Rac and p62 localization 
which would indicate the principle signalling location and whether there may be a 
possible interaction with ASMase.
The paradigm of CD28 signalling through PI3K has recently gained an unexpected twist 
in that much CD28 which is lysosomally targeted associates with PI3K (Cefai et al., 
1998). However PI3K has homology with a yeast protein involved in cytoskeletal 
rearrangements, TOR2 (Kunz et al., 1993) and therefore this may imply that PI3K 
functions partially as an effector involved in translocating CD28 to lysosomes. Therefore 
the role of PI3K in CD28 signalling may be two fold. The first function would be 
following activation, D3-phosphoinositol lipids from PI3K have been shown to activate 
distal signalling effectors eg PKB (Burgering and Coffer, 1995; Franke et al., 1995) and 
secondly PI3K may be involved in targeting CD28 to a putative signalling site i.e. 
lysosomes (Cefai et al., 1998).
C2 ceramide exerts different effects on T cell biology dependent on the species from
which the T cell is derived, the activation state of the T cell or additional stimuli the T cell
receives. On resting human T cells C2 ceramide appears to exert three effects. The first
which is apparent in T cells not receiving costimulation is death, which may be assessed
as apoptotic by analysing genomic DNA for laddering, a characteristic typical of
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apoptosis following DNA digestion in apoptotic cells. A second effect is an apparent 
inhibition of proliferation of costimulated T cells. This may be the result of death in a 
susceptible proportion of the T cell population whereby if this were the mechanism 
accounting for reduced proliferation in ceramide treated cells, the susceptible sets might 
be identified by FACS analysis of TCR V(3 regions for viability following costimulation 
in the presence or absence of ceramide. Alternatively C6 ceramide has been demonstrated 
to inhibit proliferation by dephosphorylating RbP (Dbaibo et al., 1995) and therefore 
immunoprecipitation of Rb from costimulated T cells following ceramide treatment may 
reveal RbP as a target for ceramide. The third effect of ceramide was to delay the 
activation of T cells costimulated by aCD3, CD80, but not by PMA, CD80 implying that 
ceramide sensitive targets exist between the TCR and PKC. Accordingly there have been 
reports of functional associations between Ras and ceramide resulting in apoptosis 
(Gulbins et al., 1995); PI3K and ceramide share some substrates eg PKC£ (Pushkareva 
et al., 1995; Nakanishi et al., 1993) and Ras and PI3K may activate each other (Qiu et 
al., 1995; Rodriguez-Viciana et al., 1994). Therefore there is a possibility that each of 
these three signalling effectors impinge upon each others functions in T cells, although 
how is unclear. Perhaps the small G proteins Cdc42 and Rac are involved in transducing 
signals between them. An anti-apoptotic function for CD28 might be dependent upon its 
translocation to lysosomes. Interaction with ASMase, following association with PI3K 
(Cefai et al., 1998), may divert ceramide into anti-apoptotic pathways eg in the generation 
of NFkB elements cRel and RelA which prevent TNFR-induced apoptosis (Liu et al.,
1996). Accordingly in the absence of CD28 ligation, ceramide might be utilized by Ras, 
driving apoptosis. Support for this hypothesis may be provided by testing the viability 
of C2 ceramide treated costimulated T cells in the presence of absence of wortmannin to 
assess whether the inhibition of PI3K activation prevents CD28 lysosomal translocation 
and therefore a functional association with ASMase, thereby possibly preventing a 
CD28-modulated use of ceramide. It might then be expected that ceramide would be 
available for use in a Ras-derived apoptotic pathway.
The action of ceramide on costimulated T cells has some similarity with that of CTLA4 in
that both negatively regulate T cell activation and proliferation (Krummel and Allison,
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1996). It may be possible that they share common effectors and/  or regulate the function 
of each other. These possibilities may be examined by using FACS analysis of CTLA4 
expression following ceramide treatment of costimulated T cells. Additionally incubating 
CD3 stimulated T cells in exogenous ASMase +/ - chloroquine may indicate whether 
ASMase increases CTLA4 expression. It is also possible that CTLA4 utilizes ASMase in 
its signal transduction pathways and antibody ligation of CTLA4 in costimulated T cells 
in the presence or absence of chloroquine may reveal an involvement of ASMase in 
CTLA4 signalling. Another contender which may facilitate cross-talk between CD28 and 
CTLA4 is itk which has been associated with negative regulation of costimulated T cell 
proliferation (Liao et al., 1997). It is possible to speculate that itk may associate with 
ASMase/ ceramide in T cell signalling either to activate ASMase or to become activated by 
ASMase. In either case it would be interesting to perform in vitro kinase assays against 
immunoprecipitated itk from cell lysates and lysosomes to determine whether in 
costimulated T cell cultures ceramide had a stimulatory effect on itk activity. Secondly it 
may be interesting to determine whether itk associates with CTLA4 possibly giving 
CTLA4 the initial impetus to transduce negative regulation of T cell proliferation and 
activation. A possible role for itk in CTLA4 signalling may be to activate a PTPase 
resulting in the dephosphorylation of Y 165 and so increasing the surface expression of 
CTLA4 (Shiratori et al., 1997). Alternatively itk might phosphorylate Y165, allowing 
the association of the PTPase Syp with CTLA4. As Syp has activity against SHC 
(Marengere et al., 1996), this would prevent SHC complexing with GRB2 and Sos 
thereby inhibiting Ras signalling.
There still remains a large area of CD28 signalling which has not yet been investigated 
and future studies may determine the relationship between CD28 and CTLA4, and 
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R epresentation of Plasm ids Used to T ransfect CD28+CHO Cells
a) fyn expression vector; b) lck expression vector c) ZAP expression vector.
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Appendix 2 Buffers
1) HBS for Transfection
20mM HEPES The solution was brought to pH 7.05 with HC1
137mM NaCl and filtered sterilized
5mM KC1
0.7mM Na2 HP0 4
6.0mM D-Glucose
20mM Tris.HCl pH 7.5 
150mM NaCl
h 2o
(TBS) 3)Phosphate Buffered Saline(PBS)
2.42g NaCl 8 g
17.52g KC1 0 .2 g
to 1L NaH 2P 0 4 0 .2 g
Na2H P 0 4 1.15g
H20 to 1L
4) CD28 IVK Reaction Buffer
lOOmM NaCl 1ml of 5M stock
25mM Hepes pH7.5 1.25mls of 1M stock
5mM MnCl2  250jil of 1M stock
lOmM MgCl2 500|il of 1M stock
100|iM Na3VC>4 10|xl of 0.5M stock
lOpM MgATP 5 pi  of lOOmM stock
H20  to 50mls
5) JNK Reaction Buffer




1.25mls of 1M stock 
107mg
25[il of lOOmM stock 
to 50mls
6) Coomassie Stain
0.25%w/v Coomassie Brilliant Blue R
45% v/v Methanol
10% v/v Glacial Acetic Acid
H20





Appendix 3 Cell Culture Media
1) RIO for Resting T cells
1 x R P M I1640 
10 % FCS
100 U/ ml Penicillin 
0.1 mg/ ml Streptomycin
2 mM Glutamine
500 mis (Life Technologies Cat. No 31870-025)
50 mis (Life Tech. Cat. No 10108-074)
5 mis of 10000 U/ ml
5 mis of 10 mg/ ml stock(Life Tech. Cat. No 15140-114) 
5 mis of 200 mM stock (Life Tech. Cat. No 25030-024)
2) R10 for Jurkat cells
1 x RPMI 1640 
10 % FCS
100 U/ ml Penicillin 
0.1 mg/ ml Streptomycin
2 mM Glutamine
0.2 % Sodium bicarbonate 
0.015 N Sodium hydroxide 
MilliQ H20
50 mis of lOx stock (Life Tech. Cat. No 22511-026) 
50 mis
5 mis of 10000 U/ ml 
5 mis of 10 mg/ ml stock 
5 mis of 200 mM stock
15 mis of 7.5 % stock (Life Tech. Cat No 25080-060) 
0.8 mis of 10 N stock 
400 mis
3) Glutamine Free Media for CHO Transfectants
lxDMEM 
10% FCS
100 U/ml Penicillin 
0.1 mg/ ml Streptomycin 
0.4 % Sodium bicarbonate 
1 mM Sodium pyruvate 
lx  Nucleosides 
MilliQ H20
50 mis of lOx stock (Life Tech. Cat. No 12501-029)
50 mis
5 mis of 10000U /m l 
5 mis of 10 mg/ ml 
28 mis of 7.5 % stock
5 mis of 100 mM stock (Life Tech. Cat. No 11360-039) 
5 mis Of lOOx stock (see below)
400 mis
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Appendix 3 Cell Culture Media continued
4) XMAT for PTK Transfected CHO Cells
lxDM EM  
10% FCS
100 U/ml Penicillin 
0.1 mg/ ml Streptomycin 
0.4 % Sodium bicarbonate 
1 mM Sodium pyruvate 
lx  Nucleosides 
lx  XMAT 
MilliQ H20
50 mis of lOx stock (Life Tech. Cat. No 12501-029) 
50 mis
5 mis of 10000 U/ ml 
5 mis of 1 0 mg/ ml 
28 mis of 7.5% stock
5mls of lOOmM stock (Life Tech. Cat. No 11360-039) 




These were dissolved in a combined volume of lOOmls Milli-Q H20 and filter sterilized.
For CHO and CD28+CHOs For PTK+Transfectants








lOOx Mycophenolic acid 
lOOx Hypoxanthine 
lOOx Thymidine
1250 mg in 20 mis 1M NaOH + 80 mis H20 
150 mg in 10 mis 1M NaOH + 90 mis H20 
150 mg in 10 mis 1M NaOH + 90 mis H20 
lOOmg in 100 mis H20
All components were stored separately and 5mls of mycophenolic acid, hypoxanthine and 
thymidine and 10 mis of xanthine were added to XMAT media.
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Appendix 4 Buffer Solutions
1) lOx Tris Acetate EDTA (TAE) pH 8.0 
0.4M Tris base 48.44g
0.05M NaAc 4.1g
0.01M EDTA 3.72g
H20  to 1L
2) lx  SDS Gel Running Buffer pH8.3
25mM Tris base 3.03g
192mM Glycine 14.42g
0.1% w/v SDS l g  t
H20  to 1L
3) lx  Lysis Buffer
50mM Tris.HCl, pH 7.5
150mM NaCl










20pg/ml Soybean trypsin inhibitor
H20
0.5 mis of 1M 
0.3 mis of 5M 
1 ml of 10% v/v NP-40 
1 ml of 1 0 0 %
100 jllI o f  0.5M pH8
100 pi ofO .lM
100 pi ofO .lM
200 pi of 0.5M
1 0  pi of 80mg/ml (in ethanol)
10 pi of 1.4mg/ml (in methanol) 
1 0  pi of 2 0 mg/ml 
1 0  pi of 2 0 mg/ml 
1 0  pi of 2 0 mg/ml 
to lOmls
4) 2x Loading Buffer
Glycerol 1 ml
10% w/v SDS 3 mis
0.5M Tris.HCl, pH 6 . 8  5 mis
0.5% w/v Bromophenol Blue 1 ml





lxT A E 150mls
0.005% w/v Ethidium bromide 7.5 (xl
2) 4% SDS-PAGE Stacking Ge!
0.125M Tris.HCl 2.5mls of 0.5M stock pH 6 . 6
4% Acrylamide 1.33mls of 30% 37.5: 1 acrylamide: bis stock
0.1% w/v SDS 0.1 mis of 10% w/v stock
0.15% w/v Ammonium persulphate 0 .15mls of 10% w/v stock
0.003% v/v TEMED 30pl
H2 O to lOmls
3) 12% SDS-PAGE Resolving Gel
0.375M Tris.HCl 5mls of 1.5M stock pH 8 . 8
12% Acylamide 8 mls of 30% 37.5: 1 acrylamide: bis stock
0.1% w/v SDS 0.2mls of 10% w/v stock
0.05% w/v Ammonium persulphate 0. lmls of 10% w/v stock
0.0005% v/v TEMED lOfXl
H2O to 2 0 mls
Note: For SDS-PAGE, 1mm thick gels were prepared with a stacking gel of 1cm depth 
and samples were separated at a constant current of 10mA/ gel and through the resolving 
gel at 20mA/ gel.
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Ampicillin may be added at 50(Xg/ ml following autoclaving if required once the mixture 






h 2o to 1L
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